<!DOCTYPE html>
<html lang="en">
<head>
<title>Concordances</title>
<style></style>
</head>
<body style="font-size: 16px; font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol'; padding: 4rem 2rem; direction: ltr"><h1>Term concordances</h1>
<br/><br/>
<h2 style='margin:0' id='T75'>Term ID: <a href='terminology.html#L75' target='_blank'>75</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>as only weakly stimulated by phorbol ester or TNF-alpha, multimers of the PRDII </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td>-binding domain were inducible by both agents. TNF-alpha was able to increase ex</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>id not induce the HIV LTR above a constitutive level of activity. This level of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td>-independent activity appears to be sufficient for virus multiplication, since T</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91321794' target='_blank'>91321794</a></td>
        <td style='text-align:right'>nvestigated the effects of cysteine and related thiols on HIV-1 replication and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> expression. The experiments in this report show that cysteine or N-acetylcystei</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91321794' target='_blank'>91321794</a></td>
        <td style='text-align:right'>and chloramphenicol acetyl-transferase ( CAT ) gene expression under control of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> binding sites in uninfected cells. This suggests that the cysteine deficiency i</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91321794' target='_blank'>91321794</a></td>
        <td style='text-align:right'>steine deficiency in HIV-1-infected individuals may cause an over-expression of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td>-dependent genes and enhance HIV-1 replication. NAC may be considered for the tr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>deficiency virus type 1 expression in monocytes: role of the 65-kDa plus 50-kDa </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> dimer. Although monocytic cells can provide a reservoir for viral production in</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>arkedly less viral RNA production. This absence of binding was localized to the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> region of the HIV-1 enhancer; the 65-kDa plus 50-kDa NF-kappa B heterodimer was</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>ocalized to the NF-kappa B region of the HIV-1 enhancer; the 65-kDa plus 50-kDa </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> heterodimer was preferentially lost. Adding purified NF-kappa B protein to nucl</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>ride increased viral production and NF-kappa B activity. Antiserum specific for </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> binding proteins, but not c-rel-specific antiserum, disrupted heterodimer compl</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>t c-rel-specific antiserum, disrupted heterodimer complex formation. Thus, both </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td>-binding complexes are needed for optimal viral transcription. Binding of the 65</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92135145' target='_blank'>92135145</a></td>
        <td style='text-align:right'>F-kappa B ( consisting of subunits p50 an dp65 ) and the DNA-binding subunit of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> ( p50 ) by itself, also called KBF1, are constitutively expressed and localized</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92135145' target='_blank'>92135145</a></td>
        <td style='text-align:right'>ids between IARC 301.5 and a murine myeloma. Most hybrids express both KBF1 and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> in their nuclei, but one hybrid expresses only KBF1. The kappa B enhancer of th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92135145' target='_blank'>92135145</a></td>
        <td style='text-align:right'>nal only in the hybrids expressing nuclear NF-kappa B. These findings show that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear NF-kappa B</mark>
        </td>
        <td> is necessary to activate the kappa B enhancer, while KBF1 by itself is not suff</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92135145' target='_blank'>92135145</a></td>
        <td style='text-align:right'>by itself is not sufficient. We propose that KBF1 is a competitive inhibitor of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> and discuss how these factors may be involved in the transient expression of IL</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93024468' target='_blank'>93024468</a></td>
        <td style='text-align:right'>e-specific transcription factor binding to the simian virus 40 enhancer TC-II ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> ) element. We have biochemically and functionally characterized a new transcrip</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93024468' target='_blank'>93024468</a></td>
        <td style='text-align:right'>matopoietic cells. This factor has a DNA-binding specificity similar to that of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> but is unrelated to this or other Rel proteins by functional and biochemical cr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>or by a phorbol ester to induce interleukin 2 production. Pervanadate activated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td>, as shown by an increase in DNA-binding activity of this transcription factor. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>posure of monocytic cells to bacterial lipopolysaccharide ( LPS ) activates the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> / Rel family of proteins and leads to the rapid induction of inflammatory gene </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>5 dimers but instead comigrated with c-Rel / p65 dimers. Antibodies against the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> and Rel proteins and UV cross-linking studies revealed the presence of c-Rel an</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95000924' target='_blank'>95000924</a></td>
        <td style='text-align:right'>cated LTRs confirmed that inhibition of LTR activation was not mediated through </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td>-binding activity but through the region containing the negative responding elem</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>Aspirin inhibits </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor-kappa B</mark>
        </td>
        <td> mobilization and monocyte adhesion in stimulated human endothelial cells. BACKG</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>s mediated by mobilization of the transcription factor nuclear factor-kappa B ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> ) . Since salicylates have been reported to inhibit NF-kappa B activation by pr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>SULTS: Gel-shift analyses demonstrated dose-dependent inhibition of TNF-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> mobilization by aspirin at concentrations ranging from 1 to 10 mmol / L. Induct</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>domethacin was ineffective. CONCLUSIONS: Our data suggest that aspirin inhibits </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> mobilization, induction of VCAM-1 and E-selectin, and subsequent monocyte adhes</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>iption factor, to activation of a reporter gene driven by a promoter containing </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> sites, and to increased levels of mRNAs for immediate-early genes, including th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>ssion in endothelial cells, even though the E-selectin promoter is activated by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> rather than NFAT. Hence, induction of cell surface expression of this leukocyte</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96074632' target='_blank'>96074632</a></td>
        <td style='text-align:right'>D3 [1,25 ( OH ) 2 ) D3], a steroid hormone with immunomodulating properties, on </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor kappa B</mark>
        </td>
        <td> ( NF-kappa B ) proteins was examined in in vitro activated normal human lymphoc</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96074632' target='_blank'>96074632</a></td>
        <td style='text-align:right'>a steroid hormone with immunomodulating properties, on nuclear factor kappa B ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> ) proteins was examined in in vitro activated normal human lymphocytes by Weste</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96074632' target='_blank'>96074632</a></td>
        <td style='text-align:right'> blot analysis. Over a 72-hr period of activation, the expression of the 50-kDa </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td>, p50, and its precursor, p105, was increased progressively. When cells were act</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96074632' target='_blank'>96074632</a></td>
        <td style='text-align:right'> transiently transfected with a construct containing four tandem repeats of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> binding sequence of the immunoglobulin kappa light chain gene linked to the chl</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96074632' target='_blank'>96074632</a></td>
        <td style='text-align:right'>ene. These observations demonstrate directly that there is de novo synthesis of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> during human lymphocyte activation and suggest that this process is hormonally </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>e cells as determined by electrophoretic mobility shift assay using a consensus </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> oligonucleotide. An additional significant finding was than TNF mRNA induced in</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'> that were composed of c-Fos / c-Jun AP-1. The resting and stimulated levels of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF kappa B</mark>
        </td>
        <td> were reduced in T cells from certain elderly individuals; however, alterations </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'>re reduced in T cells from certain elderly individuals; however, alterations of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF kappa B</mark>
        </td>
        <td> did not correlate with changes in IL-2 expression. Thus, these results show tha</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>nd inducible expression of the IL-9 gene in C5MJ2 cells. Within this region, an </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> site at -59 to -50 and its adjacent 20-base pair upstream sequence were demonst</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>role for the IL-9 promoter activity. DNA-protein binding studies indicated that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td>, c-Jun, and potentially novel proteins ( around 35 kDa ) can bind to this impor</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96303658' target='_blank'>96303658</a></td>
        <td style='text-align:right'>ene transcription and translation in leukocytes. Transcription factors, such as </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF kappa B</mark>
        </td>
        <td> and AP-1, are activated upon stimulation of the cells with several chemoattract</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'> terminal repeat ( HIV-1 LTR ) , a promoter largely dependent on the binding of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor kappa B</mark>
        </td>
        <td> ( NF- kappa B ) . In contrast, the cAMP-dependent protein kinase specific inhib</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'>LTR ) , a promoter largely dependent on the binding of nuclear factor kappa B ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF- kappa B</mark>
        </td>
        <td> ) . In contrast, the cAMP-dependent protein kinase specific inhibitor H-89 tota</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'>on. Electrophoretic mobility shift assay ( EMSA ) and supershift assay using an </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> binding sequence from the kappa light chain as a probe, revealed that both p65 </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'> were present in CD40-stimulated B cells. While PKC depletion did not alter the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> level, treatment of B lymphocytes with H-89 or herbimycin A provoked a decrease</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'>treatment of B lymphocytes with H-89 or herbimycin A provoked a decrease in the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> level. These observations establish the importance of different signal transduc</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97162234' target='_blank'>97162234</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Nuclear factor-kappa B</mark>
        </td>
        <td> activation in human monocytes stimulated with lipopolysaccharide is inhibited b</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97162234' target='_blank'>97162234</a></td>
        <td style='text-align:right'>accharide is inhibited by fibroblast conditioned medium and exogenous PGE2. The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor kappa B</mark>
        </td>
        <td> ( NF-kappa B ) is thought to be crucially involved in the gene activation of se</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97162234' target='_blank'>97162234</a></td>
        <td style='text-align:right'> fibroblast conditioned medium and exogenous PGE2. The nuclear factor kappa B ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> ) is thought to be crucially involved in the gene activation of several cytokin</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97162234' target='_blank'>97162234</a></td>
        <td style='text-align:right'>-kappa B activation in PBM. Furthermore, we show that exogenous PGE2 mimics the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> inhibitory effect of FCM. On the other hand, FCM produced in the presence of in</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97211823' target='_blank'>97211823</a></td>
        <td style='text-align:right'>c-Rel protein complexes are differentially distributed within human thymocytes. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Nuclear factor-kappa B</mark>
        </td>
        <td> ( NF-kappa B ) /Rel proteins are inducible transcriptional regulators of numero</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97211823' target='_blank'>97211823</a></td>
        <td style='text-align:right'>re differentially distributed within human thymocytes. Nuclear factor-kappa B ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> ) /Rel proteins are inducible transcriptional regulators of numerous cellular g</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97211823' target='_blank'>97211823</a></td>
        <td style='text-align:right'>rescent staining of thymus sections using specific Abs allowed visualization of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear NF-kappa B</mark>
        </td>
        <td> proteins in both thymocytes and nonthymocyte cells. This detection suggested a </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97211823' target='_blank'>97211823</a></td>
        <td style='text-align:right'>d c-Rel complexes play distinct roles in gene expression and that both forms of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> play critical roles during late stages of the intrathymic maturation of T cells</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97307577' target='_blank'>97307577</a></td>
        <td style='text-align:right'>verexpression of Ikappa B alpha. A role in thymic maturation for factors of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> family has long been suspected, but not yet proven. Transgenic mice with a lymp</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97307577' target='_blank'>97307577</a></td>
        <td style='text-align:right'>re severely affected. These data provide direct evidence for the involvement of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> / Rel family proteins in late stages of T lymphocyte development, coincident wi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>up-regulating the activity of several transcription factors, including AP-1 and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor-kappa B</mark>
        </td>
        <td> ( NF-kappa B ) /Rel family members as well as an uncharacterized transcription </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>y of several transcription factors, including AP-1 and nuclear factor-kappa B ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> ) /Rel family members as well as an uncharacterized transcription factor called</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>CD28 response complex. While several lines of investigation have suggested that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> / Rel family members make up the CD28 response complex transcription factor, ot</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>se complexes is specific for both the CD28RE and the adjacent AP-1 site. Of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> / Rel family members tested, this CD28RE / AP-1-specific complex contains predo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>ption factor in the regulation of gene expression in the inflammatory response, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> inhibitors have been suggested as potential therapeutic drugs for inflammatory </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>experiments at the IL-2 promoter level, and involved not only the inhibition of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td>-driven reporter activation but also that of nuclear factor of activated T cells</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>bility shift assays ( EMSAs ) indicated that pyrrolidine DTC ( PDTC ) prevented </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td>, and NFAT DNA-binding activity in T cells stimulated with either phorbol myrist</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98012705' target='_blank'>98012705</a></td>
        <td style='text-align:right'>Dysregulation of monocytic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor-kappa B</mark>
        </td>
        <td> by oxidized low-density lipoprotein. Nuclear factor-kappa B ( NF-kappa B ) /Rel</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98012705' target='_blank'>98012705</a></td>
        <td style='text-align:right'>lation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Nuclear factor-kappa B</mark>
        </td>
        <td> ( NF-kappa B ) /Rel transcription factors may be involved in atherosclerosis, a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98012705' target='_blank'>98012705</a></td>
        <td style='text-align:right'>ar factor-kappa B by oxidized low-density lipoprotein. Nuclear factor-kappa B ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> ) /Rel transcription factors may be involved in atherosclerosis, as is suggeste</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98012705' target='_blank'>98012705</a></td>
        <td style='text-align:right'>ay be involved in atherosclerosis, as is suggested by the presence of activated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> in human atherosclerotic lesions. The aim of the present study was to investiga</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98012705' target='_blank'>98012705</a></td>
        <td style='text-align:right'>e present study was to investigate the effects of oxidized LDL ( oxLDL ) on the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> system in human THP-1 monocytic cells as well as adherent monocytes. Our result</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98012705' target='_blank'>98012705</a></td>
        <td style='text-align:right'> short-term incubation of these cells with oxLDL activated p50 / p65 containing </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> dimers and induced the expression of the target gene IL-8. This activation of N</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98012705' target='_blank'>98012705</a></td>
        <td style='text-align:right'>is a potent modulator of gene expression and suggest that ( dys ) regulation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> / Rel is likely to play an important role in atherogenesis. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98090689' target='_blank'>98090689</a></td>
        <td style='text-align:right'>Constitutive expression c-fos, c-jun, and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF kappa B</mark>
        </td>
        <td> mRNA is in nucleated fetal blood cells and up-regulation of c-fos and c-jun wit</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98090689' target='_blank'>98090689</a></td>
        <td style='text-align:right'> three transcription factors implicated in T-cell activation: c-jun, c-fos, and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF kappa B</mark>
        </td>
        <td> ( p50 subunit ) . We demonstrate that mRNAs for all three of these regulatory f</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> / Rel family members regulating the ICAM-1 promoter in monocytic THP-1 cells. A</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104462' target='_blank'>98104462</a></td>
        <td style='text-align:right'> 3' cytosins are required in the DNA binding motif for detection of upregulated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> p50 homodimers. When monocytes are stimulated with LPS ( lipopolysaccharide ) r</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104462' target='_blank'>98104462</a></td>
        <td style='text-align:right'>lls still express the CD14 receptor and they can still be activated to mobilize </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> into nucleus. Analysis of the binding proteins employing the -605 motif of the </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99118181' target='_blank'>99118181</a></td>
        <td style='text-align:right'> and in vivo: role of 26S proteasome. It is becoming increasingly apparent that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> plays a critical role in regulating the inflammatory response. Data obtained fr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99118181' target='_blank'>99118181</a></td>
        <td style='text-align:right'>e inhibitors should prove useful in delineating the roles of the proteasome and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> in other pathophysiological conditions such as cancer and heart disease. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99172186' target='_blank'>99172186</a></td>
        <td style='text-align:right'>ts primary human T cell responses at the dendritic cell level: association with </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> inhibition. N-acetyl-L-cysteine ( NAC ) is an antioxidant molecule endowed with</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99201482' target='_blank'>99201482</a></td>
        <td style='text-align:right'>volved and, in a broader sense, in pathological situations in which genes under </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor-kappa B</mark>
        </td>
        <td> control are up-regulated. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99207658' target='_blank'>99207658</a></td>
        <td style='text-align:right'>o interact with transcriptional factors such as AP-1 ( activator protein-1 ) of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> ( nuclear factor-kappa B ) . Through these actions glucocorticosteroids are sus</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99207658' target='_blank'>99207658</a></td>
        <td style='text-align:right'>th transcriptional factors such as AP-1 ( activator protein-1 ) of NF-kappa B ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor-kappa B</mark>
        </td>
        <td> ) . Through these actions glucocorticosteroids are susceptible to modify functi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>transduction in human monocytes leads to activation of nuclear factor-kappa B ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> ) and TNF-alpha release. Previous studies have implicated activation of both pr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99356019' target='_blank'>99356019</a></td>
        <td style='text-align:right'>pecific mRNA were inhibited by antioxidants. These data suggest a ROI-dependent </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> mediated transcription of inflammatory cytokines in bronchial epithelial cells.</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'> proteins IKK-alpha, IKK-beta, NF-kappa B-inducing kinase ( NIK ) , IKK-gamma ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> essential modulator ) , and IKK complex-associated protein. Kinase assays showe</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>K complex-associated protein inhibited stimulus-mediated transcription, whereas </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9EFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B</mark>
        </td>
        <td> essential modulator enhanced it. The understanding of LPS- and TNF-induced sign</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T232'>Term ID: <a href='terminology.html#L232' target='_blank'>232</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'> by the alpha globin regulatory element ( HS-40 ) : functional role of specific </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9ABFAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor</mark>
        </td>
        <td>-DNA complexes. We studied the functional interaction between human embryonic ze</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>l core of HS-40, as mapped by transient expression analysis, appeared to bind a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9ABFAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor</mark>
        </td>
        <td> ( s ) in living K562 cells but not in nonerythroid cells. On the other hand, on</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>ts from adult human bone marrow exhibited a similar but nonidentical pattern of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9ABFAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor</mark>
        </td>
        <td> binding in vivo at the HS-40 region. These data suggest that transcriptional ac</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>n genes is mediated by erythroid cell-specific and developmental stage-specific </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9ABFAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor</mark>
        </td>
        <td>-DNA complexes which form at the enhancer ( HS-40 ) and the globin promoters. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>in endothelial cells by cyclosporin A and the T-cell transcription factor NFAT. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9ABFAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Nuclear factor</mark>
        </td>
        <td> of activated T cells ( NFAT ) was originally described as a T-cell-specific tra</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'> IL-4 P element sites specifically bound the transcriptional activator protein, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9ABFAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor</mark>
        </td>
        <td>-activated T cells, preformed ( NF-ATp ) , when incubated with nuclear protein e</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'>anscriptional factors AP-1 and NF-AT. Although transcriptional factors AP-1 and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9ABFAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor</mark>
        </td>
        <td> of activated T cells ( NF-AT ) are important for the normal induction of IL-2, </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97263762' target='_blank'>97263762</a></td>
        <td style='text-align:right'>ablation / supershift assays revealed that it is similar to a recently reported </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9ABFAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor</mark>
        </td>
        <td> designated SAF. These results demonstrated that LPS-mediated SAA gene induction</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'> optimal transcription of the mouse IL-4 gene: involvement of a distinct set of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9ABFAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor</mark>
        </td>
        <td> of activated T cells and activator protein-1 family proteins. We previously ide</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'>body supershift assays in EMSA, complexes formed with P or P2 proved to contain </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9ABFAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor</mark>
        </td>
        <td> of activated T cells ( NFAT ) family proteins as major components. Activator pr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97458245' target='_blank'>97458245</a></td>
        <td style='text-align:right'>ing member of the tumor necrosis factor receptor superfamily. Activation of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9ABFAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor</mark>
        </td>
        <td> of activated T cells transcription factor ( NF-AT ) is a key event underlying l</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97468093' target='_blank'>97468093</a></td>
        <td style='text-align:right'>moters, defined Interferon Stimulated Response Element ( ISRE ) , which binds a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9ABFAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor</mark>
        </td>
        <td> ( s ) translocated from the cytoplasm to the nucleus ( ISGF3 ) after the bindin</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>-cell activation by dithiocarbamates involves novel mechanisms of inhibition of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9ABFAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor</mark>
        </td>
        <td> of activated T cells. Dithiocarbamates ( DTCs ) have recently been reported as </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>t only the inhibition of NF-kappa B-driven reporter activation but also that of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9ABFAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor</mark>
        </td>
        <td> of activated T cells ( NFAT ) . Accordingly, electrophoretic mobility shift ass</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'>irus type 1 long terminal repeat quasispecies differ in basal transcription and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9ABFAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor</mark>
        </td>
        <td> recruitment in human glial cells and lymphocytes. The generation of genomic div</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T231'>Term ID: <a href='terminology.html#L231' target='_blank'>231</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>atory elements of human immunodeficiency virus and beta interferon promoters by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tumor necrosis factor</mark>
        </td>
        <td>. Three aspects of the involvement of tumor necrosis factor in human immunodefic</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>erferon promoters by tumor necrosis factor. Three aspects of the involvement of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tumor necrosis factor</mark>
        </td>
        <td> in human immunodeficiency virus ( HIV ) pathogenesis were examined. Tumor necro</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'> adhesion molecule-1 ( VCAM-1 ) and E-selectin by tumor necrosis factor-alpha ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> ) is mediated by mobilization of the transcription factor nuclear factor-kappa </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>THODS AND RESULTS: Gel-shift analyses demonstrated dose-dependent inhibition of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td>-induced NF-kappa B mobilization by aspirin at concentrations ranging from 1 to </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>from 1 to 10 mmol / L. Induction of VCAM-1 and E-selectin surface expression by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> was dose-dependently reduced by aspirin over the same range, while induction of</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'> transcription, since it dose-dependently inhibited induction of VCAM-1 mRNA by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td>. As a functional consequence, adhesion of U937 monocytes to TNF-stimulated HUVE</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'> VCAM-1 mRNA by TNF. As a functional consequence, adhesion of U937 monocytes to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td>-stimulated HUVECs was markedly reduced by aspirin due to suppression of VCAM-1 </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>E-selectin, and subsequent monocyte adhesion in endothelial cells stimulated by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td>, thereby providing an additional mechanism for therapeutic effects of aspirin. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>ce, induction of cell surface expression of this leukocyte adhesion molecule by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tumor necrosis factor</mark>
        </td>
        <td> ( TNF ) -alpha was reduced by 40% in the presence of CsA, and this was reflecte</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>rface expression of this leukocyte adhesion molecule by tumor necrosis factor ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> ) -alpha was reduced by 40% in the presence of CsA, and this was reflected by a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>IFN-gamma priming of monocytes enhances LPS-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> production by augmenting both transcription and MRNA stability. The induction o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>. However, the mechanism ( s ) by which priming occurs is poorly defined. Using </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tumour necrosis factor</mark>
        </td>
        <td> ( TNF ) induction as a model, experiments were designed to analyse in detail th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>( s ) by which priming occurs is poorly defined. Using tumour necrosis factor ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> ) induction as a model, experiments were designed to analyse in detail the prim</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'> human monocytes. Priming by IFN-gamma was primarily manifested at the level of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> mRNA accumulation. IFN-gamma pre-treatment affected the magnitude rather than t</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>uced by either IFN-gamma or GM-CSF, but not M-CSF. Primed monocytes transcribed </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> mRNA at a higher rate than freshly isolated monocytes upon activation with LPS.</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>onsensus NF-kappa B oligonucleotide. An additional significant finding was than </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> mRNA induced in primed cells was much more stable than in unprimed cells ( T1 /</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>itivity to the kinase inhibitor H-89. H-89 substantially suppressed LPS-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> mRNA accumulation in unprimed cells, but had no effect on primed monocytes foll</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97162234' target='_blank'>97162234</a></td>
        <td style='text-align:right'>e gene activation of several cytokines, including tumor necrosis factor alpha ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> ) . Previously, we showed that fibroblast conditioned medium ( FCM ) is able to</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97162234' target='_blank'>97162234</a></td>
        <td style='text-align:right'>y, we showed that fibroblast conditioned medium ( FCM ) is able to inhibit both </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> mRNA accumulation and protein release in peripheral blood-derived human monocyt</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97458245' target='_blank'>97458245</a></td>
        <td style='text-align:right'>NF-AT activation induced by a CAML-interacting member of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tumor necrosis factor</mark>
        </td>
        <td> receptor superfamily. Activation of the nuclear factor of activated T cells tra</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97458245' target='_blank'>97458245</a></td>
        <td style='text-align:right'>ducer of NF-AT activation when overexpressed in Jurkat T cells. A member of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tumor necrosis factor</mark>
        </td>
        <td> receptor superfamily was isolated by virtue of its affinity for CAML. Cross-lin</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104462' target='_blank'>98104462</a></td>
        <td style='text-align:right'>LPS ( lipopolysaccharide ) repeatedly then the initially high expression of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> ( tumor necrosis factor ) gene is only very low, i.e. the cells are tolerant to</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104462' target='_blank'>98104462</a></td>
        <td style='text-align:right'>lipopolysaccharide ) repeatedly then the initially high expression of the TNF ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tumor necrosis factor</mark>
        </td>
        <td> ) gene is only very low, i.e. the cells are tolerant to LPS. Tolerant cells sti</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104462' target='_blank'>98104462</a></td>
        <td style='text-align:right'>nucleus. Analysis of the binding proteins employing the -605 motif of the human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> promoter () revealed that in tolerant cells of the human monocytic cell line Mo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104462' target='_blank'>98104462</a></td>
        <td style='text-align:right'>urine P388D1 macrophage cell line when tested with the -516 motif of the murine </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> promoter () . Here the wild type motif gives efficient binding of p50p50 that a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'> GM-CSF and FMLP, and Sos1 and c-Raf-1 were not phosphorylated by GM-CSF, IL-3, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td>, and FMLP in monocytes, whereas all these signaling molecules were affected and</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>Differential effects of lipopolysaccharide and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tumor necrosis factor</mark>
        </td>
        <td> on monocytic Ikappa B kinase signalsome activation and Ikappa B proteolysis. Th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>Ikappa B proteolysis. The inflammatory mediators lipopolysaccharide ( LPS ) and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tumor necrosis factor</mark>
        </td>
        <td> ( TNF ) are potent activators of NF-kappa B. This study compared the effect of </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>e inflammatory mediators lipopolysaccharide ( LPS ) and tumor necrosis factor ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> ) are potent activators of NF-kappa B. This study compared the effect of these </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>ial modulator ) , and IKK complex-associated protein. Kinase assays showed that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> elicited a rapid but short-lived induction of IKK activity with a 3-fold greate</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>with NIK, Ikappa B-alpha and -epsilon in unstimulated cells. Exposure to LPS or </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td> led to differential patterns of Ikappa B-alpha and Ikappa B-epsilon disappearan</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>ereas NF-kappa B essential modulator enhanced it. The understanding of LPS- and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAD9EE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF</mark>
        </td>
        <td>-induced signaling may allow the development of specific strategies to treat sep</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T144'>Term ID: <a href='terminology.html#L144' target='_blank'>144</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>ble by both agents. TNF-alpha was able to increase expression of the HIV LTR in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>, but in monocytic cells, TNF-alpha did not induce the HIV LTR above a constitut</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>rough the cell population and increased viral RNA synthesis, indicating that in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> HIV-1 multiplication was stimulated by TNF-alpha treatment. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>tor C alpha gene enhancer in a context-dependent manner. The differentiation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> into functionally diverse subpopulations is controlled in part, by transcriptio</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93183827' target='_blank'>93183827</a></td>
        <td style='text-align:right'>ve transcription factor, requires two signals and is cyclosporin A sensitive in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. Few known genes ( IL-2, members of the IL-8 family, interferon-gamma ) are ind</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93183827' target='_blank'>93183827</a></td>
        <td style='text-align:right'>own genes ( IL-2, members of the IL-8 family, interferon-gamma ) are induced in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> only through the combined effect of phorbol myristic acetate ( PMA ) and a Ca (</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93183827' target='_blank'>93183827</a></td>
        <td style='text-align:right'> requirement for expression. Induction of the PILOT gene is detectable in human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> 20 min following activation in the presence of cycloheximide and is fully suppr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93183827' target='_blank'>93183827</a></td>
        <td style='text-align:right'>er regions of the transcription factors EGR1, EGR2, and pAT 133. In contrast to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>, in fibroblasts PILOT gene expression requires only one signal ( PMA ) and is n</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93183827' target='_blank'>93183827</a></td>
        <td style='text-align:right'> signal-dependent regulatory element obligatory for expression of some genes in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> but not in fibroblasts. This differential expression model will be valuable in </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93183827' target='_blank'>93183827</a></td>
        <td style='text-align:right'>pression model will be valuable in the dissection of the dual signal pathway in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> and the effects of CyA upon it. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93321228' target='_blank'>93321228</a></td>
        <td style='text-align:right'> became refractory to activation via the CD3 / T cell receptor ( TcR ) complex. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> preincubated with phorbol 12-myristate 13-acetate ( PMA ) and dibutyryl cAMP ( </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'> peroxide ( pervanadate ) , on the activation cascade of Jurkat human leukaemic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cells</mark>
        </td>
        <td>. Pervanadate induced activation of the tyrosine kinases lck and fyn ( 4- and 3-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'> described to induce differentiation of murine thymocytes to cytolytic effector </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cells</mark>
        </td>
        <td> by stimulating IL-6 release from adherent cells. This study shows that human pe</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95000924' target='_blank'>95000924</a></td>
        <td style='text-align:right'>Role of HIV-1 Nef expression in activation pathways in CD4+ </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. The role of the human immunodeficiency virus ( HIV-1 ) Nef protein in T cell a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95000924' target='_blank'>95000924</a></td>
        <td style='text-align:right'>f downmodulates LTR activation without significantly inhibiting the capacity of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> to respond to immunological activations. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95166251' target='_blank'>95166251</a></td>
        <td style='text-align:right'>Expression of the Runt domain-encoding PEBP2 alpha genes in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> during thymic development. The PEBP2 alpha A and PEBP2 alpha B genes encode the</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95166251' target='_blank'>95166251</a></td>
        <td style='text-align:right'>- CD8+ cell populations. The results indicated that both genes are expressed in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> throughout their development, supporting the notion that PEBP2 is a T-cell-spec</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>e nonleukemogenic virus, Akv. This difference strongly affects transcription in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> and leukemogenicity of SL3. However, no combination of CBF alpha and CBF beta s</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'> 1-bp difference in transcription assays. Thus, a complete understanding of how </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> recognize the SL3 core remains to be elucidated. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>osporin A and the T-cell transcription factor NFAT. Nuclear factor of activated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> ( NFAT ) was originally described as a T-cell-specific transcription factor ath</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96038813' target='_blank'>96038813</a></td>
        <td style='text-align:right'>Cloning a cDNA from human NK / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> which codes for a protein with high proline content. A cDNA clone, B4-2, was is</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96079922' target='_blank'>96079922</a></td>
        <td style='text-align:right'>ulate proliferation and activate transcription of over-lapping sets of genes of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. PRL and IL-2 receptor activation are both linked to the Jak / Stat ( signal tr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96085174' target='_blank'>96085174</a></td>
        <td style='text-align:right'>eukin-7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. The activation of Janus protein tyrosine kinases ( Jak ) and STAT ( signal tra</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>chromosome 5q23-31. Interleukin-13 ( IL-13 ) and IL-4 are cytokines produced by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> that are encoded by the q23-31 region of human chromosome 5. To investigate the</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>f human chromosome 5. To investigate the regulation of IL-13 gene expression by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>, we isolated and sequenced the human IL-13 gene, analyzed its 5'-flanking regio</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>gy to P elements of the IL-4 promoter involved in transcriptional activation in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. Mutation of the IL-13 P element site significantly reduced IL-13 promoter acti</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>cifically bound the transcriptional activator protein, nuclear factor-activated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>, preformed ( NF-ATp ) , when incubated with nuclear protein extracts from activ</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>formed ( NF-ATp ) , when incubated with nuclear protein extracts from activated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. Similar to IL-4, IL-13 mRNA expression was highest in T-cell populations enric</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>pression of the IL-13 and IL-4 genes in a coordinate manner. Because the primed </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> contain higher levels of nuclear NF-ATp, capable of binding to P elements of th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>binding to P elements of the IL-4 and IL-13 promoters, than do freshly-isolated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>, the NF-AT-binding P elements are attractive candidates to mediate the coordina</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96195006' target='_blank'>96195006</a></td>
        <td style='text-align:right'>hway exerts an inhibitory effect on the proliferation and effector functions of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. The ability of T cells to form high intracellular levels of cAMP is acquired d</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96195006' target='_blank'>96195006</a></td>
        <td style='text-align:right'>y effect on the proliferation and effector functions of T cells. The ability of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> to form high intracellular levels of cAMP is acquired during development in the</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96195006' target='_blank'>96195006</a></td>
        <td style='text-align:right'>y of mature peripheral T lymphocytes. Here we show that elevated cAMP levels in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> correlate with the expression of the potent transcriptional repressor ICER ( in</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96195006' target='_blank'>96195006</a></td>
        <td style='text-align:right'>T-lymphotropic virus type I ( HTLV-I ) promoter. Thus, the induction of ICER in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> may play an important role in the cAMP-induced quiescence and the persistent la</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'>Age-related decreases in IL-2 production by human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> are associated with impaired activation of nuclear transcriptional factors AP-1</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'>nd NF-AT. Although transcriptional factors AP-1 and nuclear factor of activated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> ( NF-AT ) are important for the normal induction of IL-2, it is unknown if the </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'> it is unknown if the age-related decline in IL-2 production by activated human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> may be associated with aberrancies in transcriptional regulatory proteins. In t</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'>transcriptional regulatory proteins. In the current studies, IL-2 production by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> from elderly ( mean 78 years ) and young ( mean 37 years ) humans was measured </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'>from other elderly individuals were equivalent to those observed for stimulated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> of young subjects. Analyses of nuclear extracts by electrophoretic DNA mobility</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'>ociated with impairments in the activation of both AP-1 and NF-AT. By contrast, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> from elderly subjects with normal levels of IL-2 production exhibited normal ac</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>ranscription factors are required for activation of human interleukin 9 gene in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. The genetic elements and regulatory mechanisms responsible for human interleuk</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>ion of different transcription factors is essential for IL-9 gene expression in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96322726' target='_blank'>96322726</a></td>
        <td style='text-align:right'>ibition of transcription factor Stat1 activity in mononuclear cell cultures and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> by the cyclic AMP signaling pathway. Activation of T cells results in a cascade</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96322726' target='_blank'>96322726</a></td>
        <td style='text-align:right'>( STAT ) family was analyzed in PHA-activated mononuclear cells and in purified </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> activated by cross-linking cell surface CD3. Cell activation resulted in a dela</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97025698' target='_blank'>97025698</a></td>
        <td style='text-align:right'>he proliferation of human lymphocytes in a non-specific manner and may activate </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> to express CD40 antigen. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97211823' target='_blank'>97211823</a></td>
        <td style='text-align:right'>kappa B play critical roles during late stages of the intrathymic maturation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>ng activity to the IL-2 promoter CD28 response element / AP-1 sequence in human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. CD28 is an important costimulatory molecule in the activation of human T cells</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>T cells. CD28 is an important costimulatory molecule in the activation of human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. Costimulation of T cells through both the Ag receptor and CD28 leads to high l</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>ant costimulatory molecule in the activation of human T cells. Costimulation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> through both the Ag receptor and CD28 leads to high level IL-2 production, whic</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>nd the AP-1-binding sites influence IL-2 promoter activity in CD28-costimulated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'>e mouse IL-4 gene: involvement of a distinct set of nuclear factor of activated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> and activator protein-1 family proteins. We previously identified the P sequenc</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'>SA, complexes formed with P or P2 proved to contain nuclear factor of activated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> ( NFAT ) family proteins as major components. Activator protein ( AP ) -1 famil</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97458245' target='_blank'>97458245</a></td>
        <td style='text-align:right'>osis factor receptor superfamily. Activation of the nuclear factor of activated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> transcription factor ( NF-AT ) is a key event underlying lymphocyte action. The</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97458245' target='_blank'>97458245</a></td>
        <td style='text-align:right'>igand ) protein is a coinducer of NF-AT activation when overexpressed in Jurkat </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. A member of the tumor necrosis factor receptor superfamily was isolated by vir</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>rbamates involves novel mechanisms of inhibition of nuclear factor of activated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. Dithiocarbamates ( DTCs ) have recently been reported as powerful inhibitors o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>kappa B-driven reporter activation but also that of nuclear factor of activated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> ( NFAT ) . Accordingly, electrophoretic mobility shift assays ( EMSAs ) indicat</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>Tp and NFATc, leading to their accelerated export from the nucleus of activated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. We propose that the activation of an NFAT kinase by PDTC could be responsible </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98380286' target='_blank'>98380286</a></td>
        <td style='text-align:right'>Stimulation of B and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> activates expression of transcription and differentiation factors. During B and</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99081619' target='_blank'>99081619</a></td>
        <td style='text-align:right'>zed the effects of interleukin-10 ( IL-10 ) on the entry of quiescent CD4 ( + ) </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> into the cell cycle upon stimulation with the superantigen staphylococcal enter</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99081619' target='_blank'>99081619</a></td>
        <td style='text-align:right'>n. Cell separation experiments suggest that IL-10 can effect purified CD4 ( + ) </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> directly, providing functional evidence for the presence of IL-10 receptors on </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99081619' target='_blank'>99081619</a></td>
        <td style='text-align:right'> providing functional evidence for the presence of IL-10 receptors on CD4 ( + ) </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. IL-10 also inhibited expression of IL-2 transcriptional regulators c-fos and c</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>Functional testosterone receptors in plasma membranes of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. T cells are considered to be unresponsive to testosterone due to the absence o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>Functional testosterone receptors in plasma membranes of T cells. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> are considered to be unresponsive to testosterone due to the absence of androge</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>( AR ) . Here, we demonstrate the testosterone responsiveness of murine splenic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> in vitro as well as the presence of unconventional cell surface receptors for t</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>ites for testosterone on the surface of both CD4 ( + ) and CD8 ( + ) subsets of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> are directly revealed with the impeded ligand testosterone-BSA-FITC by confocal</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>sterone-BSA conjugate induces a rapid rise ( <5 s ) in [Ca2+]i of Fura-2-loaded </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. This rise reflects influx of extracellular Ca2+ through non-voltage-gated and </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'> blocker of the AR. In addition, AR are not detectable on the surface of intact </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> when using anti-AR antibodies directed against the amino and carboxy terminus o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'> antibodies directed against the amino and carboxy terminus of the AR, although </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> contain AR, as revealed by reverse transcription-polymerase chain reactions and</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>can be visualized with the anti-AR antibodies in the cytoplasm of permeabilized </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> by using CLSM, though AR are not detectable in cytosol fractions when using the</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>ay with 3H-R1881 as ligand. Cytoplasmic AR do not translocate to the nucleus of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> in the presence of testosterone, in contrast to cytoplasmic AR in human cancer </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>er LNCaP cells. These findings suggest that the classical AR present in splenic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> are not active in the genomic pathway. By contrast, the cell surface receptors </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>surface receptors for testosterone are in a functionally active state, enabling </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> a nongenomic response to testosterone. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'>vities to the immunodominant and subdominant lytic cycle epitopes identified by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> during primary EBV infection are regularly detectable in the CTL memory of viru</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'> a novel, phosphorylated, zinc finger transcription factor that is expressed in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> 3 days after activation, coincident with RANTES expression. While Rel proteins </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'>ene expression in fibroblasts, RFLAT-1 is a strong transactivator for RANTES in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>pregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. Interferon-alpha ( IFN-alpha ) is a pleiotropic cytokine that has antiviral, a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>gulated IL-2Ralpha, c-myc, and pim-1 gene expression. IFN-alpha also sensitized </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> to IL-2-induced proliferation, further suggesting that IFN-alpha may be involve</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>est that IFN-alpha, IL-2, IL-12, and IL-15 have overlapping activities on human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. These findings thus emphasize the importance of IFN-alpha as a T-cell regulato</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99172186' target='_blank'>99172186</a></td>
        <td style='text-align:right'>odified by NAC. Finally, we found that the addition of NAC to MLR between naive </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td> and allogeneic DC resulted in a profound inhibition of alloreactive responses, </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>lation by antibody and bacterial superantigen induces Stat3 activation in human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. Recent data show that TCR / CD3 stimulation induces activation of Stat5 in mur</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>cent data show that TCR / CD3 stimulation induces activation of Stat5 in murine </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. Here, we show that CD3 ligation by mAb and Staphylococcal enterotoxin ( SE ) i</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>rapid, PP1-sensitive tyrosine and serine phosphorylation of Stat3 in human CD4+ </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEFEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells</mark>
        </td>
        <td>. Moreover, we provide evidence that TCR / CD3 and IL-2 induce Stat3 activation </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T52'>Term ID: <a href='terminology.html#L52' target='_blank'>52</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>osis factor in human immunodeficiency virus ( HIV ) pathogenesis were examined. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Tumor necrosis factor alpha</mark>
        </td>
        <td> ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplifi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>iciency virus ( HIV ) pathogenesis were examined. Tumor necrosis factor alpha ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> ) mRNA production was analyzed by polymerase chain reaction amplification in mo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>cytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ) . </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> RNA was undetectable in U937 cells, whereas a low constitutive level was detect</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>xovirus infection induced a 5- to 10-fold increase in the steady-state level of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> RNA in U9-IIIB cells compared with U937 cells, suggesting that HIV-infected mon</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>7 cells, suggesting that HIV-infected monocytic cells produced higher levels of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> than did normal cells after a secondary virus infection. The effects of TNF-alp</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>F-alpha than did normal cells after a secondary virus infection. The effects of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> on gene expression were examined by transient expression assays using reporter </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'> Jurkat T lymphoid cells, the inducibility of the different hybrid promoters by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> or phorbol ester varied in a cell type- and promoter context-specific manner; t</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'> intact beta interferon promoter was only weakly stimulated by phorbol ester or </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td>, multimers of the PRDII NF-kappa B-binding domain were inducible by both agents</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>multimers of the PRDII NF-kappa B-binding domain were inducible by both agents. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> was able to increase expression of the HIV LTR in T cells, but in monocytic cel</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'> able to increase expression of the HIV LTR in T cells, but in monocytic cells, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> did not induce the HIV LTR above a constitutive level of activity. This level o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>B-independent activity appears to be sufficient for virus multiplication, since </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infecti</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>1 ) infection and viral RNA production in U937 cells. However, in Jurkat cells, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> dramatically enhanced the spread of HIV-1 through the cell population and incre</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>NA synthesis, indicating that in T cells HIV-1 multiplication was stimulated by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> treatment. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91321794' target='_blank'>91321794</a></td>
        <td style='text-align:right'>kappa B. HIV-1-infected individuals have, on average, abnormally high levels of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tumour necrosis factor alpha</mark>
        </td>
        <td> ( TNF alpha ) and abnormally low plasma cysteine levels. We therefore investiga</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91321794' target='_blank'>91321794</a></td>
        <td style='text-align:right'>uals have, on average, abnormally high levels of tumour necrosis factor alpha ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF alpha</mark>
        </td>
        <td> ) and abnormally low plasma cysteine levels. We therefore investigated the effe</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>d monocytes ( PBMo ) also respond to MDHM with increases in IL-1 beta, IL-6 and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF alpha</mark>
        </td>
        <td> expression, both at the mRNA and protein level. The induced expression of IL-1 </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95000924' target='_blank'>95000924</a></td>
        <td style='text-align:right'>ell line stably transfected with a Nef expression vector. Secretion of IL-2 and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td>, surface expression of IL-2R, and DNA-binding activity of NF-kappa B and AP-1 (</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95000924' target='_blank'>95000924</a></td>
        <td style='text-align:right'>appa B and AP-1 ( Fos / Jun ) complex in response to phorbol myristate acetate, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td>, or immobilized antibodies to CD3 were monitored. These parameters were not mod</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>The induction of vascular cell adhesion molecule-1 ( VCAM-1 ) and E-selectin by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tumor necrosis factor-alpha</mark>
        </td>
        <td> ( TNF ) is mediated by mobilization of the transcription factor nuclear factor-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96303658' target='_blank'>96303658</a></td>
        <td style='text-align:right'>The underlying signaling pathways appear to be different from those utilized by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td>, a better characterized cytokine that induces the transcription of immediate-ea</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97162234' target='_blank'>97162234</a></td>
        <td style='text-align:right'>to be crucially involved in the gene activation of several cytokines, including </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tumor necrosis factor alpha</mark>
        </td>
        <td> ( TNF ) . Previously, we showed that fibroblast conditioned medium ( FCM ) is a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98012705' target='_blank'>98012705</a></td>
        <td style='text-align:right'>ccompanied by an inhibition of both NF-kappa B activation and the expression of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tumor necrosis factor-alpha</mark>
        </td>
        <td> and interleukin-1 beta genes. These observations provide additional evidence th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>cule-1 ( ICAM-1 ) gene, which is involved in regulation of ICAM-1 expression by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tumor necrosis factor alpha</mark>
        </td>
        <td> ( TNF-alpha ) and glucocorticoids. We now report on the transcription factors w</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>is involved in regulation of ICAM-1 expression by tumor necrosis factor alpha ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> ) and glucocorticoids. We now report on the transcription factors which bind an</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>to transactivate an ICAM-1 kappa B-reporter construct. In monocytic THP-1 cells </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> induced two nuclear complexes which in vitro bound to the ICAM-1 kappa B site. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>er. We argue that in vivo RelA homodimers are likely to play a dominant role in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td>-induced ICAM-1 transcription in monocytic cells. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>protein tyrosine kinase dependent and protein kinase C independent. BACKGROUND: </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Tumor necrosis factor alpha</mark>
        </td>
        <td> ( TNF-alpha ) is an important mediator of septic shock. Endotoxin ( LPS ) signa</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>ent and protein kinase C independent. BACKGROUND: Tumor necrosis factor alpha ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> ) is an important mediator of septic shock. Endotoxin ( LPS ) signal transducti</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>) and protein tyrosine kinases ( PTK ) in LPS-induced NF-kappa B activation and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> production. We hypothesized that inhibition of either PKC or PTK would decrease</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'> PTK inhibition with Gen attenuated both LPS-induced NF-kappa B DNA binding and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> production in human monocytes. Direct activation of PKC with PMA induced both N</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>cytes. Direct activation of PKC with PMA induced both NF-kappa B activation and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> production by human monocytes. CONCLUSIONS: These results suggest that LPS-indu</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99356019' target='_blank'>99356019</a></td>
        <td style='text-align:right'> kinase activity, protein activity of NF-kappa B and cytokine ( IL-1beta, IL-6, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> ) specific mRNA levels in BEAS-2B cells. We observed an increase in protein tyr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99406845' target='_blank'>99406845</a></td>
        <td style='text-align:right'>laddering, and typical morphology by means of transmission electron microscopy. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> and IL-1beta were measured by ELISA. GC receptor was blocked with mifepristone.</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99406845' target='_blank'>99406845</a></td>
        <td style='text-align:right'>ed by propidium iodide staining. Proinflammatory cytokines such as IL-1beta and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td> were down-regulated by GC treatment. Continuous treatment of monocytes with IL-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99406845' target='_blank'>99406845</a></td>
        <td style='text-align:right'> by GC treatment. Continuous treatment of monocytes with IL-1beta, but not with </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EAF9DB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha</mark>
        </td>
        <td>, could almost completely prevent GC-induced cell death. The addition of mifepri</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T15'>Term ID: <a href='terminology.html#L15' target='_blank'>15</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>Cell-specific differences in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activation of NF-kappa B</mark>
        </td>
        <td> regulatory elements of human immunodeficiency virus and beta interferon promote</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>varied in a cell type- and promoter context-specific manner; the levels of gene </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activity of NF-kappa B</mark>
        </td>
        <td>-containing plasmids correlated directly with induction of NF-kappa B DNA-bindin</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91321794' target='_blank'>91321794</a></td>
        <td style='text-align:right'>Inhibition of HIV-1 replication and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activity</mark>
        </td>
        <td> by cysteine and cysteine derivatives. HIV-1 proviral DNA contains two binding s</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91321794' target='_blank'>91321794</a></td>
        <td style='text-align:right'>rs not to be directly correlated with GSH levels. Cysteine and NAC also inhibit </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activity</mark>
        </td>
        <td> as determined by electrophoretic mobility shift assays and chloramphenicol acet</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>eir ability to form the heterodimer, suggesting the presence of an inhibitor of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activity</mark>
        </td>
        <td>. Furthermore, treatment of nuclear extracts from these cells that had restricte</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>ad restricted expression with lipopolysaccharide increased viral production and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activity</mark>
        </td>
        <td>. Antiserum specific for NF-kappa B binding proteins, but not c-rel-specific ant</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95000924' target='_blank'>95000924</a></td>
        <td style='text-align:right'>. Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and DNA-binding </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activity of NF-kappa B</mark>
        </td>
        <td> and AP-1 ( Fos / Jun ) complex in response to phorbol myristate acetate, TNF-al</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>factor-kappa B ( NF-kappa B ) . Since salicylates have been reported to inhibit </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activation</mark>
        </td>
        <td> by preventing the degradation of its inhibitor I kappa B, we studied a potentia</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>rtant component of an integrin signaling pathway in monocytic cells, leading to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activation of NF-kappa B</mark>
        </td>
        <td> and to increased levels of cytokine messages. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>th LPS. The increased transcriptional rate correlated with a marked increase in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear factor-kappa B activity</mark>
        </td>
        <td> in these cells as determined by electrophoretic mobility shift assay using a co</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97162234' target='_blank'>97162234</a></td>
        <td style='text-align:right'>his study we have investigated the effect of FCM on the LPS-induced DNA-binding </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activity of NF-kappa B</mark>
        </td>
        <td>, by means of electrophoretic shift assay ( EMSA ) . We provide evidence that FC</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97162234' target='_blank'>97162234</a></td>
        <td style='text-align:right'>assay ( EMSA ) . We provide evidence that FCM strongly inhibits the LPS-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activation</mark>
        </td>
        <td> in PBM. Furthermore, we show that exogenous PGE2 mimics the NF-kappa B inhibito</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97162234' target='_blank'>97162234</a></td>
        <td style='text-align:right'>n the other hand, FCM produced in the presence of indomethacin does not inhibit </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activation</mark>
        </td>
        <td> by LPS. Our results lend further support to the hypothesis that inflammatory an</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97211823' target='_blank'>97211823</a></td>
        <td style='text-align:right'>volved in immune and inflammatory responses. We have reported previously that a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear NF-kappa B activity</mark>
        </td>
        <td> was present in freshly extracted human thymocytes in the absence of in vitro tr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97307577' target='_blank'>97307577</a></td>
        <td style='text-align:right'>ected, but not yet proven. Transgenic mice with a lymphocyte-specific defect in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activation</mark>
        </td>
        <td> were produced by targeted expression of human Ikappa B alpha. The thymic cellul</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>Dithiocarbamates ( DTCs ) have recently been reported as powerful inhibitors of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activation</mark>
        </td>
        <td> in a number of cell types. Given the role of this transcription factor in the r</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98012705' target='_blank'>98012705</a></td>
        <td style='text-align:right'>ning NF-kappa B dimers and induced the expression of the target gene IL-8. This </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activation of NF-kappa B</mark>
        </td>
        <td> was inhibited by the antioxidant and H2O2 scavenger pyrrolidine dithiocarbamate</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98012705' target='_blank'>98012705</a></td>
        <td style='text-align:right'>pyrrolidine dithiocarbamate and the proteasome inhibitor PSI. The oxLDL-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activation</mark>
        </td>
        <td> was accompanied by an initial depletion of I kappa B-alpha followed by a slight</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98012705' target='_blank'>98012705</a></td>
        <td style='text-align:right'>ride-induced depletion of I kappa B-alpha, accompanied by an inhibition of both </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activation</mark>
        </td>
        <td> and the expression of tumor necrosis factor-alpha and interleukin-1 beta genes.</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99118181' target='_blank'>99118181</a></td>
        <td style='text-align:right'>Inhibition of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activation</mark>
        </td>
        <td> in vitro and in vivo: role of 26S proteasome. It is becoming increasingly appar</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>LPS-Induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activation</mark>
        </td>
        <td> and TNF-alpha release in human monocytes are protein tyrosine kinase dependent </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>septic shock. Endotoxin ( LPS ) signal transduction in human monocytes leads to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activation of nuclear factor-kappa B</mark>
        </td>
        <td> ( NF-kappa B ) and TNF-alpha release. Previous studies have implicated activati</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>th protein kinase C ( PKC ) and protein tyrosine kinases ( PTK ) in LPS-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activation</mark>
        </td>
        <td> and TNF-alpha production. We hypothesized that inhibition of either PKC or PTK </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>pha release in human monocytes. Nonspecific protein kinase inhibition inhibited </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activation</mark>
        </td>
        <td> and TNF-alpha release, while specific PKC inhibition with Bis had no effect on </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>a production in human monocytes. Direct activation of PKC with PMA induced both </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activation</mark>
        </td>
        <td> and TNF-alpha production by human monocytes. CONCLUSIONS: These results suggest</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>duction by human monocytes. CONCLUSIONS: These results suggest that LPS-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activation</mark>
        </td>
        <td> and TNF-alpha release in human monocytes are independent of PKC activity. Furth</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'> Furthermore, our results provide evidence that PTK plays a role in LPS-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activation</mark>
        </td>
        <td> and TNF-alpha release in human monocytes and thus could be a potential therapeu</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99356019' target='_blank'>99356019</a></td>
        <td style='text-align:right'>nocytes increases inflammatory cytokine-mRNA level, protein tyrosine kinase and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activity</mark>
        </td>
        <td> in co-cultured bronchial epithelial cells ( BEAS-2B ) . Some pulmonary diseases</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99356019' target='_blank'>99356019</a></td>
        <td style='text-align:right'>say ) and RT-PCR were used to measure protein tyrosine kinase activity, protein </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activity of NF-kappa B</mark>
        </td>
        <td> and cytokine ( IL-1beta, IL-6, TNF-alpha ) specific mRNA levels in BEAS-2B cell</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99356019' target='_blank'>99356019</a></td>
        <td style='text-align:right'>A were elevated ( up to 1.9 +/- 0.58-fold ) . Protein tyrosine kinase activity, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACCBD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B activity</mark>
        </td>
        <td>, and the synthesis of cytokine-specific mRNA were inhibited by antioxidants. Th</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T237'>Term ID: <a href='terminology.html#L237' target='_blank'>237</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90140708' target='_blank'>90140708</a></td>
        <td style='text-align:right'>Two distinct </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> that bind the immunoglobulin enhancer microE5 / kappa 2 motif. Activity of the </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>vity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> and the context of its binding site within the TCR alpha enhancer. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91321794' target='_blank'>91321794</a></td>
        <td style='text-align:right'>and cysteine derivatives. HIV-1 proviral DNA contains two binding sites for the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> NF-kappa B. HIV-1-infected individuals have, on average, abnormally high levels</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93024468' target='_blank'>93024468</a></td>
        <td style='text-align:right'>Characterization of a new tissue-specific </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> binding to the simian virus 40 enhancer TC-II ( NF-kappa B ) element. We have b</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93024468' target='_blank'>93024468</a></td>
        <td style='text-align:right'>F-kappa B ) element. We have biochemically and functionally characterized a new </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td>, NP-TCII, which is present in nuclei from unstimulated T and B lymphocytes but </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93183827' target='_blank'>93183827</a></td>
        <td style='text-align:right'>Expression of PILOT, a putative </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td>, requires two signals and is cyclosporin A sensitive in T cells. Few known gene</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93183827' target='_blank'>93183827</a></td>
        <td style='text-align:right'>an be fully suppressed by Cyclosporin A ( CyA ) . We have identified a putative </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td>, designated PILOT, with an identical dual signal requirement for expression. In</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93183827' target='_blank'>93183827</a></td>
        <td style='text-align:right'>carboxyl-terminus which are highly homologous to the zinc finger regions of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> EGR1, EGR2, and pAT 133. In contrast to T cells, in fibroblasts PILOT gene expr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>F-E2 / AP1 motifs of HS-40 is mediated through its binding to NF-E2 but not AP1 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td>. Finally, we did genomic footprinting of the HS-40 enhancer region in K562 cell</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93321228' target='_blank'>93321228</a></td>
        <td style='text-align:right'>D3-dependent T cell activation and leads to a persistent expression of the AP-1 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td>. The effects mediated by a combined stimulation of cAMP -and protein kinase C (</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>e activated NF-kappa B, as shown by an increase in DNA-binding activity of this </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td>. We thus conclude that PTPases play a crucial role in the negative regulation o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95166251' target='_blank'>95166251</a></td>
        <td style='text-align:right'>EBP2 alpha A and PEBP2 alpha B genes encode the DNA-binding subunit of a murine </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td>, PEBP2, which is implicated as a T-cell-specific transcriptional regulator. The</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>lyomavirus enhancer-binding protein 2 and SL3 enhancer factor 1, is a mammalian </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> that binds to an element termed the core within the enhancers of the murine leu</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95261059' target='_blank'>95261059</a></td>
        <td style='text-align:right'>B. PU.1 ( the Spi-1 oncogene ) and Spi-B are closely related members of the ets </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> family, sharing similar DNA binding specificities mediated by similar DNA bindi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'> and E-selectin expression in endothelial cells by cyclosporin A and the T-cell </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> NFAT. Nuclear factor of activated T cells ( NFAT ) was originally described as </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96079922' target='_blank'>96079922</a></td>
        <td style='text-align:right'>in and interleukin-2 receptors in T lymphocytes signal through a MGF-STAT5-like </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td>. The cell surface receptors for PRL and interleukin-2 ( IL-2 ) are structurally</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96079922' target='_blank'>96079922</a></td>
        <td style='text-align:right'>rameters were indistinguishable for one of the PRL- and IL-2-induced factors. A </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> closely related to mammary gland factor-Stat5 is rapidly activated upon interac</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'> production by human T cells are associated with impaired activation of nuclear </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional factors</mark>
        </td>
        <td> AP-1 and NF-AT. Although transcriptional factors AP-1 and nuclear factor of act</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'>impaired activation of nuclear transcriptional factors AP-1 and NF-AT. Although </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional factors</mark>
        </td>
        <td> AP-1 and nuclear factor of activated T cells ( NF-AT ) are important for the no</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>Multiple </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> are required for activation of human interleukin 9 gene in T cells. The genetic</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>inding. Taken together, these results suggest that the cooperation of different </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> is essential for IL-9 gene expression in T cells. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96303658' target='_blank'>96303658</a></td>
        <td style='text-align:right'> transduce signals leading to gene transcription and translation in leukocytes. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Transcription factors</mark>
        </td>
        <td>, such as NF kappa B and AP-1, are activated upon stimulation of the cells with </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96322726' target='_blank'>96322726</a></td>
        <td style='text-align:right'>Inhibition of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> Stat1 activity in mononuclear cell cultures and T cells by the cyclic AMP signa</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96322726' target='_blank'>96322726</a></td>
        <td style='text-align:right'>t proliferation and differentiation into effector phenotypes. The regulation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> belonging to the signal transducer and activator of transcription ( STAT ) fami</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96322726' target='_blank'>96322726</a></td>
        <td style='text-align:right'>eceptor alpha-chain and CD69 expression or the induction of activator protein 1 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td>. cAMP signaling inhibited Stat1 at several different levels, including suppress</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'>ediate effects in monocytes by activation of the Janus kinase ( JAK2 ) and STAT </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> ( STAT5 ) pathway. Recent studies have identified homologues of STAT5, STAT5A, </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97064186' target='_blank'>97064186</a></td>
        <td style='text-align:right'>phorylation of STAT4 ( signal transducer and activator of transcription-4 ) , a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> that is typically involved in IL-12 signaling. Consequently, IL-12 also failed </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97263762' target='_blank'>97263762</a></td>
        <td style='text-align:right'>Involvement of an SAF-like </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> in the activation of serum amyloid A gene in monocyte / macrophage cells by lip</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97324097' target='_blank'>97324097</a></td>
        <td style='text-align:right'>ive nuclear localization of the ETS protein Elf-1. Elf-1 is a lymphoid-specific </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> that belongs to the ETS protein family. It can bind to DNA target sequences wit</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>to the activation of the IL-2 promoter by up-regulating the activity of several </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td>, including AP-1 and nuclear factor-kappa B ( NF-kappa B ) /Rel family members a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>factor-kappa B ( NF-kappa B ) /Rel family members as well as an uncharacterized </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> called CD28 response complex. While several lines of investigation have suggest</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>uggested that NF-kappa B / Rel family members make up the CD28 response complex </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td>, other work has not supported this conclusion. Recent studies suggest that the </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97436422' target='_blank'>97436422</a></td>
        <td style='text-align:right'>ve stages of commitment and differentiation. From analyses of mice deficient in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> genes and from the characterizations of chromosome breakpoints in human leukemi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97436422' target='_blank'>97436422</a></td>
        <td style='text-align:right'>ations of chromosome breakpoints in human leukemias, it has become evident that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> are important regulators of hematopoiesis. During myelopoiesis, which includes </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97436422' target='_blank'>97436422</a></td>
        <td style='text-align:right'>poiesis, which includes the development of granulocytic and monocytic lineages, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> from several families are active, including AML1 / CBF beta, C / EBP, Ets, c-My</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97458245' target='_blank'>97458245</a></td>
        <td style='text-align:right'>tor receptor superfamily. Activation of the nuclear factor of activated T cells </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> ( NF-AT ) is a key event underlying lymphocyte action. The CAML ( calcium-modul</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97458245' target='_blank'>97458245</a></td>
        <td style='text-align:right'>transfected Jurkat cells with TACI-specific antibodies led to activation of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> NF-AT, AP-1, and NFkappa B. TACI-induced activation of NF-AT was specifically b</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97468093' target='_blank'>97468093</a></td>
        <td style='text-align:right'>. These results suggest that in human T lymphocytes IFN-beta can activate other </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> ( s ) distinct from ISGF3 to regulate PLC gamma 1 expression. In addition, the </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>tors of NF-kappa B activation in a number of cell types. Given the role of this </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> in the regulation of gene expression in the inflammatory response, NF-kappa B i</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>he NFAT, therefore transiently converting the sustained transactivation of this </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> that occurs during lymphocyte activation, and show that c-Jun NH2-terminal kina</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98012705' target='_blank'>98012705</a></td>
        <td style='text-align:right'>by oxidized low-density lipoprotein. Nuclear factor-kappa B ( NF-kappa B ) /Rel </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> may be involved in atherosclerosis, as is suggested by the presence of activate</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98038749' target='_blank'>98038749</a></td>
        <td style='text-align:right'>k-2-dependent phosphorylation. The functions of basic helix-loop-helix ( bHLH ) </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> in activating differentiation-linked gene expression and in inducing G1 cell cy</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98090689' target='_blank'>98090689</a></td>
        <td style='text-align:right'>o examine both fetal and term neonatal cord bloods for mRNA expression of three </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> implicated in T-cell activation: c-jun, c-fos, and NF kappa B ( p50 subunit ) .</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98090689' target='_blank'>98090689</a></td>
        <td style='text-align:right'>shown in fetal blood cells. Quantitative experiments comparing binding of these </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> to the IL-2 promoter are currently under investigation. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>r necrosis factor alpha ( TNF-alpha ) and glucocorticoids. We now report on the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> which bind and transactivate this enhancer sequence. In vitro, the ICAM-1 kappa</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'>red to the LAI LTR. Differences in LTR sequence also resulted in differences in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> recruitment to cis-acting sites within the U3 region of the LTR, as demonstrate</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'>ty shift assays. In particular, naturally occurring sequence variation impacted </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> binding to an activating transcription factor / cAMP response element binding (</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'>ggest that LTR sequence changes can significantly affect basal LTR function and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> recruitment, which may, in turn, alter the course of viral replication in cells</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99007236' target='_blank'>99007236</a></td>
        <td style='text-align:right'>y could regulate transcription of specific genes. Multiple cellular DNA-binding </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> are required by HIV type 1 for RNA synthesis. Two pyrrole-imidazole polyamides </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99007236' target='_blank'>99007236</a></td>
        <td style='text-align:right'>re designed to bind DNA sequences immediately adjacent to binding sites for the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factors</mark>
        </td>
        <td> Ets-1, lymphoid-enhancer binding factor 1, and TATA-box binding protein. These </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99007236' target='_blank'>99007236</a></td>
        <td style='text-align:right'>nding protein. These synthetic ligands specifically inhibit DNA-binding of each </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> and HIV type 1 transcription in cell-free assays. When used in combination, the</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'>RFLAT-1: a new zinc finger </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> that activates RANTES gene expression in T lymphocytes. RANTES ( Regulated upon</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'>sing expression cloning, we identified the first "late" T lymphocyte associated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> and named it "RANTES Factor of Late Activated T Lymphocytes-1" ( RFLAT-1 ) . RF</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'> T Lymphocytes-1" ( RFLAT-1 ) . RFLAT-1 is a novel, phosphorylated, zinc finger </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> that is expressed in T cells 3 days after activation, coincident with RANTES ex</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99172186' target='_blank'>99172186</a></td>
        <td style='text-align:right'> that NAC inhibited the constitutive as well as the LPS-induced activity of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> NF-kappa B. In parallel, NAC was shown to down-regulate the production of cytok</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99207658' target='_blank'>99207658</a></td>
        <td style='text-align:right'>ion or gene repression. Glucocorticoid receptors are also able to interact with </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional factors</mark>
        </td>
        <td> such as AP-1 ( activator protein-1 ) of NF-kappa B ( nuclear factor-kappa B ) .</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99310627' target='_blank'>99310627</a></td>
        <td style='text-align:right'>operate to promote erythroid cell survival by regulating bcl-xL expression. The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EFBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor</mark>
        </td>
        <td> GATA-1 is essential for normal erythropoiesis. By examining in vitro-differenti</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T65'>Term ID: <a href='terminology.html#L65' target='_blank'>65</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D91321794' target='_blank'>91321794</a></td>
        <td style='text-align:right'> GSH levels. Cysteine and NAC also inhibit NF-kappa B activity as determined by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">electrophoretic mobility shift assays</mark>
        </td>
        <td> and chloramphenicol acetyl-transferase ( CAT ) gene expression under control of</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>ked increase in nuclear factor-kappa B activity in these cells as determined by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">electrophoretic mobility shift assay</mark>
        </td>
        <td> using a consensus NF-kappa B oligonucleotide. An additional significant finding</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'>y at a concentration as low as 100 nM without affecting cellular proliferation. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Electrophoretic mobility shift assay</mark>
        </td>
        <td> ( EMSA ) and supershift assay using an NF-kappa B binding sequence from the kap</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'>ithout affecting cellular proliferation. Electrophoretic mobility shift assay ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EMSA</mark>
        </td>
        <td> ) and supershift assay using an NF-kappa B binding sequence from the kappa ligh</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97162234' target='_blank'>97162234</a></td>
        <td style='text-align:right'>d DNA-binding activity of NF-kappa B, by means of electrophoretic shift assay ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EMSA</mark>
        </td>
        <td> ) . We provide evidence that FCM strongly inhibits the LPS-induced NF-kappa B a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97263762' target='_blank'>97263762</a></td>
        <td style='text-align:right'> SAA promoter sequence between -280 and -226 can confer LPS responsiveness. Gel </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">electrophoretic mobility shift assay</mark>
        </td>
        <td> detected an induced DNA-binding activity in these cells in response to LPS. Cha</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'>their binding factors in the native promoter, we did transient transfection and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">electrophoretic mobility shift assays</mark>
        </td>
        <td> ( EMSA ) . Transfection of EL-4 cells with the IL-4 promoter-reporter construct</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'>oter, we did transient transfection and electrophoretic mobility shift assays ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EMSA</mark>
        </td>
        <td> ) . Transfection of EL-4 cells with the IL-4 promoter-reporter constructs carry</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'> and P4, but not P3, were required for optimal activation of the IL-4 promoter. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EMSA</mark>
        </td>
        <td> showed that both constitutive and inducible complexes bound to CLE0, P, P2 and </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'>stitutive complex bound to P3. In competition and antibody supershift assays in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EMSA</mark>
        </td>
        <td>, complexes formed with P or P2 proved to contain nuclear factor of activated T </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>on but also that of nuclear factor of activated T cells ( NFAT ) . Accordingly, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">electrophoretic mobility shift assays</mark>
        </td>
        <td> ( EMSAs ) indicated that pyrrolidine DTC ( PDTC ) prevented NF-kappa B, and NFA</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>tivated T cells ( NFAT ) . Accordingly, electrophoretic mobility shift assays ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EMSAs</mark>
        </td>
        <td> ) indicated that pyrrolidine DTC ( PDTC ) prevented NF-kappa B, and NFAT DNA-bi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>ion of erythroid-specific genes, and, in particular, the histone H5 gene. Using </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">electrophoretic mobility shift assays</mark>
        </td>
        <td>, we found that in the presence of rabbit reticulocyte lysate, human ER reduced </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'>uitment to cis-acting sites within the U3 region of the LTR, as demonstrated by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">electrophoretic mobility shift assays</mark>
        </td>
        <td>. In particular, naturally occurring sequence variation impacted transcription f</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'> supernatants was measured by an ELISA. NF-kappa B DNA binding was evaluated by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">electrophoretic mobility shift assay</mark>
        </td>
        <td>. RESULTS: LPS increased NF-kappa B DNA binding and TNF-alpha release in human m</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99356019' target='_blank'>99356019</a></td>
        <td style='text-align:right'>tration of 100 microg / 10 ( 6 ) cells. After up to 90 min exposure time ELISA, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DCFA99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EMSA</mark>
        </td>
        <td> ( electromobility shift assay ) and RT-PCR were used to measure protein tyrosin</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T218'>Term ID: <a href='terminology.html#L218' target='_blank'>218</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>did normal cells after a secondary virus infection. The effects of TNF-alpha on </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> were examined by transient expression assays using reporter chloramphenicol ace</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91321794' target='_blank'>91321794</a></td>
        <td style='text-align:right'>rophoretic mobility shift assays and chloramphenicol acetyl-transferase ( CAT ) </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> under control of NF-kappa B binding sites in uninfected cells. This suggests th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>scription can be either latent, restricted, or productive. These differences in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> have not been molecularly defined. In THP-1 cells with restricted HIV expressio</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>be negatively regulated in monocytes, providing one mechanism restricting HIV-1 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td>. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93183827' target='_blank'>93183827</a></td>
        <td style='text-align:right'>n factors EGR1, EGR2, and pAT 133. In contrast to T cells, in fibroblasts PILOT </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> requires only one signal ( PMA ) and is not affected by CyA. This observation d</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93321228' target='_blank'>93321228</a></td>
        <td style='text-align:right'>ata provide the evidence that both pathways complement each other in regulating </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> and, conversely, downregulate the TcR transduction mechanisms. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>s in T and B lymphocytes initiates signal transduction cascades which alter the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">expression of genes</mark>
        </td>
        <td> that regulate cellular proliferation and differentiation. The transmission of s</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>Lipopolysaccharide induction of tissue factor </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> in monocytic cells is mediated by binding of c-Rel / p65 heterodimers to a kapp</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>el / p65 heterodimers to a novel kappa B-like site mediated LPS induction of TF </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> in monocytic cells. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95065655' target='_blank'>95065655</a></td>
        <td style='text-align:right'>tion by BMLF1 proteins has been controversial but SM was shown to transactivate </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> from a CAT reporter construct by increasing the amount of cytoplasmic CAT mRNA.</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95261059' target='_blank'>95261059</a></td>
        <td style='text-align:right'>unlikely that Spi-B plays a significant role in myeloid lineage development and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td>. In contrast, PU.1 is expressed at high levels not only in monocytes and macrop</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95261059' target='_blank'>95261059</a></td>
        <td style='text-align:right'>ytes and macrophages but also in neutrophils, indicating that PU.1 can activate </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> in both major myeloid lineages. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>T-cell-specific transcription factor athat supported the activation of cytokine </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> and mediated the immunoregulatory effects of cyclosporin A ( CsA ) . As we obse</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96079922' target='_blank'>96079922</a></td>
        <td style='text-align:right'>t factors mammary gland factor-Stat5 and Stat1 play a role in the regulation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> during T cell development. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>the q23-31 region of human chromosome 5. To investigate the regulation of IL-13 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> by T cells, we isolated and sequenced the human IL-13 gene, analyzed its 5'-fla</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96239534' target='_blank'>96239534</a></td>
        <td style='text-align:right'> molecules. These data suggest that Tax stimulates RNA polymerase III-dependent </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> by accelerating the rate and / or extent of transcription initiation complex as</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>elements and regulatory mechanisms responsible for human interleukin 9 ( IL-9 ) </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> in a human T cell leukemia virus type I-transformed human T cell line, C5MJ2, w</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>nsformed human T cell line, C5MJ2, were investigated. We demonstrated that IL-9 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> is controlled, at least in part, by transcriptional activation. Transient expre</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>t that the cooperation of different transcription factors is essential for IL-9 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> in T cells. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96303658' target='_blank'>96303658</a></td>
        <td style='text-align:right'>nitiate an autocrine regulatory mechanism for persistent cytokine and chemokine </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td>. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97211823' target='_blank'>97211823</a></td>
        <td style='text-align:right'> These observations suggest that p65 and c-Rel complexes play distinct roles in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> and that both forms of NF-kappa B play critical roles during late stages of the</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>of cell types. Given the role of this transcription factor in the regulation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> in the inflammatory response, NF-kappa B inhibitors have been suggested as pote</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98012705' target='_blank'>98012705</a></td>
        <td style='text-align:right'>se observations provide additional evidence that oxLDL is a potent modulator of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> and suggest that ( dys ) regulation of NF-kappa B / Rel is likely to play an im</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98038749' target='_blank'>98038749</a></td>
        <td style='text-align:right'>-loop-helix ( bHLH ) transcription factors in activating differentiation-linked </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> and in inducing G1 cell cycle arrest are negatively regulated by members of the</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98038749' target='_blank'>98038749</a></td>
        <td style='text-align:right'> is not simply a function of its ability to modulate bHLH heterodimer-dependent </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> and establish a biologically important mechanism through which Cdk2 and Id-bHLH</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'>f the impact of long terminal repeat ( LTR ) sequence diversity on LTR-directed </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> in cells of the central nervous system ( CNS ) and immune system, we amplified </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98380286' target='_blank'>98380286</a></td>
        <td style='text-align:right'>ely expressed. To investigate processes related to B and T cell activation, the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA m</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98406200' target='_blank'>98406200</a></td>
        <td style='text-align:right'>ransfection of Rta leads to synthesis of ZEBRA, viral DNA replication, and late </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td>. However, Rta by itself is less potent than ZEBRA in the ability to activate mo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99007236' target='_blank'>99007236</a></td>
        <td style='text-align:right'>ithin RNA polymerase II promoters suggests a general approach for regulation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td>, as well as a mechanism for the inhibition of viral replication. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99083144' target='_blank'>99083144</a></td>
        <td style='text-align:right'>hat display agonist activity in reproductive tissue also have an effect on IL-1 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> in hemopoietic-derived tissue. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'>RFLAT-1: a new zinc finger transcription factor that activates RANTES </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> in T lymphocytes. RANTES ( Regulated upon Activation, Normal T cell Expressed a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'>ent with RANTES expression. While Rel proteins play the dominant role in RANTES </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> in fibroblasts, RFLAT-1 is a strong transactivator for RANTES in T cells. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>with IFN-alpha, IL-2, IL-12, and IL-15 upregulated IL-2Ralpha, c-myc, and pim-1 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td>. IFN-alpha also sensitized T cells to IL-2-induced proliferation, further sugge</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99310627' target='_blank'>99310627</a></td>
        <td style='text-align:right'>equired for erythroid cell survival, cooperates with GATA-1 to stimulate bcl-xL </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> and to maintain erythroid cell viability during terminal maturation. Together, </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99408303' target='_blank'>99408303</a></td>
        <td style='text-align:right'>ng the vitamin A derivative, retinoic acid. Retinoic acid can directly modulate </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEBDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene expression</mark>
        </td>
        <td> via binding to its nuclear receptors, which can, in turn, activate transcriptio</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T254'>Term ID: <a href='terminology.html#L254' target='_blank'>254</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D91164434' target='_blank'>91164434</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Glucocorticoid receptors</mark>
        </td>
        <td> on mononuclear leukocytes in Alzheimer's disease. Several lines of evidence sug</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91164434' target='_blank'>91164434</a></td>
        <td style='text-align:right'> in Alzheimer's disease ( AD ) . In an exploration of the potential role of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">glucocorticoid receptor</mark>
        </td>
        <td> ( GR ) in AD, GR density and affinity were assessed on mononuclear leukocytes o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91164434' target='_blank'>91164434</a></td>
        <td style='text-align:right'>AD ) . In an exploration of the potential role of the glucocorticoid receptor ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GR</mark>
        </td>
        <td> ) in AD, GR density and affinity were assessed on mononuclear leukocytes of 12 </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91164434' target='_blank'>91164434</a></td>
        <td style='text-align:right'> exploration of the potential role of the glucocorticoid receptor ( GR ) in AD, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GR</mark>
        </td>
        <td> density and affinity were assessed on mononuclear leukocytes of 12 AD patients </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91164434' target='_blank'>91164434</a></td>
        <td style='text-align:right'>e assessed on mononuclear leukocytes of 12 AD patients and 12 healthy controls. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GR</mark>
        </td>
        <td> binding characteristics did not differ between patients and controls or between</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91164434' target='_blank'>91164434</a></td>
        <td style='text-align:right'>ata suggest that the abnormalities of the HPA system in AD are not related to a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GR</mark>
        </td>
        <td> deficiency. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'>Regulation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">glucocorticoid receptors</mark>
        </td>
        <td> in human mononuclear cells: effects of glucocorticoid treatment, Cushing's dise</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'>cells: effects of glucocorticoid treatment, Cushing's disease and ketoconazole. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Glucocorticoid receptors</mark>
        </td>
        <td> ( GcR ) were determined by a whole cell assay in human mononulear leukocytes ( </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'>icoid treatment, Cushing's disease and ketoconazole. Glucocorticoid receptors ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GcR</mark>
        </td>
        <td> ) were determined by a whole cell assay in human mononulear leukocytes ( hMNL )</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'>zole therapy. Prolonged corticosteroid treatment resulted in down-regulation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GcR</mark>
        </td>
        <td>, while the mean level of GcR in Cushing's disease was normal. In this group, ho</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'>costeroid treatment resulted in down-regulation of GcR, while the mean level of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GcR</mark>
        </td>
        <td> in Cushing's disease was normal. In this group, however, receptor levels and mo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'> negative correlation, indicating a subtle down-regulatory effect. Furthermore, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GcR</mark>
        </td>
        <td> were unaltered after these patients received ketoconazole, in spite of a marked</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'>nary free cortisol. We also observed that ketoconazole was a weak competitor of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GcR</mark>
        </td>
        <td> in intact cells, although it significantly inhibited [3H] dexamethasone binding</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'> binding in cytosolic preparations from rat tissues. The results suggested that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GcR</mark>
        </td>
        <td> in hMNL are down-regulated by synthetic steroids given in vivo, but they showed</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'>g's disease. Finally, we did not observed either up-regulation or antagonism of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GcR</mark>
        </td>
        <td> by ketoconazole treatment, at the time that cortisol levels of patients with Cu</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'>g's disease are due to adrenal cortisol suppression and not to interaction with </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GcR</mark>
        </td>
        <td> of target cells, and that the process of GcR regulation in hMNL is a complex ph</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'>ession and not to interaction with GcR of target cells, and that the process of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GcR</mark>
        </td>
        <td> regulation in hMNL is a complex phenomenon awaiting further elucidation. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92362919' target='_blank'>92362919</a></td>
        <td style='text-align:right'>hy persons and patients with hypertension] It has been found that the number of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">glucocorticoid receptors</mark>
        </td>
        <td> in lymphocytes of the peripheral blood of healthy elderly subjects increases, w</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>ed higher affinity towards the ICAM-1 kappa B than to the HIV kappa B site. The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">glucocorticoid receptor</mark>
        </td>
        <td> was shown to repress activity of both the RelA homodimer and the NF-kappa B1 / </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98133462' target='_blank'>98133462</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Glucocorticoid receptors</mark>
        </td>
        <td> in cord blood lymphocytes of healthy neonates and of preterms suffering from re</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98133462' target='_blank'>98133462</a></td>
        <td style='text-align:right'>reterms suffering from respiratory distress syndrome. We measured the number of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">glucocorticoid receptors</mark>
        </td>
        <td> ( GR ) in cord blood lymphocytes and the binding affinity ( Kd ) in 15 term and</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98133462' target='_blank'>98133462</a></td>
        <td style='text-align:right'>iratory distress syndrome. We measured the number of glucocorticoid receptors ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GR</mark>
        </td>
        <td> ) in cord blood lymphocytes and the binding affinity ( Kd ) in 15 term and in 2</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98133462' target='_blank'>98133462</a></td>
        <td style='text-align:right'>terms developed neonatal respiratory distress syndrome ( NRDS ) . The number of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GR</mark>
        </td>
        <td> and the Kd were similar in the term and preterm ( with and without NRDS ) babie</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98133462' target='_blank'>98133462</a></td>
        <td style='text-align:right'>thasone was the same in all groups. In this study on the number and function of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GR</mark>
        </td>
        <td> in lymphocytes, we were unable to find a relation between the functionality of </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98133462' target='_blank'>98133462</a></td>
        <td style='text-align:right'>lymphocytes, we were unable to find a relation between the functionality of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GR</mark>
        </td>
        <td> and the development of NRDS. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99207658' target='_blank'>99207658</a></td>
        <td style='text-align:right'>se of allergic reaction. The action of glucocorticosteroids is mediated through </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">glucocorticoid receptors</mark>
        </td>
        <td> present in the cellular cytoplasm. When activated, glucocorticoid receptors for</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99207658' target='_blank'>99207658</a></td>
        <td style='text-align:right'>ugh glucocorticoid receptors present in the cellular cytoplasm. When activated, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">glucocorticoid receptors</mark>
        </td>
        <td> form a dimer and bind to DNA after migration into the nucleus. Interaction to D</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99207658' target='_blank'>99207658</a></td>
        <td style='text-align:right'>in the transcription rate, leading to either gene induction or gene repression. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Glucocorticoid receptors</mark>
        </td>
        <td> are also able to interact with transcriptional factors such as AP-1 ( activator</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99294118' target='_blank'>99294118</a></td>
        <td style='text-align:right'>Binding characteristics of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">glucocorticoid receptor</mark>
        </td>
        <td> in peripheral blood lymphocytes in multiple sclerosis. Although the exact etiol</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99294118' target='_blank'>99294118</a></td>
        <td style='text-align:right'>uitary-adrenal system in a substantial proportion of patients. We characterized </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">glucocorticoid receptor</mark>
        </td>
        <td> ( GR ) binding in peripheral blood lymphocytes from 39 MS patients and 14 age- </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99294118' target='_blank'>99294118</a></td>
        <td style='text-align:right'> substantial proportion of patients. We characterized glucocorticoid receptor ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GR</mark>
        </td>
        <td> ) binding in peripheral blood lymphocytes from 39 MS patients and 14 age- and s</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99294118' target='_blank'>99294118</a></td>
        <td style='text-align:right'>apacity, using a whole-cell binding assay with [3H]dexamethasone as the ligand. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GR</mark>
        </td>
        <td> binding parameters did not differ significantly between patients ( Kd 8.98 +/- </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99294118' target='_blank'>99294118</a></td>
        <td style='text-align:right'>rse, duration or severity of disease, or prior steroid treatments was detected. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GR</mark>
        </td>
        <td> binding parameters were analyzed in relation to the results of the combined dex</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99294118' target='_blank'>99294118</a></td>
        <td style='text-align:right'>s. While controls showed a moderate correlation between binding affinity of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GR</mark>
        </td>
        <td> in lymphocytes and regulatory function at the hypothalamic level, the patients </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99294118' target='_blank'>99294118</a></td>
        <td style='text-align:right'>suggest that the physiological relationship between binding and function of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABBCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">glucocorticoid receptor</mark>
        </td>
        <td> is disturbed in MS. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T12'>Term ID: <a href='terminology.html#L12' target='_blank'>12</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'>tic-specific transcript directly regulated by the retinoic acid receptor alpha. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Retinoic acid</mark>
        </td>
        <td> ( RA ) -induced maturation mediated by the retinoic acid receptor alpha ( RAR a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'>nscript directly regulated by the retinoic acid receptor alpha. Retinoic acid ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RA</mark>
        </td>
        <td> ) -induced maturation mediated by the retinoic acid receptor alpha ( RAR alpha </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'>fferential hybridization analysis of a cDNA library constructed from the murine </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RA</mark>
        </td>
        <td>-inducible MPRO promyelocyte cell line to identify immediate-early genes induced</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'>ucible MPRO promyelocyte cell line to identify immediate-early genes induced by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RA</mark>
        </td>
        <td> during granulocytic differentiation. E3, one of nine sequences identified, was </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'>diate-early manner, with transcript levels peaking after 60 minutes exposure to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RA</mark>
        </td>
        <td>. E3 transcripts were RA-inducible in HL60 cells, but not in an RA-resistant sub</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'> transcript levels peaking after 60 minutes exposure to RA. E3 transcripts were </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RA</mark>
        </td>
        <td>-inducible in HL60 cells, but not in an RA-resistant subclone, HL60R, that harbo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'>s exposure to RA. E3 transcripts were RA-inducible in HL60 cells, but not in an </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RA</mark>
        </td>
        <td>-resistant subclone, HL60R, that harbors a mutated RAR alpha gene. However, when</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'> when HL60R cells were transduced with a functional copy of the RAR alpha gene, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RA</mark>
        </td>
        <td> induced a 10-fold increase in E3 mRNA levels. E3 transcripts are present in the</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'>n expressed in myeloid cells. The murine E3 promoter harbors a single bipartite </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">retinoic acid</mark>
        </td>
        <td> response element which in transient transfection assays conferred RA sensitivit</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'>retinoic acid response element which in transient transfection assays conferred </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RA</mark>
        </td>
        <td> sensitivity. These results indicate that E3 is a hematopoietic-specific gene th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97028169' target='_blank'>97028169</a></td>
        <td style='text-align:right'>Dual action of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">retinoic acid</mark>
        </td>
        <td> on human embryonic / fetal hematopoiesis: blockade of primitive progenitor prol</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97028169' target='_blank'>97028169</a></td>
        <td style='text-align:right'> investigated the role of all-trans retinoic acid ( ATRA ) and its isomer 9-cis </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RA</mark>
        </td>
        <td> in FL hematopoiesis. Both compounds modulate the growth of purified FL HPCs, wh</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97028169' target='_blank'>97028169</a></td>
        <td style='text-align:right'> of the HPC differentiation program to the granulopoietic pathway ( rather than </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RA</mark>
        </td>
        <td>-induced down-modulation of multipotent /erythroid / monocytic HPC growth couple</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97028169' target='_blank'>97028169</a></td>
        <td style='text-align:right'>tic HPC growth coupled with recruitment of granulocytic HPCs ) . ATRA and 9-cis </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RA</mark>
        </td>
        <td> also exert their effect on the proliferation of primitive HPCs ( high-prolifera</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97028169' target='_blank'>97028169</a></td>
        <td style='text-align:right'>anulocytic differentiation. Altogether, these results suggest that ATRA / 9-cis </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RA</mark>
        </td>
        <td> may play a key role in FL hematopoiesis via a dual effect hypothetically mediat</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99408303' target='_blank'>99408303</a></td>
        <td style='text-align:right'>Neutrophil maturation and the role of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">retinoic acid</mark>
        </td>
        <td>. Neutrophil maturation occurs in well defined morphological stages that correla</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99408303' target='_blank'>99408303</a></td>
        <td style='text-align:right'>y a role in terminal neutrophil maturation, including the vitamin A derivative, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">retinoic acid</mark>
        </td>
        <td>. Retinoic acid can directly modulate gene expression via binding to its nuclear</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99408303' target='_blank'>99408303</a></td>
        <td style='text-align:right'>minal neutrophil maturation, including the vitamin A derivative, retinoic acid. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Retinoic acid</mark>
        </td>
        <td> can directly modulate gene expression via binding to its nuclear receptors, whi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99408303' target='_blank'>99408303</a></td>
        <td style='text-align:right'>ceptors, which can, in turn, activate transcription of target genes. A role for </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDB9E9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">retinoic acid</mark>
        </td>
        <td> during neutrophil maturation has been suggested from a variety of sources. Here</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T288'>Term ID: <a href='terminology.html#L288' target='_blank'>288</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96085174' target='_blank'>96085174</a></td>
        <td style='text-align:right'> of Jak 1, Jak 3 and STAT 5 proteins in murine T cells. The activation of Janus </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ECF9CE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">protein tyrosine kinases</mark>
        </td>
        <td> ( Jak ) and STAT ( signal transducer and activator of transcription ) proteins </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'>own to be directly involved in mediating CD40-dependent signals. The use of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ECF9CE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">protein tyrosine kinase</mark>
        </td>
        <td> ( PTK ) -specific inhibitor herbimycin A dramatically decreased cellular prolif</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'>d in mediating CD40-dependent signals. The use of the protein tyrosine kinase ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ECF9CE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PTK</mark>
        </td>
        <td> ) -specific inhibitor herbimycin A dramatically decreased cellular proliferatio</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97468093' target='_blank'>97468093</a></td>
        <td style='text-align:right'>ivity of the enzyme appear to be affected by pretreatment of the cells with the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ECF9CE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">protein tyrosine kinase</mark>
        </td>
        <td> inhibitor genistein, which is known to prevent the association of ISGF3 compone</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>LPS-Induced NF-kappa B activation and TNF-alpha release in human monocytes are </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ECF9CE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">protein tyrosine kinase</mark>
        </td>
        <td> dependent and protein kinase C independent. BACKGROUND: Tumor necrosis factor a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>revious studies have implicated activation of both protein kinase C ( PKC ) and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ECF9CE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">protein tyrosine kinases</mark>
        </td>
        <td> ( PTK ) in LPS-induced NF-kappa B activation and TNF-alpha production. We hypot</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>ated activation of both protein kinase C ( PKC ) and protein tyrosine kinases ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ECF9CE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PTK</mark>
        </td>
        <td> ) in LPS-induced NF-kappa B activation and TNF-alpha production. We hypothesize</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>tion and TNF-alpha production. We hypothesized that inhibition of either PKC or </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ECF9CE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PTK</mark>
        </td>
        <td> would decrease LPS-induced NF-kappa B DNA binding and TNF-alpha release in huma</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>, a specific pan-PKC inhibitor bisindolylmaleimide ( Bis ) , or an inhibitor of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ECF9CE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PTK</mark>
        </td>
        <td> genistein ( Gen ) . TNF-alpha release in culture supernatants was measured by a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>h Bis had no effect on LPS-induced NF-kappa B DNA binding or TNF-alpha release. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ECF9CE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PTK</mark>
        </td>
        <td> inhibition with Gen attenuated both LPS-induced NF-kappa B DNA binding and TNF-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>are independent of PKC activity. Furthermore, our results provide evidence that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ECF9CE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PTK</mark>
        </td>
        <td> plays a role in LPS-induced NF-kappa B activation and TNF-alpha release in huma</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99356019' target='_blank'>99356019</a></td>
        <td style='text-align:right'>-release of fibre-exposed monocytes increases inflammatory cytokine-mRNA level, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ECF9CE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">protein tyrosine kinase</mark>
        </td>
        <td> and NF-kappa B activity in co-cultured bronchial epithelial cells ( BEAS-2B ) .</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T77'>Term ID: <a href='terminology.html#L77' target='_blank'>77</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>ectin by tumor necrosis factor-alpha ( TNF ) is mediated by mobilization of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBAAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor nuclear factor-kappa B</mark>
        </td>
        <td> ( NF-kappa B ) . Since salicylates have been reported to inhibit NF-kappa B act</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>grin ligation leads to nuclear translocation of the p50 and p65 subunits of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBAAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B transcription factor</mark>
        </td>
        <td>, to activation of a reporter gene driven by a promoter containing NF-kappa B si</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97445683' target='_blank'>97445683</a></td>
        <td style='text-align:right'>Rel / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBAAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B transcription factors</mark>
        </td>
        <td> and the control of apoptosis. The process of apoptosis is used to eliminate unw</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97445683' target='_blank'>97445683</a></td>
        <td style='text-align:right'>ific fashion. Recent work from several laboratories has demonstrated that Rel / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBAAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B transcription factors</mark>
        </td>
        <td> regulate apoptosis in many cell types. In most cells, Rel / NF-kappa B transcri</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97445683' target='_blank'>97445683</a></td>
        <td style='text-align:right'>anscription factors regulate apoptosis in many cell types. In most cells, Rel / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBAAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B transcription factors</mark>
        </td>
        <td> appear to mediate survival signals that protect cells from apoptosis; however, </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'>ment binding ( ATF / CREB ) binding site ( located between the LEF-1 and distal </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBAAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B transcription factor</mark>
        </td>
        <td> binding sites ) that we identified in previous studies of the HIV-1 LTR. These </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99201482' target='_blank'>99201482</a></td>
        <td style='text-align:right'>in part, due to the ability of HTB and triflusal to block the activation of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBAAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription factor nuclear factor-kappa B</mark>
        </td>
        <td> to a higher extent than aspirin and sodium salicylate. Thus, in addition to inh</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T266'>Term ID: <a href='terminology.html#L266' target='_blank'>266</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>Cell-specific differences in activation of NF-kappa B regulatory elements of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human immunodeficiency virus</mark>
        </td>
        <td> and beta interferon promoters by tumor necrosis factor. Three aspects of the in</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>r necrosis factor. Three aspects of the involvement of tumor necrosis factor in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human immunodeficiency virus</mark>
        </td>
        <td> ( HIV ) pathogenesis were examined. Tumor necrosis factor alpha ( TNF-alpha ) m</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>s of the involvement of tumor necrosis factor in human immunodeficiency virus ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HIV</mark>
        </td>
        <td> ) pathogenesis were examined. Tumor necrosis factor alpha ( TNF-alpha ) mRNA pr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>erase chain reaction amplification in monocytic U937 cells and in a chronically </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HIV</mark>
        </td>
        <td> infected U937 cell line ( U9-IIIB ) . TNF-alpha RNA was undetectable in U937 ce</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>vel of TNF-alpha RNA in U9-IIIB cells compared with U937 cells, suggesting that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HIV</mark>
        </td>
        <td>-infected monocytic cells produced higher levels of TNF-alpha than did normal ce</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>loramphenicol acetyltransferase plasmids linked to regulatory elements from the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HIV</mark>
        </td>
        <td> long terminal repeat ( LTR ) and the beta interferon promoter. In U937 and Jurk</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>were inducible by both agents. TNF-alpha was able to increase expression of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HIV</mark>
        </td>
        <td> LTR in T cells, but in monocytic cells, TNF-alpha did not induce the HIV LTR ab</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>of the HIV LTR in T cells, but in monocytic cells, TNF-alpha did not induce the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HIV</mark>
        </td>
        <td> LTR above a constitutive level of activity. This level of NF-kappa B-independen</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>tiplication, since TNF-alpha treatment had no effect on the kinetics of de novo </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HIV</mark>
        </td>
        <td> type 1 ( HIV-1 ) infection and viral RNA production in U937 cells. However, in </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>Negative regulation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human immunodeficiency virus</mark>
        </td>
        <td> type 1 expression in monocytes: role of the 65-kDa plus 50-kDa NF-kappa B dimer</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>cells can provide a reservoir for viral production in vivo, their regulation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human immunodeficiency virus</mark>
        </td>
        <td> type 1 ( HIV-1 ) transcription can be either latent, restricted, or productive.</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>ne expression have not been molecularly defined. In THP-1 cells with restricted </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HIV</mark>
        </td>
        <td> expression, there is an absence of DNA-protein binding complex formation with t</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95000924' target='_blank'>95000924</a></td>
        <td style='text-align:right'>of HIV-1 Nef expression in activation pathways in CD4+ T cells. The role of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human immunodeficiency virus</mark>
        </td>
        <td> ( HIV-1 ) Nef protein in T cell activation pathways was investigated using a Ju</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>and RelA, and to bind with higher affinity to the consensus kappa B site in the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HIV</mark>
        </td>
        <td> long terminal repeat. The second complex contained RelA, and exhibited higher a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>ined RelA, and exhibited higher affinity towards the ICAM-1 kappa B than to the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HIV</mark>
        </td>
        <td> kappa B site. The glucocorticoid receptor was shown to repress activity of both</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Human immunodeficiency virus</mark>
        </td>
        <td> type 1 long terminal repeat quasispecies differ in basal transcription and nucl</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99007236' target='_blank'>99007236</a></td>
        <td style='text-align:right'>ific genes. Multiple cellular DNA-binding transcription factors are required by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HIV</mark>
        </td>
        <td> type 1 for RNA synthesis. Two pyrrole-imidazole polyamides were designed to bin</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99007236' target='_blank'>99007236</a></td>
        <td style='text-align:right'>hetic ligands specifically inhibit DNA-binding of each transcription factor and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HIV</mark>
        </td>
        <td> type 1 transcription in cell-free assays. When used in combination, the polyami</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'>tokine ( chemokine ) important in the generation of inflammatory infiltrate and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDACAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human immunodeficiency virus</mark>
        </td>
        <td> entry into immune cells. RANTES is expressed late ( 3-5 days ) after activation</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T100'>Term ID: <a href='terminology.html#L100' target='_blank'>100</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D93321228' target='_blank'>93321228</a></td>
        <td style='text-align:right'>Costimulation of cAMP and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">protein kinase C</mark>
        </td>
        <td> pathways inhibits the CD3-dependent T cell activation and leads to a persistent</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93321228' target='_blank'>93321228</a></td>
        <td style='text-align:right'>anscription factor. The effects mediated by a combined stimulation of cAMP -and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">protein kinase C</mark>
        </td>
        <td> ( PKC ) -dependent pathways have been investigated in different cellular system</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93321228' target='_blank'>93321228</a></td>
        <td style='text-align:right'> The effects mediated by a combined stimulation of cAMP -and protein kinase C ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PKC</mark>
        </td>
        <td> ) -dependent pathways have been investigated in different cellular systems, and</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>inducer of Fos kinase activity in all of the above populations, suggesting that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PKC</mark>
        </td>
        <td> plays a role in the regulation of this enzyme. Fos kinase phosphorylates c-Fos </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>t from other identified serine / threonine kinases, including protein kinase A, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">protein kinase C</mark>
        </td>
        <td>, casein kinase II, MAP kinases, p70S6K and p90RSK. Fos kinase was purified by a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'> system was used to examine the role of different signal transduction elements. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Protein kinase C</mark>
        </td>
        <td> ( PKC ) depletion generated by a long-term phorbol 12 myristate 13-acetate trea</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'> examine the role of different signal transduction elements. Protein kinase C ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PKC</mark>
        </td>
        <td> ) depletion generated by a long-term phorbol 12 myristate 13-acetate treatment </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'>that both p65 ( RelA ) and c-Rel were present in CD40-stimulated B cells. While </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PKC</mark>
        </td>
        <td> depletion did not alter the NF-kappa B level, treatment of B lymphocytes with H</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'> TNF-alpha release in human monocytes are protein tyrosine kinase dependent and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">protein kinase C</mark>
        </td>
        <td> independent. BACKGROUND: Tumor necrosis factor alpha ( TNF-alpha ) is an import</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'> B ) and TNF-alpha release. Previous studies have implicated activation of both </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">protein kinase C</mark>
        </td>
        <td> ( PKC ) and protein tyrosine kinases ( PTK ) in LPS-induced NF-kappa B activati</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>release. Previous studies have implicated activation of both protein kinase C ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PKC</mark>
        </td>
        <td> ) and protein tyrosine kinases ( PTK ) in LPS-induced NF-kappa B activation and</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'> activation and TNF-alpha production. We hypothesized that inhibition of either </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PKC</mark>
        </td>
        <td> or PTK would decrease LPS-induced NF-kappa B DNA binding and TNF-alpha release </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'> / threonine protein kinase inhibitor staurosporine ( Stauro ) , a specific pan-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PKC</mark>
        </td>
        <td> inhibitor bisindolylmaleimide ( Bis ) , or an inhibitor of PTK genistein ( Gen </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>nhibition inhibited NF-kappa B activation and TNF-alpha release, while specific </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PKC</mark>
        </td>
        <td> inhibition with Bis had no effect on LPS-induced NF-kappa B DNA binding or TNF-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>B DNA binding and TNF-alpha production in human monocytes. Direct activation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PKC</mark>
        </td>
        <td> with PMA induced both NF-kappa B activation and TNF-alpha production by human m</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>-kappa B activation and TNF-alpha release in human monocytes are independent of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DE9A9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PKC</mark>
        </td>
        <td> activity. Furthermore, our results provide evidence that PTK plays a role in LP</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T291'>Term ID: <a href='terminology.html#L291' target='_blank'>291</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>ascade of Jurkat human leukaemic T-cells. Pervanadate induced activation of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9ACFA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine kinases</mark>
        </td>
        <td> lck and fyn ( 4- and 3-fold respectively ) and a dramatic increase in tyrosine </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'> possible signaling role for the Syk tyrosine kinase. Activation of cytoplasmic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9ACFA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine kinases</mark>
        </td>
        <td> is an important aspect of signal transduction mediated by integrins. In the hum</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>r immediate-early genes, including the cytokine interleukin ( IL ) -1 beta. The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9ACFA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine kinase</mark>
        </td>
        <td> inhibitors genistein and herbimycin A block both integrin-mediated tyrosine pho</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9ACFA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Tyrosine kinase</mark>
        </td>
        <td> and cAMP-dependent protein kinase activities in CD40-activated human B lymphocy</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T130'>Term ID: <a href='terminology.html#L130' target='_blank'>130</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>on amplification in monocytic U937 cells and in a chronically HIV infected U937 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td> ( U9-IIIB ) . TNF-alpha RNA was undetectable in U937 cells, whereas a low const</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>t, CCRF-CEM ) and not in mature B cells ( JY, Namalwa ) or nonlymphoid ( HeLa ) </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell lines</mark>
        </td>
        <td>. A small 95-bp fragment of the TCR alpha control region that contains the TCF-1</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'> normal human T lymphocytes and in response to IL-6 and anti-IgM in the human B </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell lines</mark>
        </td>
        <td> AF10 and Ramos, respectively. The phorbol ester, PMA, was also a potent inducer</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>e and cytokine expression in human peripheral blood monocytes and the monocytic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td> THP-1 after stimulation with mycoplasma-derived material MDHM. Mycoplasma ferme</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>. The induced expression of IL-1 beta and TNF alpha mRNA in the monocytic THP-1 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td> increased as quickly as in primary cells. In contrast to PBMo, THP-1 and 14 oth</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>s. In contrast to PBMo, THP-1 and 14 other monocytic / myeloid leukemia-derived </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell lines</mark>
        </td>
        <td> did not secrete measurable amounts of the cytokines upon treatment with MDHM. I</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95000924' target='_blank'>95000924</a></td>
        <td style='text-align:right'> Nef protein in T cell activation pathways was investigated using a Jurkat CD4+ </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td> stably transfected with a Nef expression vector. Secretion of IL-2 and TNF-alph</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'>ession, we investigated tal-1 chromatin structure in erythroid / megakaryocytic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell lines</mark>
        </td>
        <td> and in T-cell lines either with or without tal-1 rearrangements. Tal-1 transcri</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'>ls, and methylated de novo on transcriptionally inactive alleles in established </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell lines</mark>
        </td>
        <td>. Five major DNase-I hypersensitive sites ( HS ) were mapped in the tal-1 locus.</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'>us. HS I, IV, and V were exclusively observed in the erythroid / megakaryocytic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell lines</mark>
        </td>
        <td> that express tal-1 from the promoters 1a and 1b. HS II was weak in hematopoieti</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'>hat express tal-1 from the promoters 1a and 1b. HS II was weak in hematopoietic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell lines</mark>
        </td>
        <td>, absent in Hela, and greatly enhanced in Jurkat, suggesting that this region mi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'>s region might be implicated in the cis-activation of tal-1 promoter 1b in this </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td>. HS III was weak in HEL and Jurkat, and greatly enhanced in DU528, a T-cell lin</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95261059' target='_blank'>95261059</a></td>
        <td style='text-align:right'>U.1 expression is maintained at stable levels during differentiation of myeloid </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell lines</mark>
        </td>
        <td> U937 and HL-60 to monocytic and neutrophilic cells. PU.1 is expressed at highes</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95261059' target='_blank'>95261059</a></td>
        <td style='text-align:right'> to PU.1, significant levels of Spi-B mRNA and protein are found only in some B-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell lines</mark>
        </td>
        <td> and spleen but are not found in myeloid cell lines, neutrophils, or macrophages</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95261059' target='_blank'>95261059</a></td>
        <td style='text-align:right'>ein are found only in some B-cell lines and spleen but are not found in myeloid </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell lines</mark>
        </td>
        <td>, neutrophils, or macrophages. In vitro translated Spi-B protein can bind to PU.</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>ant aspect of signal transduction mediated by integrins. In the human monocytic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td> THP-1, either integrin-dependent cell adhesion to fibronectin or ligation of be</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96038813' target='_blank'>96038813</a></td>
        <td style='text-align:right'>showed that B4-2 is not a lymphoid specific gene and is expressed in a hepatoma </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td> and also weakly transcribed or absent in a variety of other cells. A polyclonal</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'>is of a cDNA library constructed from the murine RA-inducible MPRO promyelocyte </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td> to identify immediate-early genes induced by RA during granulocytic differentia</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97303223' target='_blank'>97303223</a></td>
        <td style='text-align:right'>k1 ) activation, STAT6 activation, and Cepsilon germline transcripts in human B </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td> BJAB. Disruption of the Jak1-binding proline-rich Box1 region of IL-4Ralpha abo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104462' target='_blank'>98104462</a></td>
        <td style='text-align:right'>he human TNF promoter () revealed that in tolerant cells of the human monocytic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td> Mono Mac 6 there is a predominance of p50p50 of NF-kappa B. We now show that a </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104462' target='_blank'>98104462</a></td>
        <td style='text-align:right'>. The same is true for nuclear extracts taken from the murine P388D1 macrophage </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td> when tested with the -516 motif of the murine TNF promoter () . Here the wild t</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'> which varied significantly from the LAI LTR in U-373 MG cells ( an astrocytoma </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td> ) as well as in Jurkat cells ( a CD4-positive lymphocyte cell line ) . While LT</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'> astrocytoma cell line ) as well as in Jurkat cells ( a CD4-positive lymphocyte </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td> ) . While LTRs which demonstrated the highest activities in U-373 MG cells also</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98406200' target='_blank'>98406200</a></td>
        <td style='text-align:right'>xpression of Rta is also sufficient for disruption of latency in a permissive B-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td>. In HH514-16 cells, transfection of Rta leads to synthesis of ZEBRA, viral DNA </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99083144' target='_blank'>99083144</a></td>
        <td style='text-align:right'>Effect of environmental estrogens on IL-1beta promoter activity in a macrophage </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td>. Environmental estrogens or estrogen disrupters have recently received a great </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99083144' target='_blank'>99083144</a></td>
        <td style='text-align:right'> the modulation of the interleukin-1beta ( IL-1beta ) gene in a model monocytic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td>, hER + IL-1beta-CAT+. This cell line stably transfected with the human estrogen</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99083144' target='_blank'>99083144</a></td>
        <td style='text-align:right'>eta ( IL-1beta ) gene in a model monocytic cell line, hER + IL-1beta-CAT+. This </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td> stably transfected with the human estrogen receptor, and an IL-1beta promoter c</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'>y, by in vitro stimulation with the latently infected autologous lymphoblastoid </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBCCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell line</mark>
        </td>
        <td> ( LCL ) , has important limitations. First, it gives no information on memory t</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T18'>Term ID: <a href='terminology.html#L18' target='_blank'>18</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D93321228' target='_blank'>93321228</a></td>
        <td style='text-align:right'>Costimulation of cAMP and protein kinase C pathways inhibits the CD3-dependent </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9DE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cell activation</mark>
        </td>
        <td> and leads to a persistent expression of the AP-1 transcription factor. The effe</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>Induction of tyrosine phosphorylation and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9DE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell activation</mark>
        </td>
        <td> by vanadate peroxide, an inhibitor of protein tyrosine phosphatases. Rapid tyro</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95000924' target='_blank'>95000924</a></td>
        <td style='text-align:right'> T cells. The role of the human immunodeficiency virus ( HIV-1 ) Nef protein in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9DE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cell activation</mark>
        </td>
        <td> pathways was investigated using a Jurkat CD4+ cell line stably transfected with</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>-13 P element site significantly reduced IL-13 promoter activity in response to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9DE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell activation</mark>
        </td>
        <td>. Oligonucleotides containing the IL-13 or IL-4 P element sites specifically bou</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96322726' target='_blank'>96322726</a></td>
        <td style='text-align:right'>y in mononuclear cell cultures and T cells by the cyclic AMP signaling pathway. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9DE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Activation of T cells</mark>
        </td>
        <td> results in a cascade of gene activation and subsequent proliferation and differ</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>Blockade of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9DE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell activation</mark>
        </td>
        <td> by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>( IL-2 ) synthesis and membrane expression of antigens which are induced during </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9DE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell activation</mark>
        </td>
        <td>. This inhibition, which occurred with a parallel activation of c-Jun transactiv</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>icated that pyrrolidine DTC ( PDTC ) prevented NF-kappa B, and NFAT DNA-binding </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9DE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activity in T cells</mark>
        </td>
        <td> stimulated with either phorbol myristate acetate plus ionophore or antibodies a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98090689' target='_blank'>98090689</a></td>
        <td style='text-align:right'> clearly elucidated. We have hypothesized that such defects in fetal / neonatal </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9DE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell activation</mark>
        </td>
        <td> may be due to lack of expression of the transcriptional regulatory elements req</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98090689' target='_blank'>98090689</a></td>
        <td style='text-align:right'>e to lack of expression of the transcriptional regulatory elements required for </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9DE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell activation</mark>
        </td>
        <td>. We used reverse transcriptase-polymerase chain reaction to examine both fetal </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98090689' target='_blank'>98090689</a></td>
        <td style='text-align:right'>al cord bloods for mRNA expression of three transcription factors implicated in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9DE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell activation</mark>
        </td>
        <td>: c-jun, c-fos, and NF kappa B ( p50 subunit ) . We demonstrate that mRNAs for a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98380286' target='_blank'>98380286</a></td>
        <td style='text-align:right'>n genes are constitutively expressed. To investigate processes related to B and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9DE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cell activation</mark>
        </td>
        <td>, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99081619' target='_blank'>99081619</a></td>
        <td style='text-align:right'> Our studies show that the mechanism of IL-10 regulation of quiescent CD4 ( + ) </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9DE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell activation</mark>
        </td>
        <td> is mainly by blocking induction of IL-2 that is critical to downregulation of p</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99081619' target='_blank'>99081619</a></td>
        <td style='text-align:right'> is critical to downregulation of p27 ( Kip1 ) and upregulation of D cyclins in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9DE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell activation</mark>
        </td>
        <td> and entry into the cell cycle. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T48'>Term ID: <a href='terminology.html#L48' target='_blank'>48</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>LPS-Induced NF-kappa B activation and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBDFAE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha release in human monocytes</mark>
        </td>
        <td> are protein tyrosine kinase dependent and protein kinase C independent. BACKGRO</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>tion of either PKC or PTK would decrease LPS-induced NF-kappa B DNA binding and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBDFAE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha release in human monocytes</mark>
        </td>
        <td>. MATERIALS AND METHODS: Human monocytes were stimulated with PMA ( 50 ng / ml )</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>horetic mobility shift assay. RESULTS: LPS increased NF-kappa B DNA binding and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBDFAE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha release in human monocytes</mark>
        </td>
        <td>. Nonspecific protein kinase inhibition inhibited NF-kappa B activation and TNF-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>. CONCLUSIONS: These results suggest that LPS-induced NF-kappa B activation and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBDFAE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha release in human monocytes</mark>
        </td>
        <td> are independent of PKC activity. Furthermore, our results provide evidence that</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>provide evidence that PTK plays a role in LPS-induced NF-kappa B activation and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBDFAE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha release in human monocytes</mark>
        </td>
        <td> and thus could be a potential therapeutic target in inflammatory states.</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T32'>Term ID: <a href='terminology.html#L32' target='_blank'>32</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90140708' target='_blank'>90140708</a></td>
        <td style='text-align:right'>tive helix-loop-helix motifs and each possesses a distinct domain that dictates </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription activation</mark>
        </td>
        <td>. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>n of T cells into functionally diverse subpopulations is controlled in part, by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional activation</mark>
        </td>
        <td> and silencing; however, little is known in detail about the proteins that influ</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>positioned in one or more copies upstream of a heterologous promoter. Thus, the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional activity</mark>
        </td>
        <td> of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) tran</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92135145' target='_blank'>92135145</a></td>
        <td style='text-align:right'>ne the roles of these two factors, which bind to the same kappa B enhancers, in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription activation</mark>
        </td>
        <td> we have prepared somatic cell hybrids between IARC 301.5 and a murine myeloma. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Transcriptional activation</mark>
        </td>
        <td> of human zeta 2 globin promoter by the alpha globin regulatory element ( HS-40 </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'> of nuclear factor binding in vivo at the HS-40 region. These data suggest that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional activation</mark>
        </td>
        <td> of human embryonic zeta 2 globin gene and the fetal / adult alpha globin genes </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Transcriptional activity</mark>
        </td>
        <td> of core binding factor-alpha ( AML1 ) and beta subunits on murine leukemia viru</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>ic determinants of the ability of this virus to induce T-cell lymphomas and the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional activity</mark>
        </td>
        <td> of the viral long terminal repeat in T lymphocytes. CBF consists of two subunit</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>gh the core elements. Three different isoforms of CBF beta were also tested for </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional activity</mark>
        </td>
        <td> on the SL3 enhancer. The longest form, CBF beta-187, increased the transcriptio</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'> CBF alpha 2-451 twofold in HeLa cells, although it had no effect in P19 cells. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Transcriptional activation</mark>
        </td>
        <td> by CBF beta required binding to the CBF alpha subunit, as a form of CBF beta th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96074632' target='_blank'>96074632</a></td>
        <td style='text-align:right'> a labeled NF-kappa B DNA binding motif. Further, 1,25 ( OH ) 2D3 inhibited the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional activity</mark>
        </td>
        <td> of NF-kappa B in Jurkat cells transiently transfected with a construct containi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96079922' target='_blank'>96079922</a></td>
        <td style='text-align:right'>2 receptor activation are both linked to the Jak / Stat ( signal transducer and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activator of transcription</mark>
        </td>
        <td> ) pathway. We investigated the ability of PRL and IL-2 to activate Stat protein</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96085174' target='_blank'>96085174</a></td>
        <td style='text-align:right'>tion of Janus protein tyrosine kinases ( Jak ) and STAT ( signal transducer and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activator of transcription</mark>
        </td>
        <td> ) proteins has recently been linked to the signal transduction mechanism of sev</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>d sequenced the human IL-13 gene, analyzed its 5'-flanking region for potential </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional activation</mark>
        </td>
        <td> elements, and examined its expression in nontransformed T-lineage cell populati</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>a segment with sequence homology to P elements of the IL-4 promoter involved in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional activation</mark>
        </td>
        <td> in T cells. Mutation of the IL-13 P element site significantly reduced IL-13 pr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>nucleotides containing the IL-13 or IL-4 P element sites specifically bound the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional activator</mark>
        </td>
        <td> protein, nuclear factor-activated T cells, preformed ( NF-ATp ) , when incubate</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96239534' target='_blank'>96239534</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Transcriptional activation</mark>
        </td>
        <td> of RNA polymerase III-dependent genes by the human T-cell leukemia virus type 1</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>. We demonstrated that IL-9 gene expression is controlled, at least in part, by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional activation</mark>
        </td>
        <td>. Transient expression of the luciferase reporter gene linked to serially delete</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96322726' target='_blank'>96322726</a></td>
        <td style='text-align:right'> The regulation of transcription factors belonging to the signal transducer and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activator of transcription</mark>
        </td>
        <td> ( STAT ) family was analyzed in PHA-activated mononuclear cells and in purified</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97207294' target='_blank'>97207294</a></td>
        <td style='text-align:right'>and IRS-1 were phosphorylated. Additionally, we detected signal transducers and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activators of transcription</mark>
        </td>
        <td> 6 ( STAT6 ) tyrosine phosphorylation and DNA binding activity in X-SCID B cells</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97324097' target='_blank'>97324097</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Transcriptional activity</mark>
        </td>
        <td> and constitutive nuclear localization of the ETS protein Elf-1. Elf-1 is a lymp</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97324097' target='_blank'>97324097</a></td>
        <td style='text-align:right'> fusion proteins revealed that the N-terminal 86 amino acids of Elf-1 contain a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional activation</mark>
        </td>
        <td> domain, the activity of which is attenuated by an internal repression domain. F</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'> element-binding complexes are not identical and may coordinately contribute to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional activity</mark>
        </td>
        <td>. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>R for erythroid cell development, dominant interfering mutant RXRs, lacking the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional activator</mark>
        </td>
        <td> functions AF-1 and AF-2, or AF-2 only, or the entire DNA-binding domain, were i</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98406200' target='_blank'>98406200</a></td>
        <td style='text-align:right'>ion of lytic cycle genes, including BRLF1. The BRLF1 product Rta functions as a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BF9CC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcriptional activator</mark>
        </td>
        <td> in both B lymphocytes and epithelial cells. However, Rta has recently been repo</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T73'>Term ID: <a href='terminology.html#L73' target='_blank'>73</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>cells and investigated the role of the signalsome proteins IKK-alpha, IKK-beta, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C999FB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B-inducing kinase</mark>
        </td>
        <td> ( NIK ) , IKK-gamma ( NF-kappa B essential modulator ) , and IKK complex-associ</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>le of the signalsome proteins IKK-alpha, IKK-beta, NF-kappa B-inducing kinase ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C999FB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NIK</mark>
        </td>
        <td> ) , IKK-gamma ( NF-kappa B essential modulator ) , and IKK complex-associated p</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>ermore, our studies showed association of the IKK-alpha / beta heterodimer with </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C999FB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NIK</mark>
        </td>
        <td>, Ikappa B-alpha and -epsilon in unstimulated cells. Exposure to LPS or TNF led </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>rance from and reassembly with the signalsome, whereas IKK-alpha, IKK-beta, and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C999FB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NIK</mark>
        </td>
        <td> remained complex-associated. NIK cannot phosphorylate Ikappa B-alpha directly, </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>e signalsome, whereas IKK-alpha, IKK-beta, and NIK remained complex-associated. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C999FB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NIK</mark>
        </td>
        <td> cannot phosphorylate Ikappa B-alpha directly, but it appears to be a functional</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>irectly, but it appears to be a functionally important subunit, because mutated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C999FB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NIK</mark>
        </td>
        <td> inhibited stimulus-induced kappa B-dependent transcription more effectively tha</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T69'>Term ID: <a href='terminology.html#L69' target='_blank'>69</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>ctivity of NF-kappa B-containing plasmids correlated directly with induction of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACF9FD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B DNA-binding</mark>
        </td>
        <td> activity. Although the intact beta interferon promoter was only weakly stimulat</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96074632' target='_blank'>96074632</a></td>
        <td style='text-align:right'>d upon incubation of nuclear extracts from activated lymphocytes with a labeled </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACF9FD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B DNA binding</mark>
        </td>
        <td> motif. Further, 1,25 ( OH ) 2D3 inhibited the transcriptional activity of NF-ka</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>We hypothesized that inhibition of either PKC or PTK would decrease LPS-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACF9FD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B DNA binding</mark>
        </td>
        <td> and TNF-alpha release in human monocytes. MATERIALS AND METHODS: Human monocyte</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>n ( Gen ) . TNF-alpha release in culture supernatants was measured by an ELISA. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACF9FD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B DNA binding</mark>
        </td>
        <td> was evaluated by electrophoretic mobility shift assay. RESULTS: LPS increased N</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>g was evaluated by electrophoretic mobility shift assay. RESULTS: LPS increased </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACF9FD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B DNA binding</mark>
        </td>
        <td> and TNF-alpha release in human monocytes. Nonspecific protein kinase inhibition</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>ha release, while specific PKC inhibition with Bis had no effect on LPS-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACF9FD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B DNA binding</mark>
        </td>
        <td> or TNF-alpha release. PTK inhibition with Gen attenuated both LPS-induced NF-ka</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>nding or TNF-alpha release. PTK inhibition with Gen attenuated both LPS-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACF9FD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B DNA binding</mark>
        </td>
        <td> and TNF-alpha production in human monocytes. Direct activation of PKC with PMA </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T107'>Term ID: <a href='terminology.html#L107' target='_blank'>107</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>olvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EF9F; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CD28 response element</mark>
        </td>
        <td> / AP-1 sequence in human T cells. CD28 is an important costimulatory molecule i</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>, other work has not supported this conclusion. Recent studies suggest that the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EF9F; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CD28 response element</mark>
        </td>
        <td> ( CD28RE ) does not function independently but works instead in conjunction wit</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>ported this conclusion. Recent studies suggest that the CD28 response element ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EF9F; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CD28RE</mark>
        </td>
        <td> ) does not function independently but works instead in conjunction with the adj</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>ypothesis is confirmed here. Also in the current study, binding activity to the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EF9F; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CD28RE</mark>
        </td>
        <td> / AP-1 sequence of the IL-2 promoter is evaluated. Although four specific compl</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'> binding to this sequence, only one of these complexes is specific for both the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EF9F; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CD28RE</mark>
        </td>
        <td> and the adjacent AP-1 site. Of the NF-kappa B / Rel family members tested, this</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>and the adjacent AP-1 site. Of the NF-kappa B / Rel family members tested, this </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EF9F; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CD28RE</mark>
        </td>
        <td> / AP-1-specific complex contains predominantly c-Rel, despite the fact that bot</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>ntly c-Rel, despite the fact that both p50 and RelA can efficiently bind to the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EF9F; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CD28RE</mark>
        </td>
        <td>. c-Fos and c-Jun are also found in this CD28RE / AP-1-specific complex. These d</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>RelA can efficiently bind to the CD28RE. c-Fos and c-Jun are also found in this </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EF9F; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CD28RE</mark>
        </td>
        <td> / AP-1-specific complex. These data indicate that functional complexes encompas</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>ic complex. These data indicate that functional complexes encompassing both the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9EF9F; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CD28RE</mark>
        </td>
        <td> and the AP-1-binding sites influence IL-2 promoter activity in CD28-costimulate</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T54'>Term ID: <a href='terminology.html#L54' target='_blank'>54</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFEAC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Interferon-alpha</mark>
        </td>
        <td> activates multiple STAT proteins and upregulates proliferation-associated IL-2R</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>s proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFEAC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Interferon-alpha</mark>
        </td>
        <td> ( IFN-alpha ) is a pleiotropic cytokine that has antiviral, antiproliferative, </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>ociated IL-2Ralpha, c-myc, and pim-1 genes in human T cells. Interferon-alpha ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFEAC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-alpha</mark>
        </td>
        <td> ) is a pleiotropic cytokine that has antiviral, antiproliferative, and immunore</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>roliferative, and immunoregulatory functions. There is increasing evidence that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFEAC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-alpha</mark>
        </td>
        <td> has an important role in T-cell biology. We have analyzed the expression of IL-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>eukin-2 ( IL-2 ) -induced T-cell proliferation. Treatment of T lymphocytes with </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFEAC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-alpha</mark>
        </td>
        <td>, IL-2, IL-12, and IL-15 upregulated IL-2Ralpha, c-myc, and pim-1 gene expressio</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>L-2, IL-12, and IL-15 upregulated IL-2Ralpha, c-myc, and pim-1 gene expression. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFEAC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-alpha</mark>
        </td>
        <td> also sensitized T cells to IL-2-induced proliferation, further suggesting that </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'> also sensitized T cells to IL-2-induced proliferation, further suggesting that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFEAC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-alpha</mark>
        </td>
        <td> may be involved in the regulation of T-cell mitogenesis. When we analyzed the n</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>-2Ralpha, pim-1, and IRF-1 GAS elements after cytokine stimulation, we observed </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFEAC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-alpha</mark>
        </td>
        <td>-induced binding of STAT1, STAT3, and STAT4, but not STAT5 to all of these eleme</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>inding of STAT1, STAT3, and STAT4, but not STAT5 to all of these elements. Yet, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFEAC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-alpha</mark>
        </td>
        <td> was able to activate binding of STAT5 to the high-affinity IFP53 GAS site. IFN-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>lpha was able to activate binding of STAT5 to the high-affinity IFP53 GAS site. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFEAC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-alpha</mark>
        </td>
        <td> enhanced tyrosine phosphorylation of STAT1, STAT3, STAT4, STAT5a, and STAT5b. I</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>ced STAT5 binding to the GAS elements. Taken together, our results suggest that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFEAC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-alpha</mark>
        </td>
        <td>, IL-2, IL-12, and IL-15 have overlapping activities on human T cells. These fin</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>ng activities on human T cells. These findings thus emphasize the importance of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFEAC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-alpha</mark>
        </td>
        <td> as a T-cell regulatory cytokine. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T142'>Term ID: <a href='terminology.html#L142' target='_blank'>142</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90110496' target='_blank'>90110496</a></td>
        <td style='text-align:right'>Anti-Ro ( SSA ) autoantibodies are associated with </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cell receptor</mark>
        </td>
        <td> beta genes in systemic lupus erythematosus patients. Several of the heterogeneo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90110496' target='_blank'>90110496</a></td>
        <td style='text-align:right'>molecules present antigen to T cell receptors ( TCRs ) , we have searched for a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR</mark>
        </td>
        <td> gene associated with the production of anti-Ro ( SSA ) antibodies. A pair of re</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90110496' target='_blank'>90110496</a></td>
        <td style='text-align:right'>iction fragment length polymorphisms ( RFLPs ) , one of which hybridizes to the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR</mark>
        </td>
        <td> constant region C beta 1 and the other to the C beta 2 gene, has been identifie</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90110496' target='_blank'>90110496</a></td>
        <td style='text-align:right'>tified, suggesting these may be genotypic markers for an extended region of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR</mark>
        </td>
        <td> beta locus. This RFLP pair occurs in 76% of patients with Ro ( SSA ) precipitin</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90110496' target='_blank'>90110496</a></td>
        <td style='text-align:right'>Ps are not disease susceptibility markers, but rather are important markers for </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR</mark>
        </td>
        <td> genes whose products are involved in the production of anti-Ro ( SSA ) antibodi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>ation of TCF-1 alpha, a T-cell-specific transcription factor that activates the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell receptor</mark>
        </td>
        <td> C alpha gene enhancer in a context-dependent manner. The differentiation of T c</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>s implicated in the activation of genes encoding a major component of the human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell receptor</mark>
        </td>
        <td> ( TCR ) . TCF-1 alpha, originally identified and purified through its binding s</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>e activation of genes encoding a major component of the human T-cell receptor ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR</mark>
        </td>
        <td> ) . TCF-1 alpha, originally identified and purified through its binding sites o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'> genes expressed at significantly earlier stages of T-cell development than the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR</mark>
        </td>
        <td> alpha gene ( e.g., p56 lck and CD3 delta ) . Sequences related to the TCF-1 alp</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>related to the TCF-1 alpha binding motif ( 5'--3' ) are also found in the human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR</mark>
        </td>
        <td> delta ( and possibly TCR beta ) enhancers. Southwestern and gel renaturation ex</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>a binding motif ( 5'--3' ) are also found in the human TCR delta ( and possibly </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR</mark>
        </td>
        <td> beta ) enhancers. Southwestern and gel renaturation experiments with the use of</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>JY, Namalwa ) or nonlymphoid ( HeLa ) cell lines. A small 95-bp fragment of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR</mark>
        </td>
        <td> alpha control region that contains the TCF-1 alpha binding site juxtaposed betw</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93321228' target='_blank'>93321228</a></td>
        <td style='text-align:right'>on of both pathways T lymphocytes became refractory to activation via the CD3 / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cell receptor</mark>
        </td>
        <td> ( TcR ) complex. T cells preincubated with phorbol 12-myristate 13-acetate ( PM</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93321228' target='_blank'>93321228</a></td>
        <td style='text-align:right'>s T lymphocytes became refractory to activation via the CD3 / T cell receptor ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TcR</mark>
        </td>
        <td> ) complex. T cells preincubated with phorbol 12-myristate 13-acetate ( PMA ) an</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93321228' target='_blank'>93321228</a></td>
        <td style='text-align:right'> IL-2R ) . Analysis of intracellular Ca2+ mobilization suggested that the CD3 / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TcR</mark>
        </td>
        <td>-dependent signal transduction was impaired in PMA / Bt2cAMP-treated cells. Rema</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93321228' target='_blank'>93321228</a></td>
        <td style='text-align:right'>ment each other in regulating gene expression and, conversely, downregulate the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TcR</mark>
        </td>
        <td> transduction mechanisms. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>h either phorbol myristate acetate plus ionophore or antibodies against the CD3-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell receptor</mark>
        </td>
        <td> complex and simultaneously activated the binding of AP-1. Furthermore, PDTC dif</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>Cutting edge: </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR</mark>
        </td>
        <td> stimulation by antibody and bacterial superantigen induces Stat3 activation in </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>l superantigen induces Stat3 activation in human T cells. Recent data show that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR</mark>
        </td>
        <td> / CD3 stimulation induces activation of Stat5 in murine T cells. Here, we show </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>sphorylation of Stat3 in human CD4+ T cells. Moreover, we provide evidence that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCCE9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR</mark>
        </td>
        <td> / CD3 and IL-2 induce Stat3 activation via distinct signaling pathways. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T20'>Term ID: <a href='terminology.html#L20' target='_blank'>20</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AB9AE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RFLAT-1</mark>
        </td>
        <td>: a new zinc finger transcription factor that activates RANTES gene expression i</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'>ied the first "late" T lymphocyte associated transcription factor and named it "</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AB9AE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RANTES Factor of Late Activated T Lymphocytes-1</mark>
        </td>
        <td>" ( RFLAT-1 ) . RFLAT-1 is a novel, phosphorylated, zinc finger transcription fa</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'>ription factor and named it "RANTES Factor of Late Activated T Lymphocytes-1" ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AB9AE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RFLAT-1</mark>
        </td>
        <td> ) . RFLAT-1 is a novel, phosphorylated, zinc finger transcription factor that i</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'>or and named it "RANTES Factor of Late Activated T Lymphocytes-1" ( RFLAT-1 ) . </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AB9AE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RFLAT-1</mark>
        </td>
        <td> is a novel, phosphorylated, zinc finger transcription factor that is expressed </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'>e Rel proteins play the dominant role in RANTES gene expression in fibroblasts, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AB9AE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RFLAT-1</mark>
        </td>
        <td> is a strong transactivator for RANTES in T cells. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T299'>Term ID: <a href='terminology.html#L299' target='_blank'>299</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D93321228' target='_blank'>93321228</a></td>
        <td style='text-align:right'>erentiation. In this report, we show that upon the stimulation of both pathways </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td> became refractory to activation via the CD3 / T cell receptor ( TcR ) complex. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>llular proteins is a crucial event in the transduction of activation signals to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-lymphocytes</mark>
        </td>
        <td>. The regulatory role of protein tyrosine phosphatases ( PTPases ) in this proce</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>e c-fos gene and accumulation of its mRNA as well as several other hallmarks of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-lymphocyte</mark>
        </td>
        <td> activation such as surface expression of the CD69 antigen and the interleukin 2</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>a crucial role in the negative regulation of signal transduction culminating in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-lymphocyte</mark>
        </td>
        <td> activation. Moreover, induction of tyrosine phosphorylation appears sufficient </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>ctivated after ligation of the CD3 and CD2 receptors in Jurkat and normal human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td> and in response to IL-6 and anti-IgM in the human B cell lines AF10 and Ramos, </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95166251' target='_blank'>95166251</a></td>
        <td style='text-align:right'>e, transcripts of PEBP2 alpha A and mouse AML1 / PEBP2 alpha B were detected in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td> in the thymuses from day 16 embryos and newborns, as well as 4-week-old adult m</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>lymphomas and the transcriptional activity of the viral long terminal repeat in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td>. CBF consists of two subunits, a DNA binding subunit, CBF alpha, and a second s</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>subunits. They also provided support for the hypothesis that CBF is a factor in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td> that is responsible for recognition of the SL3 cores. We also examined whether </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96079922' target='_blank'>96079922</a></td>
        <td style='text-align:right'>Prolactin and interleukin-2 receptors in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td> signal through a MGF-STAT5-like transcription factor. The cell surface receptor</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96079922' target='_blank'>96079922</a></td>
        <td style='text-align:right'>interleukin-2 ( IL-2 ) are structurally distinct, but share regulatory tasks in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td>. They can stimulate proliferation and activate transcription of over-lapping se</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96195006' target='_blank'>96195006</a></td>
        <td style='text-align:right'>P inducibility of transcriptional repressor ICER in developing and mature human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td> [published erratum appears in Proc Natl Acad Sci U S A 1996 Jul 23;93 ( 15 ) :8</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96195006' target='_blank'>96195006</a></td>
        <td style='text-align:right'>opment in the human thymus and is retained by the majority of mature peripheral </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td>. Here we show that elevated cAMP levels in T cells correlate with the expressio</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96239534' target='_blank'>96239534</a></td>
        <td style='text-align:right'>nd cell extracts derived from human T-cell leukemia virus type 1-infected human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td> support higher levels of 5S rRNA and tRNA gene transcription than chromatin or </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96239534' target='_blank'>96239534</a></td>
        <td style='text-align:right'> 5S rRNA and tRNA gene transcription than chromatin or extracts from uninfected </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td>. The viral protein Tax was likely responsible for this higher level of class II</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97207294' target='_blank'>97207294</a></td>
        <td style='text-align:right'>ned immunodeficiency. Interleukin-4 ( IL-4 ) is an important cytokine for B and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocyte</mark>
        </td>
        <td> function and mediates its effects via a receptor that contains gammac. B cells </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97307577' target='_blank'>97307577</a></td>
        <td style='text-align:right'>Abnormal </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocyte</mark>
        </td>
        <td> development induced by targeted overexpression of Ikappa B alpha. A role in thy</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97307577' target='_blank'>97307577</a></td>
        <td style='text-align:right'>ct in maturation resulted in a transgene dose-dependent reduction in peripheral </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td>, with the CD8 lineage being more severely affected. These data provide direct e</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97307577' target='_blank'>97307577</a></td>
        <td style='text-align:right'>dence for the involvement of NF-kappa B / Rel family proteins in late stages of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocyte</mark>
        </td>
        <td> development, coincident with positive and negative selection. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97468093' target='_blank'>97468093</a></td>
        <td style='text-align:right'>ase C gamma 1 overexpression and activation induced by interferon beta in human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td>: an ISGF3-independent response. Interferons exert their antiviral, antiprolifer</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97468093' target='_blank'>97468093</a></td>
        <td style='text-align:right'> of the hydrolytic activity of phospholipase C gamma 1 ( PLC gamma 1 ) in human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td> by IFN-beta. The increased level of PLC gamma 1 becomes evident after 90 min of</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97468093' target='_blank'>97468093</a></td>
        <td style='text-align:right'>revent the association of ISGF3 components. These results suggest that in human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td> IFN-beta can activate other transcription factor ( s ) distinct from ISGF3 to r</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'>a new zinc finger transcription factor that activates RANTES gene expression in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td>. RANTES ( Regulated upon Activation, Normal T cell Expressed and Secreted ) is </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'>ry into immune cells. RANTES is expressed late ( 3-5 days ) after activation in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td>. Using expression cloning, we identified the first "late" T lymphocyte associat</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'>tion in T lymphocytes. Using expression cloning, we identified the first "late" </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocyte</mark>
        </td>
        <td> associated transcription factor and named it "RANTES Factor of Late Activated T</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>he expression of IL-2Ralpha, c-myc, and pim-1 genes in anti-CD3-activated human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td>. The induction of these genes is associated with interleukin-2 ( IL-2 ) -induce</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>ociated with interleukin-2 ( IL-2 ) -induced T-cell proliferation. Treatment of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AF9EF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T lymphocytes</mark>
        </td>
        <td> with IFN-alpha, IL-2, IL-12, and IL-15 upregulated IL-2Ralpha, c-myc, and pim-1</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T133'>Term ID: <a href='terminology.html#L133' target='_blank'>133</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>y of 57- to 53-kD proteins that are abundantly expressed in mature and immature </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEC9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell lines</mark>
        </td>
        <td> ( Jurkat, CCRF-CEM ) and not in mature B cells ( JY, Namalwa ) or nonlymphoid (</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'> Tandem copies of this enhancer functioned synergistically in mature ( Jurkat ) </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEC9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell lines</mark>
        </td>
        <td> as well as resting and activated immature ( CCRF-CEM ) T-cell lines. Mutation o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'> ( Jurkat ) T-cell lines as well as resting and activated immature ( CCRF-CEM ) </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEC9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell lines</mark>
        </td>
        <td>. Mutation of the TCF-1 alpha binding site diminished enhancer activity and disr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92135145' target='_blank'>92135145</a></td>
        <td style='text-align:right'>ed KBF1, are constitutively expressed and localized in the nucleus of the human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEC9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell line</mark>
        </td>
        <td> IARC 301.5. In order to define the roles of these two factors, which bind to th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'>I hypersensitive sites are associated with TAL-1 transcription in erythroid and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEC9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell lines</mark>
        </td>
        <td>. The tal-1 gene, frequently activated in human T-cell acute lymphoblastic leuke</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'>gated tal-1 chromatin structure in erythroid / megakaryocytic cell lines and in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEC9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell lines</mark>
        </td>
        <td> either with or without tal-1 rearrangements. Tal-1 transcription was shown to b</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'>-1 rearrangements. Tal-1 transcription was shown to be monoallelic in Jurkat, a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEC9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell line</mark>
        </td>
        <td> that expresses tal-1 in the absence of apparent genomic alteration of the locus</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'> cell line. HS III was weak in HEL and Jurkat, and greatly enhanced in DU528, a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEC9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell line</mark>
        </td>
        <td> that bears a t ( 1;14 ) and initiates tal-1 transcription within exon 4. These </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96079922' target='_blank'>96079922</a></td>
        <td style='text-align:right'>investigated the ability of PRL and IL-2 to activate Stat proteins in different </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEC9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cell lines</mark>
        </td>
        <td>. The DNA binding specificities, the reactivities toward Stat-specific antisera,</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96079922' target='_blank'>96079922</a></td>
        <td style='text-align:right'>a, and the mol wt of IL-2 -and PRL-induced DNA-binding proteins in Nb2 and C196 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEC9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cell lines</mark>
        </td>
        <td> were investigated. A comparison with the Stat proteins induced by interferon-ga</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>L-9 ) gene expression in a human T cell leukemia virus type I-transformed human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEC9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cell line</mark>
        </td>
        <td>, C5MJ2, were investigated. We demonstrated that IL-9 gene expression is control</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>erine phosphorylation of Stat3 ( but not Stat5 ) in allogen-specific human CD4+ </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEC9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cell lines</mark>
        </td>
        <td>. In contrast, IL-2 induces a rapid and transient tyrosine and serine phosphoryl</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T217'>Term ID: <a href='terminology.html#L217' target='_blank'>217</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95127261' target='_blank'>95127261</a></td>
        <td style='text-align:right'>uction through its specific receptor ( the AhR ) and not through effects on the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">estrogen receptor</mark>
        </td>
        <td>. Both TCDD and estradiol induce extrathymic T-cell differentiation in the liver</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Estrogen receptor</mark>
        </td>
        <td> diminishes DNA-binding activities of chicken GATA-1 and-binding proteins. The e</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>r diminishes DNA-binding activities of chicken GATA-1 and-binding proteins. The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">estrogen receptor</mark>
        </td>
        <td> ( ER ) repressed erythroid differentiation and erythroid-specific gene expressi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>ding activities of chicken GATA-1 and-binding proteins. The estrogen receptor ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ER</mark>
        </td>
        <td> ) repressed erythroid differentiation and erythroid-specific gene expression. I</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>rythroid-specific gene expression. In this study, we investigated the effect of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ER</mark>
        </td>
        <td> alpha ( referred to throughout as ER ) on DNA-binding activities of transcripti</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'> this study, we investigated the effect of ER alpha ( referred to throughout as </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ER</mark>
        </td>
        <td> ) on DNA-binding activities of transcription factors involved in regulating the</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>hift assays, we found that in the presence of rabbit reticulocyte lysate, human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ER</mark>
        </td>
        <td> reduced the binding activities of chicken immature erythrocyte nuclear extracte</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>hancer. In contrast, the binding activities of NF1 and Sp1 were not affected by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ER</mark>
        </td>
        <td>. Binding of ER to an estrogen response element was enhanced by addition of rabb</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>rast, the binding activities of NF1 and Sp1 were not affected by ER. Binding of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ER</mark>
        </td>
        <td> to an estrogen response element was enhanced by addition of rabbit reticulocyte</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>d by addition of rabbit reticulocyte lysate. This lysate was also necessary for </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ER</mark>
        </td>
        <td> to diminish the DNA-binding activity of GATA-1. These results suggest that addi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>TA-1. These results suggest that additional factor ( s ) are necessary for full </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ER</mark>
        </td>
        <td> function. Both GATA-1 and-binding proteins are critical for the developmentally</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>binding activities of GATA-1 and-binding proteins is the mechanism by which the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ER</mark>
        </td>
        <td> inhibits regulation of these genes. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99083144' target='_blank'>99083144</a></td>
        <td style='text-align:right'>ell line, hER + IL-1beta-CAT+. This cell line stably transfected with the human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">estrogen receptor</mark>
        </td>
        <td>, and an IL-1beta promoter construct fused to the CAT reporter gene allows us to</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99083144' target='_blank'>99083144</a></td>
        <td style='text-align:right'>ic response. The activity of the mycotoxins appeared to be mediated through the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">estrogen receptor</mark>
        </td>
        <td>, since both the antiestrogens H1285 and ICI 182,780 effectively inhibited their</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99394774' target='_blank'>99394774</a></td>
        <td style='text-align:right'>Gender and vascular reactivity. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Estrogen receptors</mark>
        </td>
        <td> are found on vascular endothelial and smooth muscle cells; their expression is </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99394774' target='_blank'>99394774</a></td>
        <td style='text-align:right'>smooth muscle cells; their expression is influenced by exposure to the hormone. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Estrogen receptors</mark>
        </td>
        <td> influence non-genomic events, which are rapid in onset and genomic events, whic</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99394774' target='_blank'>99394774</a></td>
        <td style='text-align:right'>iate vascular responses, genomic sex may influence and / or limit expression of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE99A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">estrogen receptors</mark>
        </td>
        <td> and therefore actions of sex steroid hormones throughout the vasculature. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T308'>Term ID: <a href='terminology.html#L308' target='_blank'>308</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>Induction of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> and T-cell activation by vanadate peroxide, an inhibitor of protein tyrosine ph</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>tion by vanadate peroxide, an inhibitor of protein tyrosine phosphatases. Rapid </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> of key cellular proteins is a crucial event in the transduction of activation s</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>e kinases lck and fyn ( 4- and 3-fold respectively ) and a dramatic increase in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> of cellular proteins, notably phospholipase C gamma 1. After this event, we obs</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>nts of Jurkat cells. In the CD45-negative variant, the effect of pervanadate on </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> was globally decreased and some phosphorylated substrates were specifically mis</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>nal transduction culminating in T-lymphocyte activation. Moreover, induction of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> appears sufficient per se to initiate a complete activation programme. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>Integrin-mediated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> and cytokine message induction in monocytic cells. A possible signaling role fo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>ctin or ligation of beta 1 integrins with antibodies causes a rapid and intense </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> of two sets of proteins of about 65-75 and 120-125 kDa. In addition, integrin l</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>osine kinase inhibitors genistein and herbimycin A block both integrin-mediated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> and increases in IL-1 beta message levels, indicating a causal relationship bet</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>ing tyrosine kinase Syk. In contrast, integrin ligation with antibodies induces </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> of Syk but not of FAK or paxillin. In adhering cells, pre-treatment with cytoch</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>AK or paxillin. In adhering cells, pre-treatment with cytochalasin D suppresses </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> of FAK and paxillin but not of Syk, while IL-1 beta message induction is unaffe</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96085174' target='_blank'>96085174</a></td>
        <td style='text-align:right'>sm of several cytokines. IL-7 was observed to induce a rapid and dose-dependent </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> of Jak 1 and Jak 3 and concomitantly, the tyrosine phosphorylation and DNA bind</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96085174' target='_blank'>96085174</a></td>
        <td style='text-align:right'>se-dependent tyrosine phosphorylation of Jak 1 and Jak 3 and concomitantly, the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> and DNA binding activity of multiple STAT proteins. The STAT proteins utilized </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'>ophages by culture in macrophage-CSF ( M-CSF ) , we measured the GM-CSF induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> of STAT5A, STAT5B, and any lower molecular weight STAT5 isoforms. Freshly isola</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'>ol 12 myristate 13-acetate treatment had weak effects on proliferation. Rather, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> was shown to be directly involved in mediating CD40-dependent signals. The use </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97207294' target='_blank'>97207294</a></td>
        <td style='text-align:right'>lly, we detected signal transducers and activators of transcription 6 ( STAT6 ) </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> and DNA binding activity in X-SCID B cells with a wide range of gammac mutation</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>tivate binding of STAT5 to the high-affinity IFP53 GAS site. IFN-alpha enhanced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> of STAT1, STAT3, STAT4, STAT5a, and STAT5b. IL-12 induced STAT4 and IL-2 and IL</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>crophage colony-stimulating factor ( GM-CSF ) and interleukin ( IL ) -3 induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> of 92-kDa protein in normal human monocytes. We identified this 92-kDa protein </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>nyl-leucyl-phenylalanine ( FMLP ) and phorbol myristate acetate ( PMA ) induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> of 42- and 44-kDa proteins, which were identified as extracellular signal-regul</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>ocytes. In marked contrast to neutrophils and MO7e cells, GM-CSF did not induce </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FDEDCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine phosphorylation</mark>
        </td>
        <td> and activation of ERK in monocytes. Among upstream signaling molecules of ERK, </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T269'>Term ID: <a href='terminology.html#L269' target='_blank'>269</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95261059' target='_blank'>95261059</a></td>
        <td style='text-align:right'>monocytic and neutrophilic cells. PU.1 is expressed at highest levels in mature </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td> and human peripheral blood neutrophils. In contrast to PU.1, significant levels</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>ts were designed to analyse in detail the priming effect on the LPS response in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td>. Priming by IFN-gamma was primarily manifested at the level of TNF mRNA accumul</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'>ne the activation of the STAT5 homologues and lower molecular weight variant in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td> and monocytes differentiated into macrophages by culture in macrophage-CSF ( M-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97162234' target='_blank'>97162234</a></td>
        <td style='text-align:right'>Nuclear factor-kappa B activation in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td> stimulated with lipopolysaccharide is inhibited by fibroblast conditioned mediu</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97162234' target='_blank'>97162234</a></td>
        <td style='text-align:right'>ibit both TNF mRNA accumulation and protein release in peripheral blood-derived </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td> ( PBM ) stimulated with lipopolysaccharide ( LPS ) . In this study we have inve</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>an important mediator of septic shock. Endotoxin ( LPS ) signal transduction in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td> leads to activation of nuclear factor-kappa B ( NF-kappa B ) and TNF-alpha rele</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'> B DNA binding and TNF-alpha release in human monocytes. MATERIALS AND METHODS: </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Human monocytes</mark>
        </td>
        <td> were stimulated with PMA ( 50 ng / ml ) alone or LPS ( 100 ng / ml ) with and w</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'> attenuated both LPS-induced NF-kappa B DNA binding and TNF-alpha production in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td>. Direct activation of PKC with PMA induced both NF-kappa B activation and TNF-a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'> of PKC with PMA induced both NF-kappa B activation and TNF-alpha production by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td>. CONCLUSIONS: These results suggest that LPS-induced NF-kappa B activation and </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>Signal transduction pathways in normal </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td> stimulated by cytokines and mediators: comparative study with normal human neut</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>erleukin ( IL ) -3 induced tyrosine phosphorylation of 92-kDa protein in normal </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td>. We identified this 92-kDa protein as STAT5, but not as STATs1, 3, and 6 nor c-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>ns, which were identified as extracellular signal-regulated kinase ( ERK ) , in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td>. In marked contrast to neutrophils and MO7e cells, GM-CSF did not induce tyrosi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>ylated and agonist-dependent phosphorylation and activation was not detected in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td>. Superoxide release stimulated by FMLP was inhibited partially by PD98059 or SB</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>rancriptional roles of STAT5 and functional roles of ERK and / or p38 in normal </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td> stimulated by physiological receptor-mediated agonists GM-CSF and FMLP. Possibl</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99406845' target='_blank'>99406845</a></td>
        <td style='text-align:right'>Glucocorticoids induce apoptosis in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td>: potential role of IL-1 beta. Glucocorticoids ( GC ) are potent anti-inflammato</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99406845' target='_blank'>99406845</a></td>
        <td style='text-align:right'> still unknown. In our study, we determined the induction of apoptosis by GC in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td>. Peripheral blood monocytes were isolated by density centrifugation methods wit</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99406845' target='_blank'>99406845</a></td>
        <td style='text-align:right'>L-1beta. This is the first study to demonstrate induction of apoptosis by GC in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FADBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human monocytes</mark>
        </td>
        <td>. GC-induced monocyte apoptosis may be partially mediated through effects on IL-</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T243'>Term ID: <a href='terminology.html#L243' target='_blank'>243</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'> DNA binding capacity, and potentiation of trancriptional activity by GM-CSF. N-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AAFDCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">formyl-methionyl-leucyl-phenylalanine</mark>
        </td>
        <td> ( FMLP ) and phorbol myristate acetate ( PMA ) induced tyrosine phosphorylation</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>of trancriptional activity by GM-CSF. N-formyl-methionyl-leucyl-phenylalanine ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AAFDCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">FMLP</mark>
        </td>
        <td> ) and phorbol myristate acetate ( PMA ) induced tyrosine phosphorylation of 42-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>tutively associated with Grb2 and was not tyrosine-phosphorylated by GM-CSF and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AAFDCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">FMLP</mark>
        </td>
        <td>, and Sos1 and c-Raf-1 were not phosphorylated by GM-CSF, IL-3, TNF, and FMLP in</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>nd FMLP, and Sos1 and c-Raf-1 were not phosphorylated by GM-CSF, IL-3, TNF, and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AAFDCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">FMLP</mark>
        </td>
        <td> in monocytes, whereas all these signaling molecules were affected and / or util</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>ctivation was not detected in human monocytes. Superoxide release stimulated by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AAFDCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">FMLP</mark>
        </td>
        <td> was inhibited partially by PD98059 or SB203580, a specific inhibitor of ERK or </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>man monocytes stimulated by physiological receptor-mediated agonists GM-CSF and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AAFDCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">FMLP</mark>
        </td>
        <td>. Possible roles of ERK in proliferation of transformed cells were also suggeste</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T177'>Term ID: <a href='terminology.html#L177' target='_blank'>177</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>nd inhibited the activity of granulocyte-macrophage colony-stimulating factor ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td> ) gene regulatory elements that use NFAT by 60%. CsA similarly mediated a reduc</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>ements that use NFAT by 60%. CsA similarly mediated a reduction of up to 65% in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td> mRNA and protein expression in activated endothelial cells. CsA also suppressed</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>t the chromatin structure level, as DNasel hypersensitive sites within both the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td> enhancer and the E-selectin promoter were suppressed by CsA. This represents th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>ral hours of treatment, and the primed state was induced by either IFN-gamma or </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td>, but not M-CSF. Primed monocytes transcribed TNF mRNA at a higher rate than fre</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'> peripheral blood monocytes. Granulocyte-macrophage colony-stimulating factor ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td> ) induces immediate effects in monocytes by activation of the Janus kinase ( JA</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'>iated into macrophages by culture in macrophage-CSF ( M-CSF ) , we measured the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td> induced tyrosine phosphorylation of STAT5A, STAT5B, and any lower molecular wei</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'>. STAT5A-STAT5A homodimers and STAT5A-STAT5B heterodimers formed in response to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td>. Therefore, activation of STAT5A predominates compared to STAT5B when assayed b</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'>ide specificity and control to genes expressed in response to cytokines such as </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td>. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>ctionality and cell biology. Granulocyte-macrophage colony-stimulating factor ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td> ) and interleukin ( IL ) -3 induced tyrosine phosphorylation of 92-kDa protein </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>f specific DNA binding capacity, and potentiation of trancriptional activity by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td>. N-formyl-methionyl-leucyl-phenylalanine ( FMLP ) and phorbol myristate acetate</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>( ERK ) , in human monocytes. In marked contrast to neutrophils and MO7e cells, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td> did not induce tyrosine phosphorylation and activation of ERK in monocytes. Amo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'> was constitutively associated with Grb2 and was not tyrosine-phosphorylated by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td> and FMLP, and Sos1 and c-Raf-1 were not phosphorylated by GM-CSF, IL-3, TNF, an</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>sphorylated by GM-CSF and FMLP, and Sos1 and c-Raf-1 were not phosphorylated by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td>, IL-3, TNF, and FMLP in monocytes, whereas all these signaling molecules were a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>cytes, whereas all these signaling molecules were affected and / or utilized by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td> in MO7e cells. In contrast to neutrophils, p38 was constitutively phosphorylate</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>e release was resistant to these two inhibitors in monocytes. PD98059 inhibited </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td>-dependent proliferation of MO7e cells. Present results indicate trancriptional </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>n normal human monocytes stimulated by physiological receptor-mediated agonists </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9DBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">GM-CSF</mark>
        </td>
        <td> and FMLP. Possible roles of ERK in proliferation of transformed cells were also</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T153'>Term ID: <a href='terminology.html#L153' target='_blank'>153</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D98438422' target='_blank'>98438422</a></td>
        <td style='text-align:right'>fect of translocations involving the inactive X chromosome: physical linkage to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EF9BBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">XIC</mark>
        </td>
        <td> / XIST does not lead to long-range de novo inactivation in human differentiated</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98438422' target='_blank'>98438422</a></td>
        <td style='text-align:right'>X-chromosome inactivation ( X inactivation ) in relation to the position of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EF9BBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">X-inactivation center</mark>
        </td>
        <td> ( XIC ) /XIST in differentiated cells. Autosome / Xi translocations were detect</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98438422' target='_blank'>98438422</a></td>
        <td style='text-align:right'>n ( X inactivation ) in relation to the position of the X-inactivation center ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EF9BBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">XIC</mark>
        </td>
        <td> ) /XIST in differentiated cells. Autosome / Xi translocations were detected by </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98438422' target='_blank'>98438422</a></td>
        <td style='text-align:right'>her BrdU incorporated at late S phase or acetylated histone H4. The position of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EF9BBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">XIC</mark>
        </td>
        <td> / XIST in the reciprocal products of the translocation was determined by XIST-s</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98438422' target='_blank'>98438422</a></td>
        <td style='text-align:right'>c FISH and computer enhancement. In other experiments, the Xq13 region carrying </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EF9BBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">XIC</mark>
        </td>
        <td> / XIST was localized by computer enhancement of the DAPI banding pattern. Our s</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98438422' target='_blank'>98438422</a></td>
        <td style='text-align:right'>ferentiated cells provides a visual demonstration that physical separation from </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EF9BBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">XIC</mark>
        </td>
        <td> / XIST does not result in reactivation of inactive X-chromosome material and th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98438422' target='_blank'>98438422</a></td>
        <td style='text-align:right'>ion is not spread to the translocated autosomes irrespective of the position of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EF9BBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">XIC</mark>
        </td>
        <td> / XIST. This observation suggests that physical linkage to XIC / XIST does not </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98438422' target='_blank'>98438422</a></td>
        <td style='text-align:right'> the position of XIC / XIST. This observation suggests that physical linkage to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EF9BBC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">XIC</mark>
        </td>
        <td> / XIST does not lead to de novo inactivation of autosomal material. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T95'>Term ID: <a href='terminology.html#L95' target='_blank'>95</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>ocation and turnover of the vitamin D receptor in human HL60 leukemia cells and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEEBBF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">peripheral blood lymphocytes</mark>
        </td>
        <td>-coincident rise of DNA-relaxing activity in nuclear extracts. High affinity rec</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>( calcitriol ) are expressed in HL60 human leukemia cells and in low numbers in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEEBBF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">peripheral blood lymphocytes</mark>
        </td>
        <td> ( PBL ) . HL60 cells, expressing some characteristics of promyelocytes, can be </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'> HL60 human leukemia cells and in low numbers in peripheral blood lymphocytes ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEEBBF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PBL</mark>
        </td>
        <td> ) . HL60 cells, expressing some characteristics of promyelocytes, can be induce</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>s a maximum of approximately 310 binding sites / nucleus was found after 3 h in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEEBBF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PBL</mark>
        </td>
        <td>. Pulse exposure of HL60 to radiolabeled hormone for 3 h followed by culture in </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'> difference of VDR retention in pulse and pulse / chase-experiments was seen in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEEBBF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PBL</mark>
        </td>
        <td>, where VDR halflife was approximately 30 min. No specific translocation into th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>ation with calcitriol ( final ethanol concentration 0.0001% v / v ) in HL60 and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEEBBF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PBL</mark>
        </td>
        <td>. The enhanced activity disappeared after 2 h in PBL, whereas it was still enhan</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>0.0001% v / v ) in HL60 and PBL. The enhanced activity disappeared after 2 h in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEEBBF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PBL</mark>
        </td>
        <td>, whereas it was still enhanced by 4 h in HL60. No effect was seen in ethanol tr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99007236' target='_blank'>99007236</a></td>
        <td style='text-align:right'>combination, the polyamides inhibit virus replication by >99% in isolated human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEEBBF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">peripheral blood lymphocytes</mark>
        </td>
        <td>, with no detectable cell toxicity. The ability of small molecules to target pre</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99294118' target='_blank'>99294118</a></td>
        <td style='text-align:right'>Binding characteristics of the glucocorticoid receptor in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEEBBF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">peripheral blood lymphocytes</mark>
        </td>
        <td> in multiple sclerosis. Although the exact etiology of multiple sclerosis ( MS )</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99294118' target='_blank'>99294118</a></td>
        <td style='text-align:right'>portion of patients. We characterized glucocorticoid receptor ( GR ) binding in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEEBBF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">peripheral blood lymphocytes</mark>
        </td>
        <td> from 39 MS patients and 14 age- and sex-matched controls with respect to dissoc</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T126'>Term ID: <a href='terminology.html#L126' target='_blank'>126</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96239534' target='_blank'>96239534</a></td>
        <td style='text-align:right'>Transcriptional activation of RNA polymerase III-dependent genes by the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EACBAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human T-cell leukemia virus</mark>
        </td>
        <td> type 1 tax protein. The human T-cell leukemia virus-encoded tax protein is a po</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96239534' target='_blank'>96239534</a></td>
        <td style='text-align:right'> III-dependent genes by the human T-cell leukemia virus type 1 tax protein. The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EACBAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human T-cell leukemia virus</mark>
        </td>
        <td>-encoded tax protein is a potent activator of many viral and cellular genes tran</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96239534' target='_blank'>96239534</a></td>
        <td style='text-align:right'>y RNA polymerase II. We find that both chromatin and cell extracts derived from </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EACBAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human T-cell leukemia virus</mark>
        </td>
        <td> type 1-infected human T lymphocytes support higher levels of 5S rRNA and tRNA g</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>ry mechanisms responsible for human interleukin 9 ( IL-9 ) gene expression in a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EACBAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human T cell leukemia virus</mark>
        </td>
        <td> type I-transformed human T cell line, C5MJ2, were investigated. We demonstrated</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T121'>Term ID: <a href='terminology.html#L121' target='_blank'>121</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>Purification of TCF-1 alpha, a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CAEC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell-specific transcription factor</mark>
        </td>
        <td> that activates the T-cell receptor C alpha gene enhancer in a context-dependent</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>ctive extracts from Jurkat but not HeLa cells, confirming that TCF-1 alpha is a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CAEC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell-specific transcription factor</mark>
        </td>
        <td>. Curiously, the TCF-1 alpha binding element was inactive in vivo when removed f</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95166251' target='_blank'>95166251</a></td>
        <td style='text-align:right'> in T cells throughout their development, supporting the notion that PEBP2 is a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CAEC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell-specific transcription factor</mark>
        </td>
        <td>. Transcripts of mouse AML1 / PEBP2 alpha B were also detected in day 12 fetal h</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>FAT. Nuclear factor of activated T cells ( NFAT ) was originally described as a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CAEC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T-cell-specific transcription factor</mark>
        </td>
        <td> athat supported the activation of cytokine gene expression and mediated the imm</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T209'>Term ID: <a href='terminology.html#L209' target='_blank'>209</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>nd. The IL-13 gene 5' flank region included a segment with sequence homology to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">P elements</mark>
        </td>
        <td> of the IL-4 promoter involved in transcriptional activation in T cells. Mutatio</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>omoter involved in transcriptional activation in T cells. Mutation of the IL-13 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">P element</mark>
        </td>
        <td> site significantly reduced IL-13 promoter activity in response to T-cell activa</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>in response to T-cell activation. Oligonucleotides containing the IL-13 or IL-4 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">P element</mark>
        </td>
        <td> sites specifically bound the transcriptional activator protein, nuclear factor-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>e primed T cells contain higher levels of nuclear NF-ATp, capable of binding to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">P elements</mark>
        </td>
        <td> of the IL-4 and IL-13 promoters, than do freshly-isolated T cells, the NF-AT-bi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>e IL-4 and IL-13 promoters, than do freshly-isolated T cells, the NF-AT-binding </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">P elements</mark>
        </td>
        <td> are attractive candidates to mediate the coordinate expression of these two cyt</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'>Four </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">P-like elements</mark>
        </td>
        <td> are required for optimal transcription of the mouse IL-4 gene: involvement of a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'>hokine element 0 ( CLE0 ) , P, P2, P3 and P4. To characterize the role of these </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">P-like elements</mark>
        </td>
        <td> and their binding factors in the native promoter, we did transient transfection</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'>ction of EL-4 cells with the IL-4 promoter-reporter constructs carrying mutated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">P-like elements</mark>
        </td>
        <td> showed that four P-like elements, CLE0, P, P2 and P4, but not P3, were required</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'> promoter-reporter constructs carrying mutated P-like elements showed that four </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">P-like elements</mark>
        </td>
        <td>, CLE0, P, P2 and P4, but not P3, were required for optimal activation of the IL</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'>AT / AP-1 complex formed only with P and P2. Cross-competition assays among the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">P-like elements</mark>
        </td>
        <td> revealed element-specific and common complexes. Six tandem repeats of the P ele</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'>ments revealed element-specific and common complexes. Six tandem repeats of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">P element</mark>
        </td>
        <td> linked to the SV40 promoter responded to phorbol 12-myristate 13-acetate, while</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T279'>Term ID: <a href='terminology.html#L279' target='_blank'>279</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D98438422' target='_blank'>98438422</a></td>
        <td style='text-align:right'>autosomes to study the maintenance and spreading of X-chromosome inactivation ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #D9CDDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">X inactivation</mark>
        </td>
        <td> ) in relation to the position of the X-inactivation center ( XIC ) /XIST in dif</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98438422' target='_blank'>98438422</a></td>
        <td style='text-align:right'>XIST does not result in reactivation of inactive X-chromosome material and that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #D9CDDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">X inactivation</mark>
        </td>
        <td> is not spread to the translocated autosomes irrespective of the position of XIC</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99155344' target='_blank'>99155344</a></td>
        <td style='text-align:right'>of the human androgen receptor gene ( HUMARA ) has been shown to correlate with </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #D9CDDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">X-inactivation</mark>
        </td>
        <td>. In this study, we have used the polymerase chain reaction ( PCR ) with nested </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99155344' target='_blank'>99155344</a></td>
        <td style='text-align:right'> have used the polymerase chain reaction ( PCR ) with nested primers to analyze </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #D9CDDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">X-inactivation</mark>
        </td>
        <td> patterns of the HUMARA loci in purified eosinophils from female patients with e</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99155344' target='_blank'>99155344</a></td>
        <td style='text-align:right'>om a female patient presenting with IHES were found to show a clonal pattern of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #D9CDDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">X-inactivation</mark>
        </td>
        <td>. Eosinophil-depleted leukocytes from this patient were polyclonal by HUMARA ana</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99155344' target='_blank'>99155344</a></td>
        <td style='text-align:right'>patient were polyclonal by HUMARA analysis, thus excluding skewedness of random </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #D9CDDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">X-inactivation</mark>
        </td>
        <td>. After corticosteroid suppression of her blood eosinophilia, a clonal populatio</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99155344' target='_blank'>99155344</a></td>
        <td style='text-align:right'>o allergy, parasitic infection, or drug reaction showed a polyclonal pattern of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #D9CDDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">X-inactivation</mark>
        </td>
        <td> by HUMARA analysis. The finding of clonal eosinophilia in a patient presenting </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T244'>Term ID: <a href='terminology.html#L244' target='_blank'>244</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D93183827' target='_blank'>93183827</a></td>
        <td style='text-align:right'>rin A sensitive in T cells. Few known genes ( IL-2, members of the IL-8 family, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBCDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">interferon-gamma</mark>
        </td>
        <td> ) are induced in T cells only through the combined effect of phorbol myristic a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBCDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-gamma</mark>
        </td>
        <td> priming of monocytes enhances LPS-induced TNF production by augmenting both tra</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>l, highly regulated host defence response. The augmentation of LPS responses by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBCDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">interferon gamma</mark>
        </td>
        <td> ( IFN-gamma ) , referred to as priming, is well established. However, the mecha</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'> host defence response. The augmentation of LPS responses by interferon gamma ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBCDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-gamma</mark>
        </td>
        <td> ) , referred to as priming, is well established. However, the mechanism ( s ) b</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>in detail the priming effect on the LPS response in human monocytes. Priming by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBCDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-gamma</mark>
        </td>
        <td> was primarily manifested at the level of TNF mRNA accumulation. IFN-gamma pre-t</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>ng by IFN-gamma was primarily manifested at the level of TNF mRNA accumulation. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBCDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-gamma</mark>
        </td>
        <td> pre-treatment affected the magnitude rather than the sensitivity of the LPS res</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>ed after several hours of treatment, and the primed state was induced by either </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBCDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-gamma</mark>
        </td>
        <td> or GM-CSF, but not M-CSF. Primed monocytes transcribed TNF mRNA at a higher rat</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96079922' target='_blank'>96079922</a></td>
        <td style='text-align:right'> T cell lines were investigated. A comparison with the Stat proteins induced by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBCDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">interferon-gamma</mark>
        </td>
        <td>, PRL, and IL-6 in T47D mammary tumor cells was made. We found that these parame</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97064186' target='_blank'>97064186</a></td>
        <td style='text-align:right'>a powerful skewer of CD4+ T cell responses toward the Th1 phenotype by inducing </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBCDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-gamma</mark>
        </td>
        <td> production in naive Th cells. In the present study we addressed the question of</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97064186' target='_blank'>97064186</a></td>
        <td style='text-align:right'>L-12 can reverse established Th2 responses into Th1 / Th0 responses by inducing </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBCDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-gamma</mark>
        </td>
        <td> production in memory Th2 cells. To this aim, allergen-specific CD4+ T cell clon</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97064186' target='_blank'>97064186</a></td>
        <td style='text-align:right'> TCC exhibited a strongly polarized Th2 cytokine profile, and the production of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBCDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-gamma</mark>
        </td>
        <td> could not be induced by exogenous IL-12. Only those TCC with low IFN-gamma leve</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97064186' target='_blank'>97064186</a></td>
        <td style='text-align:right'>n of IFN-gamma could not be induced by exogenous IL-12. Only those TCC with low </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBCDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-gamma</mark>
        </td>
        <td> levels in the absence of IL-12 responded to IL-12 by additional enhancement of </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97064186' target='_blank'>97064186</a></td>
        <td style='text-align:right'> levels in the absence of IL-12 responded to IL-12 by additional enhancement of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBCDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-gamma</mark>
        </td>
        <td> production. The IL-12 nonresponsiveness of the Th2 clones was further evident b</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97064186' target='_blank'>97064186</a></td>
        <td style='text-align:right'>e profiles do not respond to IL-12 and, therefore, cannot be induced to produce </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBCDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IFN-gamma</mark>
        </td>
        <td>. The apparent high frequency of IL-12-nonresponsive Th cells within the allerge</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T196'>Term ID: <a href='terminology.html#L196' target='_blank'>196</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D98133462' target='_blank'>98133462</a></td>
        <td style='text-align:right'> the latter group received prenatal steroid treatment. Seven preterms developed </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AD9CFD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">neonatal respiratory distress syndrome</mark>
        </td>
        <td> ( NRDS ) . The number of GR and the Kd were similar in the term and preterm ( w</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98133462' target='_blank'>98133462</a></td>
        <td style='text-align:right'>id treatment. Seven preterms developed neonatal respiratory distress syndrome ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AD9CFD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NRDS</mark>
        </td>
        <td> ) . The number of GR and the Kd were similar in the term and preterm ( with and</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98133462' target='_blank'>98133462</a></td>
        <td style='text-align:right'>number of GR and the Kd were similar in the term and preterm ( with and without </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AD9CFD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NRDS</mark>
        </td>
        <td> ) babies. The maximum ( 3H ) -thymidine incorporation into DNA of cord blood ly</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98133462' target='_blank'>98133462</a></td>
        <td style='text-align:right'>rporation into DNA of cord blood lymphocytes from all preterms, with or without </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AD9CFD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NRDS</mark>
        </td>
        <td> was suppressed when compared to that from term babies or adults. This could par</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98133462' target='_blank'>98133462</a></td>
        <td style='text-align:right'>e to find a relation between the functionality of the GR and the development of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AD9CFD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NRDS</mark>
        </td>
        <td>. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T97'>Term ID: <a href='terminology.html#L97' target='_blank'>97</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D92362919' target='_blank'>92362919</a></td>
        <td style='text-align:right'>as been found that the number of glucocorticoid receptors in lymphocytes of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBEFAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">peripheral blood</mark>
        </td>
        <td> of healthy elderly subjects increases, while the number of mineralocorticoid re</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95261059' target='_blank'>95261059</a></td>
        <td style='text-align:right'> cells. PU.1 is expressed at highest levels in mature human monocytes and human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBEFAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">peripheral blood</mark>
        </td>
        <td> neutrophils. In contrast to PU.1, significant levels of Spi-B mRNA and protein </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97064186' target='_blank'>97064186</a></td>
        <td style='text-align:right'> this aim, allergen-specific CD4+ T cell clones ( TCC ) were generated from the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBEFAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">peripheral blood</mark>
        </td>
        <td> of three atopic patients, and their cytokine profiles were analyzed. The majori</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97162234' target='_blank'>97162234</a></td>
        <td style='text-align:right'>um ( FCM ) is able to inhibit both TNF mRNA accumulation and protein release in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBEFAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">peripheral blood</mark>
        </td>
        <td>-derived human monocytes ( PBM ) stimulated with lipopolysaccharide ( LPS ) . In</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'>immune system, we amplified and cloned LTRs from proviral DNA in HIV-1-infected </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBEFAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">peripheral blood</mark>
        </td>
        <td>. Sequence analysis of nineteen LTRs cloned from 2 adult and 3 pediatric patient</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99155344' target='_blank'>99155344</a></td>
        <td style='text-align:right'>the HUMARA loci in purified eosinophils from female patients with eosinophilia. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBEFAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Peripheral blood</mark>
        </td>
        <td> eosinophils were isolated by their autofluoresence using flow cytometric sortin</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T60'>Term ID: <a href='terminology.html#L60' target='_blank'>60</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>T cells are considered to be unresponsive to testosterone due to the absence of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDC9ED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">androgen receptors</mark>
        </td>
        <td> ( AR ) . Here, we demonstrate the testosterone responsiveness of murine splenic</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>d to be unresponsive to testosterone due to the absence of androgen receptors ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDC9ED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AR</mark>
        </td>
        <td> ) . Here, we demonstrate the testosterone responsiveness of murine splenic T ce</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>onventional cell surface receptors for testosterone and classical intracellular </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDC9ED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AR</mark>
        </td>
        <td>. Binding sites for testosterone on the surface of both CD4 ( + ) and CD8 ( + ) </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>terone-BSA-induced Ca2+ import is not affected by cyproterone, a blocker of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDC9ED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AR</mark>
        </td>
        <td>. In addition, AR are not detectable on the surface of intact T cells when using</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>d Ca2+ import is not affected by cyproterone, a blocker of the AR. In addition, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDC9ED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AR</mark>
        </td>
        <td> are not detectable on the surface of intact T cells when using anti-AR antibodi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>ddition, AR are not detectable on the surface of intact T cells when using anti-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDC9ED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AR</mark>
        </td>
        <td> antibodies directed against the amino and carboxy terminus of the AR, although </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>using anti-AR antibodies directed against the amino and carboxy terminus of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDC9ED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AR</mark>
        </td>
        <td>, although T cells contain AR, as revealed by reverse transcription-polymerase c</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>cted against the amino and carboxy terminus of the AR, although T cells contain </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDC9ED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AR</mark>
        </td>
        <td>, as revealed by reverse transcription-polymerase chain reactions and Western bl</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>ealed by reverse transcription-polymerase chain reactions and Western blotting. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDC9ED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AR</mark>
        </td>
        <td> can be visualized with the anti-AR antibodies in the cytoplasm of permeabilized</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>merase chain reactions and Western blotting. AR can be visualized with the anti-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDC9ED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AR</mark>
        </td>
        <td> antibodies in the cytoplasm of permeabilized T cells by using CLSM, though AR a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>i-AR antibodies in the cytoplasm of permeabilized T cells by using CLSM, though </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDC9ED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AR</mark>
        </td>
        <td> are not detectable in cytosol fractions when using the charcoal binding assay w</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>ions when using the charcoal binding assay with 3H-R1881 as ligand. Cytoplasmic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDC9ED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AR</mark>
        </td>
        <td> do not translocate to the nucleus of T cells in the presence of testosterone, i</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'> nucleus of T cells in the presence of testosterone, in contrast to cytoplasmic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDC9ED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AR</mark>
        </td>
        <td> in human cancer LNCaP cells. These findings suggest that the classical AR prese</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99091536' target='_blank'>99091536</a></td>
        <td style='text-align:right'>asmic AR in human cancer LNCaP cells. These findings suggest that the classical </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDC9ED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AR</mark>
        </td>
        <td> present in splenic T cells are not active in the genomic pathway. By contrast, </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T25'>Term ID: <a href='terminology.html#L25' target='_blank'>25</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D97468093' target='_blank'>97468093</a></td>
        <td style='text-align:right'>possibility that this enzyme can exert its hydrolytic activity independently of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDADB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">protein tyrosine kinase activation</mark>
        </td>
        <td>. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99356019' target='_blank'>99356019</a></td>
        <td style='text-align:right'>ime ELISA, EMSA ( electromobility shift assay ) and RT-PCR were used to measure </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDADB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">protein tyrosine kinase activity</mark>
        </td>
        <td>, protein activity of NF-kappa B and cytokine ( IL-1beta, IL-6, TNF-alpha ) spec</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99356019' target='_blank'>99356019</a></td>
        <td style='text-align:right'>, TNF-alpha ) specific mRNA levels in BEAS-2B cells. We observed an increase in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDADB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">protein tyrosine kinase activity</mark>
        </td>
        <td> ( up to 1.8 +/- 0.5-fold ) and NF-kappa B protein activity in BEAS-2B cells aft</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99356019' target='_blank'>99356019</a></td>
        <td style='text-align:right'>IL-1beta-, IL-6- and TNF-alpha-mRNA were elevated ( up to 1.9 +/- 0.58-fold ) . </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDADB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Protein tyrosine kinase activity</mark>
        </td>
        <td>, NF-kappa B activity, and the synthesis of cytokine-specific mRNA were inhibite</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T186'>Term ID: <a href='terminology.html#L186' target='_blank'>186</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96338163' target='_blank'>96338163</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9F9FDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CTL</mark>
        </td>
        <td> recognition of an altered peptide associated with asparagine bond rearrangement</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96338163' target='_blank'>96338163</a></td>
        <td style='text-align:right'>d post-translationally modified amino acid side chains are recognized by primed </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9F9FDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CTL</mark>
        </td>
        <td> has not been clearly defined. We report on the CTL recognition of a MHC class I</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96338163' target='_blank'>96338163</a></td>
        <td style='text-align:right'>ins are recognized by primed CTL has not been clearly defined. We report on the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9F9FDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CTL</mark>
        </td>
        <td> recognition of a MHC class I-restricted peptide containing a cyclized asparagin</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96338163' target='_blank'>96338163</a></td>
        <td style='text-align:right'>aining amino acids and also occurs as a side reaction in peptide synthesis. The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9F9FDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CTL</mark>
        </td>
        <td> specifically recognized the succinimide-containing peptide showing only weak cr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96338163' target='_blank'>96338163</a></td>
        <td style='text-align:right'>ncentrations of the parent peptide containing unmodified asparagine. Similarly, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9F9FDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CTL</mark>
        </td>
        <td> raised against the parent peptide did not recognize the succinimide derivative </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'>c cells. The conventional means of studying Epstein-Barr virus ( EBV ) -induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9F9FDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cytotoxic T-lymphocyte</mark>
        </td>
        <td> ( CTL ) memory, by in vitro stimulation with the latently infected autologous l</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'> means of studying Epstein-Barr virus ( EBV ) -induced cytotoxic T-lymphocyte ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9F9FDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CTL</mark>
        </td>
        <td> ) memory, by in vitro stimulation with the latently infected autologous lymphob</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'> epitope peptide-loaded dendritic cells ( DCs ) , which allows one to probe the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9F9FDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CTL</mark>
        </td>
        <td> repertoire for any individual reactivity of choice; this method proved signific</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'>ntified by T cells during primary EBV infection are regularly detectable in the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9F9FDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CTL</mark>
        </td>
        <td> memory of virus carriers; this implies that in such carriers chronic virus repl</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'>ns, can be reactivated by DC stimulation and selectively expanded as polyclonal </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9F9FDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CTL</mark>
        </td>
        <td> lines; the adoptive transfer of such preparations may be of value in targeting </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T85'>Term ID: <a href='terminology.html#L85' target='_blank'>85</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95065655' target='_blank'>95065655</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Epstein-Barr virus</mark>
        </td>
        <td> SM protein. The protein products of the Epstein-Barr virus ( EBV ) BMLF1 open r</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95065655' target='_blank'>95065655</a></td>
        <td style='text-align:right'>Epstein-Barr virus SM protein. The protein products of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Epstein-Barr virus</mark>
        </td>
        <td> ( EBV ) BMLF1 open reading frame have been characterized in the early productiv</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95065655' target='_blank'>95065655</a></td>
        <td style='text-align:right'>Epstein-Barr virus SM protein. The protein products of the Epstein-Barr virus ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EBV</mark>
        </td>
        <td> ) BMLF1 open reading frame have been characterized in the early productive cycl</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95065655' target='_blank'>95065655</a></td>
        <td style='text-align:right'>ing BSLF2 to BMLF1 is much the most abundant protein. SM is a phosphoprotein in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EBV</mark>
        </td>
        <td>-infected cells and can be phosphorylated in vitro with casein kinase II ( CKII </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95065655' target='_blank'>95065655</a></td>
        <td style='text-align:right'>other herpesviruses and revealed consensus CKII sites near the N termini of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EBV</mark>
        </td>
        <td> SM protein, the herpes simplex virus ( HSV ) ICP27 protein and the herpesvirus </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95065655' target='_blank'>95065655</a></td>
        <td style='text-align:right'>ading frame 57 protein. Site-directed mutagenesis of the consensus CKII site in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EBV</mark>
        </td>
        <td> SM greatly reduced the in vitro phosphorylation of SM by CKII. The mechanism of</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'>cell surface. The nature of CD40-dependent signals in proliferating fresh human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Epstein-Barr virus</mark>
        </td>
        <td>-negative B lymphocytes is currently unknown. In this study, a CD40-dependent B </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98406200' target='_blank'>98406200</a></td>
        <td style='text-align:right'>The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Epstein-Barr virus</mark>
        </td>
        <td> Rta protein activates lytic cycle genes and can disrupt latency in B lymphocyte</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98406200' target='_blank'>98406200</a></td>
        <td style='text-align:right'>s lytic cycle genes and can disrupt latency in B lymphocytes. The transition of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Epstein-Barr virus</mark>
        </td>
        <td> ( EBV ) from latency into the lytic cycle is associated with the expression of </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98406200' target='_blank'>98406200</a></td>
        <td style='text-align:right'>nd can disrupt latency in B lymphocytes. The transition of Epstein-Barr virus ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EBV</mark>
        </td>
        <td> ) from latency into the lytic cycle is associated with the expression of two im</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98406200' target='_blank'>98406200</a></td>
        <td style='text-align:right'> implicating ZEBRA in the activation of Rta, we suggest a cooperative model for </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EBV</mark>
        </td>
        <td> entry into the lytic cycle. Expression of either BZLF1 or BRLF1 triggers expres</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'>Accessing </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Epstein-Barr virus</mark>
        </td>
        <td>-specific T-cell memory with peptide-loaded dendritic cells. The conventional me</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'> memory with peptide-loaded dendritic cells. The conventional means of studying </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Epstein-Barr virus</mark>
        </td>
        <td> ( EBV ) -induced cytotoxic T-lymphocyte ( CTL ) memory, by in vitro stimulation</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'>loaded dendritic cells. The conventional means of studying Epstein-Barr virus ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EBV</mark>
        </td>
        <td> ) -induced cytotoxic T-lymphocyte ( CTL ) memory, by in vitro stimulation with </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'>inant and subdominant lytic cycle epitopes identified by T cells during primary </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EBV</mark>
        </td>
        <td> infection are regularly detectable in the CTL memory of virus carriers; this im</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'>the adoptive transfer of such preparations may be of value in targeting certain </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F9FC9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">EBV</mark>
        </td>
        <td>-positive malignancies. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T38'>Term ID: <a href='terminology.html#L38' target='_blank'>38</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>was dose-dependently reduced by aspirin over the same range, while induction of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFDEA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">intercellular adhesion molecule-1</mark>
        </td>
        <td> ( ICAM-1 ) was hardly affected. Aspirin appeared to prevent VCAM-1 transcriptio</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>rin over the same range, while induction of intercellular adhesion molecule-1 ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFDEA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ICAM-1</mark>
        </td>
        <td> ) was hardly affected. Aspirin appeared to prevent VCAM-1 transcription, since </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>NF-kappa B / Rel family members regulating the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFDEA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ICAM-1</mark>
        </td>
        <td> promoter in monocytic THP-1 cells. A kappa B-site was identified in the promote</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'> in monocytic THP-1 cells. A kappa B-site was identified in the promoter of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFDEA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">intercellular adhesion molecule-1</mark>
        </td>
        <td> ( ICAM-1 ) gene, which is involved in regulation of ICAM-1 expression by tumor </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>-site was identified in the promoter of the intercellular adhesion molecule-1 ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFDEA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ICAM-1</mark>
        </td>
        <td> ) gene, which is involved in regulation of ICAM-1 expression by tumor necrosis </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>ellular adhesion molecule-1 ( ICAM-1 ) gene, which is involved in regulation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFDEA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ICAM-1</mark>
        </td>
        <td> expression by tumor necrosis factor alpha ( TNF-alpha ) and glucocorticoids. We</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>tion factors which bind and transactivate this enhancer sequence. In vitro, the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFDEA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ICAM-1</mark>
        </td>
        <td> kappa B site appeared to bind RelA and c-Rel homodimers as well as heterodimers</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>ition, both RelA and c-Rel, but not NF-kappa B1, were shown to transactivate an </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFDEA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ICAM-1</mark>
        </td>
        <td> kappa B-reporter construct. In monocytic THP-1 cells TNF-alpha induced two nucl</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>THP-1 cells TNF-alpha induced two nuclear complexes which in vitro bound to the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFDEA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ICAM-1</mark>
        </td>
        <td> kappa B site. Using antibodies in an electrophoretic mobility supershift assay,</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>t. The second complex contained RelA, and exhibited higher affinity towards the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFDEA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ICAM-1</mark>
        </td>
        <td> kappa B than to the HIV kappa B site. The glucocorticoid receptor was shown to </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>in vivo RelA homodimers are likely to play a dominant role in TNF-alpha-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFDEA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ICAM-1</mark>
        </td>
        <td> transcription in monocytic cells. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>CD3 ligation induces a delayed Stat3 binding to oligonucleotide probes from the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFDEA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">ICAM-1</mark>
        </td>
        <td> and IL-2R alpha promoter. CD3-mediated activation of Stat3 is almost completely</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T11'>Term ID: <a href='terminology.html#L11' target='_blank'>11</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D97028169' target='_blank'>97028169</a></td>
        <td style='text-align:right'>cating that murine adult HPCs transduced with dominant negative ATRA receptor ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EACEFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RAR</mark>
        </td>
        <td> ) gene are immortalized and show a selective blockade of granulocytic different</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97028169' target='_blank'>97028169</a></td>
        <td style='text-align:right'>hematopoiesis via a dual effect hypothetically mediated by interaction with the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EACEFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RAR</mark>
        </td>
        <td> / RXR heterodimer, ie, inhibition of HSC/ primitive HPC proliferation and induc</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>l development. Here we investigated the impact of retinoid X receptor ( RXR ) , </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EACEFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">retinoic acid receptor</mark>
        </td>
        <td> ( RAR ) , and of the c-erbA / thyroid hormone ( T3 ) receptor ( c-erbA / TR ) o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>vestigated the impact of retinoid X receptor ( RXR ) , retinoic acid receptor ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EACEFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RAR</mark>
        </td>
        <td> ) , and of the c-erbA / thyroid hormone ( T3 ) receptor ( c-erbA / TR ) on grow</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'> vitro culture system of stem cell factor-dependent erythroid progenitors. RXR, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EACEFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RAR</mark>
        </td>
        <td>, and c-erbA / TR-specific ligands were found to induce erythroid-specific gene </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99408303' target='_blank'>99408303</a></td>
        <td style='text-align:right'>ggested from a variety of sources. Here we present a review of the mechanism of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EACEFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">retinoic acid receptor</mark>
        </td>
        <td> action and the major evidence showing that normal retinoid signaling is require</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T111'>Term ID: <a href='terminology.html#L111' target='_blank'>111</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'>Accessing Epstein-Barr virus-specific T-cell memory with peptide-loaded </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADBBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">dendritic cells</mark>
        </td>
        <td>. The conventional means of studying Epstein-Barr virus ( EBV ) -induced cytotox</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'>alternative approach, based on in vitro stimulation with epitope peptide-loaded </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADBBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">dendritic cells</mark>
        </td>
        <td> ( DCs ) , which allows one to probe the CTL repertoire for any individual react</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'>ch, based on in vitro stimulation with epitope peptide-loaded dendritic cells ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADBBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DCs</mark>
        </td>
        <td> ) , which allows one to probe the CTL repertoire for any individual reactivity </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99102590' target='_blank'>99102590</a></td>
        <td style='text-align:right'>though rarely undetectable in LCL-stimulated populations, can be reactivated by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADBBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DC</mark>
        </td>
        <td> stimulation and selectively expanded as polyclonal CTL lines; the adoptive tran</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99172186' target='_blank'>99172186</a></td>
        <td style='text-align:right'>N-acetyl-L-cysteine inhibits primary human T cell responses at the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADBBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">dendritic cell</mark>
        </td>
        <td> level: association with NF-kappa B inhibition. N-acetyl-L-cysteine ( NAC ) is a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99172186' target='_blank'>99172186</a></td>
        <td style='text-align:right'>NAC on the induction phase of T cell responses, we analyzed its action on human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADBBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">dendritic cells</mark>
        </td>
        <td> ( DC ) derived from adherent PBMC cultured with IL-4 and granulocyte-macrophage</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99172186' target='_blank'>99172186</a></td>
        <td style='text-align:right'>on phase of T cell responses, we analyzed its action on human dendritic cells ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADBBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DC</mark>
        </td>
        <td> ) derived from adherent PBMC cultured with IL-4 and granulocyte-macrophage CSF.</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99172186' target='_blank'>99172186</a></td>
        <td style='text-align:right'>a B. In parallel, NAC was shown to down-regulate the production of cytokines by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADBBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DC</mark>
        </td>
        <td> as well as their surface expression of HLA-DR, CD86 ( B7-2 ) , and CD40 molecul</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99172186' target='_blank'>99172186</a></td>
        <td style='text-align:right'>0 molecules both at the basal state and upon LPS activation. NAC also inhibited </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADBBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DC</mark>
        </td>
        <td> responses induced by CD40 engagement. The inhibitory effects of NAC were not du</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99172186' target='_blank'>99172186</a></td>
        <td style='text-align:right'>effects of NAC were not due to nonspecific toxicity as neither the viability of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADBBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DC</mark>
        </td>
        <td> nor their mannose receptor-mediated endocytosis were modified by NAC. Finally, </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99172186' target='_blank'>99172186</a></td>
        <td style='text-align:right'>, we found that the addition of NAC to MLR between naive T cells and allogeneic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADBBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DC</mark>
        </td>
        <td> resulted in a profound inhibition of alloreactive responses, which could be att</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99172186' target='_blank'>99172186</a></td>
        <td style='text-align:right'> inhibition of alloreactive responses, which could be attributed to a defect of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADBBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DC</mark>
        </td>
        <td> as APC-independent T cell responses were not inhibited by NAC. Altogether, our </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99172186' target='_blank'>99172186</a></td>
        <td style='text-align:right'>neration of primary immune responses in humans through its inhibitory action on </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADBBB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DC</mark>
        </td>
        <td>. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T110'>Term ID: <a href='terminology.html#L110' target='_blank'>110</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96185499' target='_blank'>96185499</a></td>
        <td style='text-align:right'>ibits histone deacetylation in vivo and causes mammalian cells to arrest in the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBBCA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell cycle</mark>
        </td>
        <td>. A trapoxin affinity matrix was used to isolate two nuclear proteins that copur</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98038749' target='_blank'>98038749</a></td>
        <td style='text-align:right'>Regulation of Id3 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBBCA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell cycle</mark>
        </td>
        <td> function by Cdk-2-dependent phosphorylation. The functions of basic helix-loop-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98038749' target='_blank'>98038749</a></td>
        <td style='text-align:right'>factors in activating differentiation-linked gene expression and in inducing G1 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBBCA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell cycle</mark>
        </td>
        <td> arrest are negatively regulated by members of the Id family of HLH proteins. Th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98038749' target='_blank'>98038749</a></td>
        <td style='text-align:right'>r5 ) in Id2 has been shown to occur during late G1-to-S phase transition of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBBCA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell cycle</mark>
        </td>
        <td>, and this neutralizes the function of Id2 in abrogating E-box-dependent bHLH ho</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98038749' target='_blank'>98038749</a></td>
        <td style='text-align:right'>M.Hall, and G.Peters, EMBO J.16:332-342, 1997 ) . We now show that an analogous </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBBCA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell-cycle</mark>
        </td>
        <td>-regulated phosphorylation of Id3 alters the specificity of Id3 for abrogating b</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98038749' target='_blank'>98038749</a></td>
        <td style='text-align:right'>type Id3, an Id3 Asp5 mutant ( mimicking phosphorylation ) is unable to promote </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBBCA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell cycle</mark>
        </td>
        <td> S phase entry in transfected fibroblasts, whereas an Id3 Ala5 mutant ( ablating</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98038749' target='_blank'>98038749</a></td>
        <td style='text-align:right'>ore provides a switch during late G1-to-S phase that both nullifies an early G1 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBBCA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell cycle</mark>
        </td>
        <td> regulatory function of Id3 and modulates its target bHLH specificity. These dat</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98038749' target='_blank'>98038749</a></td>
        <td style='text-align:right'>HLH specificity. These data also demonstrate that the ability of Id3 to promote </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBBCA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell cycle</mark>
        </td>
        <td> S phase entry is not simply a function of its ability to modulate bHLH heterodi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99081619' target='_blank'>99081619</a></td>
        <td style='text-align:right'>n-10 inhibition of T-helper cell activation by superantigen at the level of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBBCA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell cycle</mark>
        </td>
        <td>. We have analyzed the effects of interleukin-10 ( IL-10 ) on the entry of quies</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99081619' target='_blank'>99081619</a></td>
        <td style='text-align:right'>f interleukin-10 ( IL-10 ) on the entry of quiescent CD4 ( + ) T cells into the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBBCA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell cycle</mark>
        </td>
        <td> upon stimulation with the superantigen staphylococcal enterotoxin B ( SEB ) . I</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99081619' target='_blank'>99081619</a></td>
        <td style='text-align:right'> ) , an inhibitory protein that controls progression out of the G0 phase of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBBCA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell cycle</mark>
        </td>
        <td>. IL-10 also prevented the upregulation of the G1 cyclins D2 and D3, proteins ne</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99081619' target='_blank'>99081619</a></td>
        <td style='text-align:right'>nd D3, proteins necessary for entry and progression through the G1 phase of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBBCA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell cycle</mark>
        </td>
        <td>. Associated with the inhibition of the cell cycle, IL-10 suppressed SEB inducti</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99081619' target='_blank'>99081619</a></td>
        <td style='text-align:right'>n through the G1 phase of the cell cycle. Associated with the inhibition of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBBCA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell cycle</mark>
        </td>
        <td>, IL-10 suppressed SEB induction of interleukin-2 ( IL-2 ) . Addition of exogeno</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99081619' target='_blank'>99081619</a></td>
        <td style='text-align:right'> ( Kip1 ) and upregulation of D cyclins in T-cell activation and entry into the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FBBCA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cell cycle</mark>
        </td>
        <td>. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T70'>Term ID: <a href='terminology.html#L70' target='_blank'>70</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>ssed in mature and immature T-cell lines ( Jurkat, CCRF-CEM ) and not in mature </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAC9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">B cells</mark>
        </td>
        <td> ( JY, Namalwa ) or nonlymphoid ( HeLa ) cell lines. A small 95-bp fragment of t</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95261059' target='_blank'>95261059</a></td>
        <td style='text-align:right'>usly described as being predominantly expressed coordinately in macrophages and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAC9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">B cells</mark>
        </td>
        <td>, but their expression in early hematopoietic stages and during the course of my</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97025698' target='_blank'>97025698</a></td>
        <td style='text-align:right'>he oligo sequence I stimulated proliferation of both T and, to a lesser extent, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAC9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">B cells</mark>
        </td>
        <td>. The percentage of cells expressing CD40 in T and B cell co-cultures increased </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'>robe, revealed that both p65 ( RelA ) and c-Rel were present in CD40-stimulated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAC9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">B cells</mark>
        </td>
        <td>. While PKC depletion did not alter the NF-kappa B level, treatment of B lymphoc</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97207294' target='_blank'>97207294</a></td>
        <td style='text-align:right'>mphocyte function and mediates its effects via a receptor that contains gammac. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAC9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">B cells</mark>
        </td>
        <td> derived from patients with X-linked severe combined immunodeficiency ( X-SCID )</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97207294' target='_blank'>97207294</a></td>
        <td style='text-align:right'>t in IL-4-mediated signaling. We found that although IL-4 stimulation of X-SCID </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAC9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">B cells</mark>
        </td>
        <td> did not result in Janus tyrosine kinase-3 ( JAK3 ) phosphorylation, other IL-4 </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97207294' target='_blank'>97207294</a></td>
        <td style='text-align:right'>ription 6 ( STAT6 ) tyrosine phosphorylation and DNA binding activity in X-SCID </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAC9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">B cells</mark>
        </td>
        <td> with a wide range of gammac mutations. However, reconstitution of these X-SCID </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97207294' target='_blank'>97207294</a></td>
        <td style='text-align:right'> with a wide range of gammac mutations. However, reconstitution of these X-SCID </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAC9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">B cells</mark>
        </td>
        <td> with gammac enhanced IL-4-mediated responses including STAT6 phosphorylation an</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97207294' target='_blank'>97207294</a></td>
        <td style='text-align:right'>expression. Thus, gammac is not necessary to trigger IL-4-mediated responses in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAC9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">B cells</mark>
        </td>
        <td>, but its presence is important for optimal IL-4-signaling. These results sugges</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97303223' target='_blank'>97303223</a></td>
        <td style='text-align:right'>man interleukin 4 receptor alpha chain induces Cepsilon germline transcripts in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAC9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">B cells</mark>
        </td>
        <td> in the absence of the interleukin 2 receptor gamma chain. The cytokines interle</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97303223' target='_blank'>97303223</a></td>
        <td style='text-align:right'>le in inducing Cepsilon germline transcripts and IgE isotype switching in human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAC9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">B cells</mark>
        </td>
        <td>. The IL-4 receptor ( IL-4R ) in B cells is composed of two chains, the IL-4-bin</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97303223' target='_blank'>97303223</a></td>
        <td style='text-align:right'>ipts and IgE isotype switching in human B cells. The IL-4 receptor ( IL-4R ) in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAC9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">B cells</mark>
        </td>
        <td> is composed of two chains, the IL-4-binding IL-4Ralpha chain, which is shared w</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97303223' target='_blank'>97303223</a></td>
        <td style='text-align:right'>IL-15R. IL-4 induces Cepsilon germline transcripts and IgE isotype switching in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAC9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">B cells</mark>
        </td>
        <td> from patients with gammac chain deficiency. Induction of Cepsilon germline tran</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97303223' target='_blank'>97303223</a></td>
        <td style='text-align:right'> gammac chain deficiency. Induction of Cepsilon germline transcripts by IL-4 in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAC9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">B cells</mark>
        </td>
        <td> that lack the gammac chain may involve signaling via the IL-13R. Alternatively,</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97303223' target='_blank'>97303223</a></td>
        <td style='text-align:right'>egion of IL-4Ralpha abolished signaling by this chimeric receptor. Furthermore, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAC9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">B cells</mark>
        </td>
        <td> transfected with a chimeric CD8alpha / IL-4Ralpha receptor, which is expressed </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T56'>Term ID: <a href='terminology.html#L56' target='_blank'>56</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>Purification of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEBFA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCF-1 alpha</mark>
        </td>
        <td>, a T-cell-specific transcription factor that activates the T-cell receptor C al</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>ence this developmental process. We have purified a new T-cell-specific factor, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEBFA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCF-1 alpha</mark>
        </td>
        <td>, that is implicated in the activation of genes encoding a major component of th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>tion of genes encoding a major component of the human T-cell receptor ( TCR ) . </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEBFA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCF-1 alpha</mark>
        </td>
        <td>, originally identified and purified through its binding sites on the HIV-1 prom</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>n the TCR alpha gene ( e.g., p56 lck and CD3 delta ) . Sequences related to the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEBFA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCF-1 alpha</mark>
        </td>
        <td> binding motif ( 5'--3' ) are also found in the human TCR delta ( and possibly T</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>naturation experiments with the use of purified protein fractions revealed that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEBFA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCF-1 alpha</mark>
        </td>
        <td> activity is derived from a family of 57- to 53-kD proteins that are abundantly </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>lines. A small 95-bp fragment of the TCR alpha control region that contains the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEBFA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCF-1 alpha</mark>
        </td>
        <td> binding site juxtaposed between a cAMP-response element ( the CRE or T alpha 1 </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>ll as resting and activated immature ( CCRF-CEM ) T-cell lines. Mutation of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEBFA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCF-1 alpha</mark>
        </td>
        <td> binding site diminished enhancer activity and disrupted the synergism observed </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>d disrupted the synergism observed in vivo between tandem enhancer repeats. The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEBFA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCF-1 alpha</mark>
        </td>
        <td> binding site was also required for TCR alpha enhancer activity in transcription</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>anscriptionally active extracts from Jurkat but not HeLa cells, confirming that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEBFA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCF-1 alpha</mark>
        </td>
        <td> is a T-cell-specific transcription factor. Curiously, the TCF-1 alpha binding e</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>ming that TCF-1 alpha is a T-cell-specific transcription factor. Curiously, the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEBFA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCF-1 alpha</mark>
        </td>
        <td> binding element was inactive in vivo when removed from its neighboring elements</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>pies upstream of a heterologous promoter. Thus, the transcriptional activity of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEBFA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCF-1 alpha</mark>
        </td>
        <td> appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription facto</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T116'>Term ID: <a href='terminology.html#L116' target='_blank'>116</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>udied a potential inhibition of this pathway by acetylsalicylate ( aspirin ) in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCCEFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">human umbilical vein endothelial cells</mark>
        </td>
        <td> ( HUVECs ) . METHODS AND RESULTS: Gel-shift analyses demonstrated dose-dependen</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>way by acetylsalicylate ( aspirin ) in human umbilical vein endothelial cells ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCCEFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HUVECs</mark>
        </td>
        <td> ) . METHODS AND RESULTS: Gel-shift analyses demonstrated dose-dependent inhibit</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'> TNF. As a functional consequence, adhesion of U937 monocytes to TNF-stimulated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCCEFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HUVECs</mark>
        </td>
        <td> was markedly reduced by aspirin due to suppression of VCAM-1 and E-selectin upr</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T76'>Term ID: <a href='terminology.html#L76' target='_blank'>76</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>kDa plus 50-kDa NF-kappa B heterodimer was preferentially lost. Adding purified </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCFEDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B protein</mark>
        </td>
        <td> to nuclear extracts from cells with restricted expression overcomes this lack o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92135145' target='_blank'>92135145</a></td>
        <td style='text-align:right'> cell hybrids is accompanied by the nuclear localization of NF-kappa B. The two </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCFEDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear proteins NF-kappa B</mark>
        </td>
        <td> ( consisting of subunits p50 an dp65 ) and the DNA-binding subunit of NF-kappa </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96074632' target='_blank'>96074632</a></td>
        <td style='text-align:right'>Down-regulation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCFEDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B protein</mark>
        </td>
        <td> levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3 [published er</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96074632' target='_blank'>96074632</a></td>
        <td style='text-align:right'> were ineffective. Besides p50, 1,25 ( OH ) 2D3 decreased the levels of another </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCFEDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B protein</mark>
        </td>
        <td>, namely c-rel. In addition, 1,25 ( OH ) 2D3 decreased the abundance of a specif</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97211823' target='_blank'>97211823</a></td>
        <td style='text-align:right'>ence of in vitro treatment of these cells. In the present report, we identified </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCFEDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B proteins</mark>
        </td>
        <td> extracted from human thymocyte nuclei as being p50 / p65 and p50 / c-Rel comple</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99356019' target='_blank'>99356019</a></td>
        <td style='text-align:right'> an increase in protein tyrosine kinase activity ( up to 1.8 +/- 0.5-fold ) and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCFEDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B protein</mark>
        </td>
        <td> activity in BEAS-2B cells after particle or fibre exposure of co-cultured BM. C</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T50'>Term ID: <a href='terminology.html#L50' target='_blank'>50</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>uman monocytes leads to activation of nuclear factor-kappa B ( NF-kappa B ) and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FFABBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha release</mark>
        </td>
        <td>. Previous studies have implicated activation of both protein kinase C ( PKC ) a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>ibitor bisindolylmaleimide ( Bis ) , or an inhibitor of PTK genistein ( Gen ) . </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FFABBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha release</mark>
        </td>
        <td> in culture supernatants was measured by an ELISA. NF-kappa B DNA binding was ev</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'>ytes. Nonspecific protein kinase inhibition inhibited NF-kappa B activation and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FFABBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha release</mark>
        </td>
        <td>, while specific PKC inhibition with Bis had no effect on LPS-induced NF-kappa B</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99228708' target='_blank'>99228708</a></td>
        <td style='text-align:right'> PKC inhibition with Bis had no effect on LPS-induced NF-kappa B DNA binding or </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FFABBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha release</mark>
        </td>
        <td>. PTK inhibition with Gen attenuated both LPS-induced NF-kappa B DNA binding and</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T49'>Term ID: <a href='terminology.html#L49' target='_blank'>49</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>on, both at the mRNA and protein level. The induced expression of IL-1 beta and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EEEDD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF alpha mRNA</mark>
        </td>
        <td> in the monocytic THP-1 cell line increased as quickly as in primary cells. In c</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>e c-myc protein are involved in the MDHM-induced increase in IL-1 beta, IL-6 or </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EEEDD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF alpha mRNA</mark>
        </td>
        <td> levels. Furthermore, the present results demonstrate clearly that mycoplasma pr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99356019' target='_blank'>99356019</a></td>
        <td style='text-align:right'> particle or fibre exposure of co-cultured BM. Consecutive IL-1beta-, IL-6- and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EEEDD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TNF-alpha-mRNA</mark>
        </td>
        <td> were elevated ( up to 1.9 +/- 0.58-fold ) . Protein tyrosine kinase activity, N</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T44'>Term ID: <a href='terminology.html#L44' target='_blank'>44</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>ified through its binding sites on the HIV-1 promoter, was found to bind to the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9FEFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR alpha enhancer</mark>
        </td>
        <td> and to promoters for several genes expressed at significantly earlier stages of</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>een tandem enhancer repeats. The TCF-1 alpha binding site was also required for </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9FEFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR alpha enhancer</mark>
        </td>
        <td> activity in transcriptionally active extracts from Jurkat but not HeLa cells, c</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'> element was inactive in vivo when removed from its neighboring elements on the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9FEFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR alpha enhancer</mark>
        </td>
        <td> and positioned in one or more copies upstream of a heterologous promoter. Thus,</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>1 ( CREB ) transcription factors and the context of its binding site within the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9FEFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TCR alpha enhancer</mark>
        </td>
        <td>. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T36'>Term ID: <a href='terminology.html#L36' target='_blank'>36</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>on and monocyte adhesion in stimulated human endothelial cells. BACKGROUND: The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACFCAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">induction of vascular cell adhesion molecule-1</mark>
        </td>
        <td> ( VCAM-1 ) and E-selectin by tumor necrosis factor-alpha ( TNF ) is mediated by</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>appa B mobilization by aspirin at concentrations ranging from 1 to 10 mmol / L. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACFCAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Induction of VCAM-1</mark>
        </td>
        <td> and E-selectin surface expression by TNF was dose-dependently reduced by aspiri</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>n appeared to prevent VCAM-1 transcription, since it dose-dependently inhibited </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACFCAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">induction of VCAM-1</mark>
        </td>
        <td> mRNA by TNF. As a functional consequence, adhesion of U937 monocytes to TNF-sti</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>e. CONCLUSIONS: Our data suggest that aspirin inhibits NF-kappa B mobilization, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACFCAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">induction of VCAM-1</mark>
        </td>
        <td> and E-selectin, and subsequent monocyte adhesion in endothelial cells stimulate</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T118'>Term ID: <a href='terminology.html#L118' target='_blank'>118</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>entic enhancer for high-level zeta 2 globin promoter activity in K562 cells, an </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAADBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cell</mark>
        </td>
        <td> line of embryonic and / or fetal origin. Although sequences located between -55</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>onic zeta 2 globin gene and the fetal / adult alpha globin genes is mediated by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAADBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cell</mark>
        </td>
        <td>-specific and developmental stage-specific nuclear factor-DNA complexes which fo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>Retinoid X receptor and c-cerbA / thyroid hormone receptor regulate </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAADBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cell</mark>
        </td>
        <td> growth and differentiation. Nuclear receptors are important regulators of eryth</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'> cell growth and differentiation. Nuclear receptors are important regulators of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAADBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cell</mark>
        </td>
        <td> development. Here we investigated the impact of retinoid X receptor ( RXR ) , r</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>hyroid hormone ( T3 ) receptor ( c-erbA / TR ) on growth and differentiation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAADBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cells</mark>
        </td>
        <td> using an in vitro culture system of stem cell factor-dependent erythroid progen</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>rowth in culture. Thus, c-erbA / TR appears to act as a binary switch affecting </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAADBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cell</mark>
        </td>
        <td> fate: unliganded c-erbA / TR supports growth while ligand-activated c-erbA / TR</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'> / TR induces differentiation. Additionally, to determine the impact of RXR for </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAADBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cell</mark>
        </td>
        <td> development, dominant interfering mutant RXRs, lacking the transcriptional acti</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>the RXR mutants devoid of AF-1 and / or AF-2 supported a transient outgrowth of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAADBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cells</mark>
        </td>
        <td>. In marked contrast, expression of the dominant interfering deltaDNA-binding do</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>, containing a deletion of the entire DNA-binding domain, was incompatible with </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAADBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cell</mark>
        </td>
        <td> growth in vitro, suggesting a pivotal role of RXR for erythroid cell developmen</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>tible with erythroid cell growth in vitro, suggesting a pivotal role of RXR for </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAADBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cell</mark>
        </td>
        <td> development. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99310627' target='_blank'>99310627</a></td>
        <td style='text-align:right'>isms by which GATA-1 controls cell survival are unknown. Here we report that in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAADBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cells</mark>
        </td>
        <td>, GATA-1 strongly induces the expression of the anti-apoptotic protein bcl-xL, b</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99310627' target='_blank'>99310627</a></td>
        <td style='text-align:right'>tiated bcl-xL-/- embryonic stem cells fail to generate viable mature definitive </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAADBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cells</mark>
        </td>
        <td>, a phenotype resembling that of GATA-1 gene disruption. In addition, we show th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99310627' target='_blank'>99310627</a></td>
        <td style='text-align:right'>val, cooperates with GATA-1 to stimulate bcl-xL gene expression and to maintain </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAADBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cell</mark>
        </td>
        <td> viability during terminal maturation. Together, our data show that bcl-xL is es</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T272'>Term ID: <a href='terminology.html#L272' target='_blank'>272</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99155344' target='_blank'>99155344</a></td>
        <td style='text-align:right'>Clonality of isolated eosinophils in the hypereosinophilic syndrome. The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DFE9BE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">idiopathic hypereosinophilic syndrome</mark>
        </td>
        <td> ( IHES ) is a rare disorder characterized by unexplained, persistent eosinophil</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99155344' target='_blank'>99155344</a></td>
        <td style='text-align:right'> in the hypereosinophilic syndrome. The idiopathic hypereosinophilic syndrome ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DFE9BE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IHES</mark>
        </td>
        <td> ) is a rare disorder characterized by unexplained, persistent eosinophilia asso</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99155344' target='_blank'>99155344</a></td>
        <td style='text-align:right'>typic abnormalities, there is no specific test to detect clonal eosinophilia in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DFE9BE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IHES</mark>
        </td>
        <td>. Analysis of X-chromosome inactivation patterns can be used to determine whethe</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99155344' target='_blank'>99155344</a></td>
        <td style='text-align:right'> cytometric sorting. Eosinophils purified from a female patient presenting with </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DFE9BE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IHES</mark>
        </td>
        <td> were found to show a clonal pattern of X-inactivation. Eosinophil-depleted leuk</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99155344' target='_blank'>99155344</a></td>
        <td style='text-align:right'>UMARA analysis. The finding of clonal eosinophilia in a patient presenting with </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DFE9BE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IHES</mark>
        </td>
        <td> indicates that such patients may have, in reality, a low-grade clonal disorder </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T104'>Term ID: <a href='terminology.html#L104' target='_blank'>104</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>ified serine / threonine kinases, including protein kinase A, protein kinase C, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9CBFD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">casein kinase II</mark>
        </td>
        <td>, MAP kinases, p70S6K and p90RSK. Fos kinase was purified by anion exchange chro</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95065655' target='_blank'>95065655</a></td>
        <td style='text-align:right'> a phosphoprotein in EBV-infected cells and can be phosphorylated in vitro with </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9CBFD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">casein kinase II</mark>
        </td>
        <td> ( CKII ) . Computer analysis of the SM protein sequence showed a C terminal sec</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95065655' target='_blank'>95065655</a></td>
        <td style='text-align:right'>n EBV-infected cells and can be phosphorylated in vitro with casein kinase II ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9CBFD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CKII</mark>
        </td>
        <td> ) . Computer analysis of the SM protein sequence showed a C terminal section of</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95065655' target='_blank'>95065655</a></td>
        <td style='text-align:right'>genome positional homologues of four other herpesviruses and revealed consensus </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9CBFD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CKII</mark>
        </td>
        <td> sites near the N termini of the EBV SM protein, the herpes simplex virus ( HSV </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95065655' target='_blank'>95065655</a></td>
        <td style='text-align:right'>HVS ) open reading frame 57 protein. Site-directed mutagenesis of the consensus </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9CBFD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CKII</mark>
        </td>
        <td> site in EBV SM greatly reduced the in vitro phosphorylation of SM by CKII. The </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95065655' target='_blank'>95065655</a></td>
        <td style='text-align:right'>ensus CKII site in EBV SM greatly reduced the in vitro phosphorylation of SM by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9CBFD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CKII</mark>
        </td>
        <td>. The mechanism of transactivation by BMLF1 proteins has been controversial but </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95065655' target='_blank'>95065655</a></td>
        <td style='text-align:right'> construct by increasing the amount of cytoplasmic CAT mRNA. Mutagenesis of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9CBFD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CKII</mark>
        </td>
        <td> site in SM made no difference to the transactivation in this transient transfec</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T96'>Term ID: <a href='terminology.html#L96' target='_blank'>96</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>Induction of proto-oncogene and cytokine expression in human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBDFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">peripheral blood monocytes</mark>
        </td>
        <td> and the monocytic cell line THP-1 after stimulation with mycoplasma-derived mat</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>ls by stimulating IL-6 release from adherent cells. This study shows that human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBDFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">peripheral blood monocytes</mark>
        </td>
        <td> ( PBMo ) also respond to MDHM with increases in IL-1 beta, IL-6 and TNF alpha e</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>e from adherent cells. This study shows that human peripheral blood monocytes ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBDFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PBMo</mark>
        </td>
        <td> ) also respond to MDHM with increases in IL-1 beta, IL-6 and TNF alpha expressi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>ocytic THP-1 cell line increased as quickly as in primary cells. In contrast to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBDFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PBMo</mark>
        </td>
        <td>, THP-1 and 14 other monocytic / myeloid leukemia-derived cell lines did not sec</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>though these data suggest AP-1 regulated cytokine mRNA expression, results from </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBDFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PBMo</mark>
        </td>
        <td> are not in accordance with this notion. In the primary cells MDHM-induced eleva</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'> expression, constitutively high in THP-1 cells, was induced in MDHM-stimulated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBDFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PBMo</mark>
        </td>
        <td>. In conclusion, MDHM-stimulated induction of cytokine mRNA expression was accom</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>tokine mRNA expression was accompanied by different proto-oncogene responses in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBDFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PBMo</mark>
        </td>
        <td> and THP-1 cells. These differences may represent different regulatory pathways </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'> preferentially activates the 94-kD STAT5A and an 80-kD STAT5A isoform in human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBDFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">peripheral blood monocytes</mark>
        </td>
        <td>. Granulocyte-macrophage colony-stimulating factor ( GM-CSF ) induces immediate </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99406845' target='_blank'>99406845</a></td>
        <td style='text-align:right'>n our study, we determined the induction of apoptosis by GC in human monocytes. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEBDFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Peripheral blood monocytes</mark>
        </td>
        <td> were isolated by density centrifugation methods with a purity of >90% and were </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T81'>Term ID: <a href='terminology.html#L81' target='_blank'>81</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>sion in monocytic cells is mediated by binding of c-Rel / p65 heterodimers to a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AAEE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kappa B-like site</mark>
        </td>
        <td>. Exposure of monocytic cells to bacterial lipopolysaccharide ( LPS ) activates </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>haracterization of a nuclear complex from human monocytic cells that bound to a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AAEE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kappa B-like site</mark>
        </td>
        <td>, 5'--3', in the 5'-flanking region of the human TF gene. This nuclear complex w</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>ex and further showed that c-Rel / p65 heterodimers selectively bound to the TF </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AAEE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kappa B-like site</mark>
        </td>
        <td>. Functional studies indicated that the TF site conferred LPS inducibility on a </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>r, our results demonstrated that binding of c-Rel / p65 heterodimers to a novel </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AAEE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kappa B-like site</mark>
        </td>
        <td> mediated LPS induction of TF gene expression in monocytic cells. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>/ Rel family members regulating the ICAM-1 promoter in monocytic THP-1 cells. A </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AAEE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kappa B-site</mark>
        </td>
        <td> was identified in the promoter of the intercellular adhesion molecule-1 ( ICAM-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>ctors which bind and transactivate this enhancer sequence. In vitro, the ICAM-1 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AAEE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kappa B site</mark>
        </td>
        <td> appeared to bind RelA and c-Rel homodimers as well as heterodimers with NF-kapp</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>ells TNF-alpha induced two nuclear complexes which in vitro bound to the ICAM-1 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AAEE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kappa B site</mark>
        </td>
        <td>. Using antibodies in an electrophoretic mobility supershift assay, one of these</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>contain NF-kappa B1 and RelA, and to bind with higher affinity to the consensus </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AAEE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kappa B site</mark>
        </td>
        <td> in the HIV long terminal repeat. The second complex contained RelA, and exhibit</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'> RelA, and exhibited higher affinity towards the ICAM-1 kappa B than to the HIV </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AAEE9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kappa B site</mark>
        </td>
        <td>. The glucocorticoid receptor was shown to repress activity of both the RelA hom</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T71'>Term ID: <a href='terminology.html#L71' target='_blank'>71</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D92135145' target='_blank'>92135145</a></td>
        <td style='text-align:right'>Activity of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FCFBEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kappa B enhancer</mark>
        </td>
        <td> of the interleukin-2 receptor alpha chain in somatic cell hybrids is accompanie</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92135145' target='_blank'>92135145</a></td>
        <td style='text-align:right'>01.5. In order to define the roles of these two factors, which bind to the same </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FCFBEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kappa B enhancers</mark>
        </td>
        <td>, in transcription activation we have prepared somatic cell hybrids between IARC</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92135145' target='_blank'>92135145</a></td>
        <td style='text-align:right'>th KBF1 and NF-kappa B in their nuclei, but one hybrid expresses only KBF1. The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FCFBEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kappa B enhancer</mark>
        </td>
        <td> of the gene encoding the interleukin-2 ( IL-2 ) receptor alpha chain ( IL-2R al</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92135145' target='_blank'>92135145</a></td>
        <td style='text-align:right'>ppa B. These findings show that nuclear NF-kappa B is necessary to activate the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FCFBEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kappa B enhancer</mark>
        </td>
        <td>, while KBF1 by itself is not sufficient. We propose that KBF1 is a competitive </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T45'>Term ID: <a href='terminology.html#L45' target='_blank'>45</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D92135145' target='_blank'>92135145</a></td>
        <td style='text-align:right'>Activity of the kappa B enhancer of the interleukin-2 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFB9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">receptor alpha chain</mark>
        </td>
        <td> in somatic cell hybrids is accompanied by the nuclear localization of NF-kappa </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92135145' target='_blank'>92135145</a></td>
        <td style='text-align:right'>only KBF1. The kappa B enhancer of the gene encoding the interleukin-2 ( IL-2 ) </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFB9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">receptor alpha chain</mark>
        </td>
        <td> ( IL-2R alpha ) is functional only in the hybrids expressing nuclear NF-kappa B</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>activation such as surface expression of the CD69 antigen and the interleukin 2 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFB9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">receptor alpha-chain</mark>
        </td>
        <td> ( CD25 ) . Pervanadate synergized with signals delivered by T-cell antigen rece</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96322726' target='_blank'>96322726</a></td>
        <td style='text-align:right'>e induction of expression of IL-2 receptor components, but did not inhibit IL-4 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFB9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">receptor alpha-chain</mark>
        </td>
        <td> and CD69 expression or the induction of activator protein 1 transcription facto</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97303223' target='_blank'>97303223</a></td>
        <td style='text-align:right'>Homodimerization of the human interleukin 4 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFB9AC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">receptor alpha chain</mark>
        </td>
        <td> induces Cepsilon germline transcripts in B cells in the absence of the interleu</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T242'>Term ID: <a href='terminology.html#L242' target='_blank'>242</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>ine kinase that phosphorylated the proto-oncogene product, c-Fos, and is termed </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBDFDD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Fos kinase</mark>
        </td>
        <td>. Fos kinase was rapidly activated after ligation of the CD3 and CD2 receptors i</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>hat phosphorylated the proto-oncogene product, c-Fos, and is termed Fos kinase. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBDFDD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Fos kinase</mark>
        </td>
        <td> was rapidly activated after ligation of the CD3 and CD2 receptors in Jurkat and</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>0 and Ramos, respectively. The phorbol ester, PMA, was also a potent inducer of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBDFDD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Fos kinase</mark>
        </td>
        <td> activity in all of the above populations, suggesting that PKC plays a role in t</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>populations, suggesting that PKC plays a role in the regulation of this enzyme. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBDFDD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Fos kinase</mark>
        </td>
        <td> phosphorylates c-Fos at a site near the C-terminus, as well as a peptide derive</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>RKGSSSNEPSSD ) , and Fos peptide competitively inhibited c-Fos phosphorylation. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBDFDD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Fos kinase</mark>
        </td>
        <td> was shown to be distinct from other identified serine / threonine kinases, incl</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>n kinase A, protein kinase C, casein kinase II, MAP kinases, p70S6K and p90RSK. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBDFDD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Fos kinase</mark>
        </td>
        <td> was purified by anion exchange chromatography and exhibited an apparent M ( r )</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>ography and exhibited an apparent M ( r ) = 65,000 and isoelectric point = 6.1. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBDFDD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Fos kinase</mark>
        </td>
        <td> may play a role in transcriptional regulation through its capacity to phosphory</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T214'>Term ID: <a href='terminology.html#L214' target='_blank'>214</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'> proteins. The estrogen receptor ( ER ) repressed erythroid differentiation and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BAB9EF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid-specific gene expression</mark>
        </td>
        <td>. In this study, we investigated the effect of ER alpha ( referred to throughout</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>) on DNA-binding activities of transcription factors involved in regulating the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BAB9EF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">expression of erythroid-specific genes</mark>
        </td>
        <td>, and, in particular, the histone H5 gene. Using electrophoretic mobility shift </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>Both GATA-1 and-binding proteins are critical for the developmentally regulated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BAB9EF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">expression of erythroid-specific genes</mark>
        </td>
        <td>. We hypothesize that interference in DNA-binding activities of GATA-1 and-bindi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>id progenitors. RXR, RAR, and c-erbA / TR-specific ligands were found to induce </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BAB9EF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid-specific gene expression</mark>
        </td>
        <td> and to accelerate erythroid differentiation in culture, with T3 being most effe</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T179'>Term ID: <a href='terminology.html#L179' target='_blank'>179</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'>coid receptors in human mononuclear cells: effects of glucocorticoid treatment, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EEB9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Cushing's disease</mark>
        </td>
        <td> and ketoconazole. Glucocorticoid receptors ( GcR ) were determined by a whole c</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'>l subjects, patients receiving glucocorticoid therapy for systemic diseases and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EEB9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Cushing's disease</mark>
        </td>
        <td> patients with or without ketoconazole therapy. Prolonged corticosteroid treatme</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'>id treatment resulted in down-regulation of GcR, while the mean level of GcR in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EEB9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Cushing's disease</mark>
        </td>
        <td> was normal. In this group, however, receptor levels and morning plasma cortisol</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'>y showed very mild down-regulation in hypercortisolemic patients suffering from </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EEB9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Cushing's disease</mark>
        </td>
        <td>. Finally, we did not observed either up-regulation or antagonism of GcR by keto</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'>cR by ketoconazole treatment, at the time that cortisol levels of patients with </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EEB9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Cushing's disease</mark>
        </td>
        <td> were reduced. This indicates that the beneficial effects of ketoconazole in Cus</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91363265' target='_blank'>91363265</a></td>
        <td style='text-align:right'>ase were reduced. This indicates that the beneficial effects of ketoconazole in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EEB9DE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Cushing's disease</mark>
        </td>
        <td> are due to adrenal cortisol suppression and not to interaction with GcR of targ</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T115'>Term ID: <a href='terminology.html#L115' target='_blank'>115</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>s nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBB9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">endothelial cells</mark>
        </td>
        <td>. BACKGROUND: The induction of vascular cell adhesion molecule-1 ( VCAM-1 ) and </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>zation, induction of VCAM-1 and E-selectin, and subsequent monocyte adhesion in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBB9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">endothelial cells</mark>
        </td>
        <td> stimulated by TNF, thereby providing an additional mechanism for therapeutic ef</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>f granulocyte-macrophage colony-stimulating factor and E-selectin expression in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBB9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">endothelial cells</mark>
        </td>
        <td> by cyclosporin A and the T-cell transcription factor NFAT. Nuclear factor of ac</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>munoregulatory effects of cyclosporin A ( CsA ) . As we observed that activated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBB9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">endothelial cells</mark>
        </td>
        <td> also expressed NFAT, we tested the antiinflammatory properties of CsA in endoth</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'> cells also expressed NFAT, we tested the antiinflammatory properties of CsA in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBB9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">endothelial cells</mark>
        </td>
        <td>. Significantly, CsA completely suppressed the induction of NFAT in endothelial </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>helial cells. Significantly, CsA completely suppressed the induction of NFAT in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBB9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">endothelial cells</mark>
        </td>
        <td> and inhibited the activity of granulocyte-macrophage colony-stimulating factor </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>ted a reduction of up to 65% in GM-CSF mRNA and protein expression in activated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBB9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">endothelial cells</mark>
        </td>
        <td>. CsA also suppressed E-selectin, but not vascular cell adhesion molecule-1 ( VC</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'> E-selectin, but not vascular cell adhesion molecule-1 ( VCAM-1 ) expression in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBB9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">endothelial cells</mark>
        </td>
        <td>, even though the E-selectin promoter is activated by NF-kappa B rather than NFA</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>s was reflected by a 29% decrease in neutrophil adhesion. The effects of CsA on </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBB9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">endothelial cells</mark>
        </td>
        <td> were also detected at the chromatin structure level, as DNasel hypersensitive s</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>in promoter were suppressed by CsA. This represents the first report of NFAT in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AFBB9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">endothelial cells</mark>
        </td>
        <td> and suggests mechanisms by which CsA could function as an antiinflammatory agen</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T37'>Term ID: <a href='terminology.html#L37' target='_blank'>37</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>thelial cells. BACKGROUND: The induction of vascular cell adhesion molecule-1 ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DFEEDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">VCAM-1</mark>
        </td>
        <td> ) and E-selectin by tumor necrosis factor-alpha ( TNF ) is mediated by mobiliza</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'>adhesion molecule-1 ( ICAM-1 ) was hardly affected. Aspirin appeared to prevent </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DFEEDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">VCAM-1</mark>
        </td>
        <td> transcription, since it dose-dependently inhibited induction of VCAM-1 mRNA by </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95202809' target='_blank'>95202809</a></td>
        <td style='text-align:right'> to TNF-stimulated HUVECs was markedly reduced by aspirin due to suppression of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DFEEDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">VCAM-1</mark>
        </td>
        <td> and E-selectin upregulation. These effects of aspirin were not related to the i</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>ression in activated endothelial cells. CsA also suppressed E-selectin, but not </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DFEEDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">vascular cell adhesion molecule-1</mark>
        </td>
        <td> ( VCAM-1 ) expression in endothelial cells, even though the E-selectin promoter</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>ls. CsA also suppressed E-selectin, but not vascular cell adhesion molecule-1 ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DFEEDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">VCAM-1</mark>
        </td>
        <td> ) expression in endothelial cells, even though the E-selectin promoter is activ</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T7'>Term ID: <a href='terminology.html#L7' target='_blank'>7</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'>E3, a hematopoietic-specific transcript directly regulated by the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CDCC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">retinoic acid receptor alpha</mark>
        </td>
        <td>. Retinoic acid ( RA ) -induced maturation mediated by the retinoic acid recepto</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'>c acid receptor alpha. Retinoic acid ( RA ) -induced maturation mediated by the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CDCC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">retinoic acid receptor alpha</mark>
        </td>
        <td> ( RAR alpha ) has been implicated in myeloid development. We have used differen</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'> acid ( RA ) -induced maturation mediated by the retinoic acid receptor alpha ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CDCC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RAR alpha</mark>
        </td>
        <td> ) has been implicated in myeloid development. We have used differential hybridi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'> HL60 cells, but not in an RA-resistant subclone, HL60R, that harbors a mutated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CDCC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RAR alpha</mark>
        </td>
        <td> gene. However, when HL60R cells were transduced with a functional copy of the R</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'>a gene. However, when HL60R cells were transduced with a functional copy of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CDCC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RAR alpha</mark>
        </td>
        <td> gene, RA induced a 10-fold increase in E3 mRNA levels. E3 transcripts are prese</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'> is a hematopoietic-specific gene that is an immediate target for the activated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CDCC9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RAR alpha</mark>
        </td>
        <td> during myelopoiesis. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T236'>Term ID: <a href='terminology.html#L236' target='_blank'>236</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>Lipopolysaccharide induction of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FCF9CF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tissue factor</mark>
        </td>
        <td> gene expression in monocytic cells is mediated by binding of c-Rel / p65 hetero</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>teins and leads to the rapid induction of inflammatory gene products, including </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FCF9CF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tissue factor</mark>
        </td>
        <td> ( TF ) . TF is the primary cellular initiator of the coagulation protease casca</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>to the rapid induction of inflammatory gene products, including tissue factor ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FCF9CF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TF</mark>
        </td>
        <td> ) . TF is the primary cellular initiator of the coagulation protease cascades. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>rapid induction of inflammatory gene products, including tissue factor ( TF ) . </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FCF9CF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TF</mark>
        </td>
        <td> is the primary cellular initiator of the coagulation protease cascades. Here we</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>at bound to a kappa B-like site, 5'--3', in the 5'-flanking region of the human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FCF9CF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TF</mark>
        </td>
        <td> gene. This nuclear complex was activated by LPS with kinetics that preceded ind</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>clear complex was activated by LPS with kinetics that preceded induction of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FCF9CF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TF</mark>
        </td>
        <td> gene. In vitro binding studies demonstrated that the TF site bound translated c</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>cluded binding of NF-kappa B. In fact, under low-ionic-strength conditions, the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FCF9CF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TF</mark>
        </td>
        <td> complex did not migrate with translated p50 / p65 dimers but instead comigrated</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>ng studies revealed the presence of c-Rel and p65 and the absence of p50 in the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FCF9CF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TF</mark>
        </td>
        <td> complex and further showed that c-Rel / p65 heterodimers selectively bound to t</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>mplex and further showed that c-Rel / p65 heterodimers selectively bound to the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FCF9CF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TF</mark>
        </td>
        <td> kappa B-like site. Functional studies indicated that the TF site conferred LPS </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>c-Rel / p65 heterodimers to a novel kappa B-like site mediated LPS induction of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FCF9CF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TF</mark>
        </td>
        <td> gene expression in monocytic cells. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T320'>Term ID: <a href='terminology.html#L320' target='_blank'>320</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96079922' target='_blank'>96079922</a></td>
        <td style='text-align:right'>f T cells. PRL and IL-2 receptor activation are both linked to the Jak / Stat ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">signal transducer</mark>
        </td>
        <td> and activator of transcription ) pathway. We investigated the ability of PRL an</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96085174' target='_blank'>96085174</a></td>
        <td style='text-align:right'>ne T cells. The activation of Janus protein tyrosine kinases ( Jak ) and STAT ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">signal transducer</mark>
        </td>
        <td> and activator of transcription ) proteins has recently been linked to the signa</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96322726' target='_blank'>96322726</a></td>
        <td style='text-align:right'>o effector phenotypes. The regulation of transcription factors belonging to the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">signal transducer</mark>
        </td>
        <td> and activator of transcription ( STAT ) family was analyzed in PHA-activated mo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97064186' target='_blank'>97064186</a></td>
        <td style='text-align:right'>s further evident by the total lack of IL-12-induced phosphorylation of STAT4 ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">signal transducer</mark>
        </td>
        <td> and activator of transcription-4 ) , a transcription factor that is typically i</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97207294' target='_blank'>97207294</a></td>
        <td style='text-align:right'>strates including JAK1 and IRS-1 were phosphorylated. Additionally, we detected </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BCAFDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">signal transducers</mark>
        </td>
        <td> and activators of transcription 6 ( STAT6 ) tyrosine phosphorylation and DNA bi</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T253'>Term ID: <a href='terminology.html#L253' target='_blank'>253</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>Transcriptional activation of human zeta 2 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEECAC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">globin promoter</mark>
        </td>
        <td> by the alpha globin regulatory element ( HS-40 ) : functional role of specific </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>complexes. We studied the functional interaction between human embryonic zeta 2 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEECAC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">globin promoter</mark>
        </td>
        <td> and the alpha globin regulatory element ( HS-40 ) located 40 kb upstream of the</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>ression assay that HS-40 behaved as an authentic enhancer for high-level zeta 2 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEECAC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">globin promoter</mark>
        </td>
        <td> activity in K562 cells, an erythroid cell line of embryonic and / or fetal orig</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>mids, they were required for the HS-40 enhancer-mediated activity of the zeta 2 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEECAC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">globin promoter</mark>
        </td>
        <td>. Site-directed mutagenesis demonstrated that this HS-40 enhancer-zeta 2 globin </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>romoter. Site-directed mutagenesis demonstrated that this HS-40 enhancer-zeta 2 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEECAC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">globin promoter</mark>
        </td>
        <td> interaction is mediated by the two GATA-1 factor binding motifs located at -230</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>the functional core of HS-40 in the erythroid-specific activation of the zeta 2 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEECAC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">globin promoter</mark>
        </td>
        <td>. Site-directed mutagenesis further demonstrated that the enhancer function of o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>cific nuclear factor-DNA complexes which form at the enhancer ( HS-40 ) and the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEECAC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">globin promoters</mark>
        </td>
        <td>. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T135'>Term ID: <a href='terminology.html#L135' target='_blank'>135</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>pha RNA in U9-IIIB cells compared with U937 cells, suggesting that HIV-infected </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEFB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">monocytic cells</mark>
        </td>
        <td> produced higher levels of TNF-alpha than did normal cells after a secondary vir</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>ts. TNF-alpha was able to increase expression of the HIV LTR in T cells, but in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEFB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">monocytic cells</mark>
        </td>
        <td>, TNF-alpha did not induce the HIV LTR above a constitutive level of activity. T</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>ression in monocytes: role of the 65-kDa plus 50-kDa NF-kappa B dimer. Although </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEFB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">monocytic cells</mark>
        </td>
        <td> can provide a reservoir for viral production in vivo, their regulation of human</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>Lipopolysaccharide induction of tissue factor gene expression in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEFB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">monocytic cells</mark>
        </td>
        <td> is mediated by binding of c-Rel / p65 heterodimers to a kappa B-like site. Expo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>ated by binding of c-Rel / p65 heterodimers to a kappa B-like site. Exposure of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEFB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">monocytic cells</mark>
        </td>
        <td> to bacterial lipopolysaccharide ( LPS ) activates the NF-kappa B / Rel family o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>e cascades. Here we report the characterization of a nuclear complex from human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEFB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">monocytic cells</mark>
        </td>
        <td> that bound to a kappa B-like site, 5'--3', in the 5'-flanking region of the hum</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>rs to a novel kappa B-like site mediated LPS induction of TF gene expression in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEFB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">monocytic cells</mark>
        </td>
        <td>. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>Integrin-mediated tyrosine phosphorylation and cytokine message induction in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEFB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">monocytic cells</mark>
        </td>
        <td>. A possible signaling role for the Syk tyrosine kinase. Activation of cytoplasm</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>rosine kinase may be an important component of an integrin signaling pathway in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEFB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">monocytic cells</mark>
        </td>
        <td>, leading to activation of NF-kappa B and to increased levels of cytokine messag</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98012705' target='_blank'>98012705</a></td>
        <td style='text-align:right'>e the effects of oxidized LDL ( oxLDL ) on the NF-kappa B system in human THP-1 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEFB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">monocytic cells</mark>
        </td>
        <td> as well as adherent monocytes. Our results demonstrate that short-term incubati</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>are likely to play a dominant role in TNF-alpha-induced ICAM-1 transcription in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEFB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">monocytic cells</mark>
        </td>
        <td>. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>IKK ) signalsome activation and Ikappa B phosphorylation / proteolysis in human </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DBEFB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">monocytic cells</mark>
        </td>
        <td> and investigated the role of the signalsome proteins IKK-alpha, IKK-beta, NF-ka</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T129'>Term ID: <a href='terminology.html#L129' target='_blank'>129</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'> type 1 ( HIV-1 ) infection and viral RNA production in U937 cells. However, in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9BBBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Jurkat cells</mark>
        </td>
        <td>, TNF-alpha dramatically enhanced the spread of HIV-1 through the cell populatio</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>xpression of the CD45 PTPase and was not observed in CD45-deficient variants of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9BBBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Jurkat cells</mark>
        </td>
        <td>. In the CD45-negative variant, the effect of pervanadate on tyrosine phosphoryl</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95000924' target='_blank'>95000924</a></td>
        <td style='text-align:right'> to CD3 were monitored. These parameters were not modified by Nef expression in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9BBBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Jurkat cells</mark>
        </td>
        <td>, whereas stimulation with the same stimuli resulted in partial inhibition of LT</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95000924' target='_blank'>95000924</a></td>
        <td style='text-align:right'> with the same stimuli resulted in partial inhibition of LTR activation in Nef+ </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9BBBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Jurkat cells</mark>
        </td>
        <td>. This inhibition was not mediated through Nef phosphorylation on Thr-15 or GTP-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96074632' target='_blank'>96074632</a></td>
        <td style='text-align:right'>urther, 1,25 ( OH ) 2D3 inhibited the transcriptional activity of NF-kappa B in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9BBBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Jurkat cells</mark>
        </td>
        <td> transiently transfected with a construct containing four tandem repeats of the </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97458245' target='_blank'>97458245</a></td>
        <td style='text-align:right'>( transmembrane activator and CAML-interactor ) , on the surface of transfected </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9BBBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Jurkat cells</mark>
        </td>
        <td> with TACI-specific antibodies led to activation of the transcription factors NF</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'>y from the LAI LTR in U-373 MG cells ( an astrocytoma cell line ) as well as in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9BBBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Jurkat cells</mark>
        </td>
        <td> ( a CD4-positive lymphocyte cell line ) . While LTRs which demonstrated the hig</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'>trated the highest activities in U-373 MG cells also yielded high activities in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9BBBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Jurkat cells</mark>
        </td>
        <td>, the LTRs were generally more active in Jurkat cells when compared to the LAI L</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'>yielded high activities in Jurkat cells, the LTRs were generally more active in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9BBBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Jurkat cells</mark>
        </td>
        <td> when compared to the LAI LTR. Differences in LTR sequence also resulted in diff</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98380286' target='_blank'>98380286</a></td>
        <td style='text-align:right'> cell activation, the gene expression of stimulated and nonstimulated Ramos and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #B9BBBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Jurkat cells</mark>
        </td>
        <td> was studied using cDNA microarray technology. Simultaneous analysis of close to</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T30'>Term ID: <a href='terminology.html#L30' target='_blank'>30</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96322726' target='_blank'>96322726</a></td>
        <td style='text-align:right'>d not inhibit IL-4 receptor alpha-chain and CD69 expression or the induction of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDAF9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activator protein</mark>
        </td>
        <td> 1 transcription factors. cAMP signaling inhibited Stat1 at several different le</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'>clear factor of activated T cells ( NFAT ) family proteins as major components. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDAF9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Activator protein</mark>
        </td>
        <td> ( AP ) -1 family proteins interacted with CLE0, P, P2 and P4. NFAT / AP-1 compl</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'>vated T cells ( NFAT ) family proteins as major components. Activator protein ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EDAF9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AP</mark>
        </td>
        <td> ) -1 family proteins interacted with CLE0, P, P2 and P4. NFAT / AP-1 complex fo</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T29'>Term ID: <a href='terminology.html#L29' target='_blank'>29</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96184791' target='_blank'>96184791</a></td>
        <td style='text-align:right'>on in T cells. Mutation of the IL-13 P element site significantly reduced IL-13 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9BFCCD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">promoter activity</mark>
        </td>
        <td> in response to T-cell activation. Oligonucleotides containing the IL-13 or IL-4</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>e pair upstream sequence were demonstrated to play a critical role for the IL-9 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9BFCCD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">promoter activity</mark>
        </td>
        <td>. DNA-protein binding studies indicated that NF-kappa B, c-Jun, and potentially </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>Mutations at different sites within this proximal promoter region abolished the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9BFCCD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">promoter activity</mark>
        </td>
        <td> as well as the DNA binding. Taken together, these results suggest that the coop</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>omplexes encompassing both the CD28RE and the AP-1-binding sites influence IL-2 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9BFCCD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">promoter activity</mark>
        </td>
        <td> in CD28-costimulated T cells. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99005376' target='_blank'>99005376</a></td>
        <td style='text-align:right'>4, and a novel regulatory element, CPRE ( -- ) at -49/-41, is essential for the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9BFCCD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">promoter activity</mark>
        </td>
        <td> in murine erythroleukemia ( MEL ) cells. In nonerythroid NIH3T3 cells, however,</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99083144' target='_blank'>99083144</a></td>
        <td style='text-align:right'>Effect of environmental estrogens on IL-1beta </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9BFCCD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">promoter activity</mark>
        </td>
        <td> in a macrophage cell line. Environmental estrogens or estrogen disrupters have </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99083144' target='_blank'>99083144</a></td>
        <td style='text-align:right'>porter gene allows us to monitor the effect of estrogenic compounds on IL-1beta </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9BFCCD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">promoter activity</mark>
        </td>
        <td>. 17beta-estradiol ( E2 ) markedly enhanced lipopolysaccharide - ( LPS ) induced</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99083144' target='_blank'>99083144</a></td>
        <td style='text-align:right'>ounds, with the exception of genistein, synergized with LPS to enhance IL-1beta </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9BFCCD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">promoter activity</mark>
        </td>
        <td>. When tested for antiestrogenic activity, the industrial compound 4-octylphenol</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T314'>Term ID: <a href='terminology.html#L314' target='_blank'>314</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D97028169' target='_blank'>97028169</a></td>
        <td style='text-align:right'>poiesis via a dual effect hypothetically mediated by interaction with the RAR / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9DFBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RXR</mark>
        </td>
        <td> heterodimer, ie, inhibition of HSC/ primitive HPC proliferation and induction o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9DFBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Retinoid X receptor</mark>
        </td>
        <td> and c-cerbA / thyroid hormone receptor regulate erythroid cell growth and diffe</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>nt regulators of erythroid cell development. Here we investigated the impact of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9DFBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">retinoid X receptor</mark>
        </td>
        <td> ( RXR ) , retinoic acid receptor ( RAR ) , and of the c-erbA / thyroid hormone </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>roid cell development. Here we investigated the impact of retinoid X receptor ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9DFBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RXR</mark>
        </td>
        <td> ) , retinoic acid receptor ( RAR ) , and of the c-erbA / thyroid hormone ( T3 )</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>an in vitro culture system of stem cell factor-dependent erythroid progenitors. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9DFBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RXR</mark>
        </td>
        <td>, RAR, and c-erbA / TR-specific ligands were found to induce erythroid-specific </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>d c-erbA / TR induces differentiation. Additionally, to determine the impact of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9DFBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RXR</mark>
        </td>
        <td> for erythroid cell development, dominant interfering mutant RXRs, lacking the t</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'> erythroid progenitor cells via recombinant retrovirus vectors and analyzed for </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9DFBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RXR</mark>
        </td>
        <td>-specific effects. It was found that expression of wild-type RXR and of the RXR </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>nd analyzed for RXR-specific effects. It was found that expression of wild-type </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9DFBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RXR</mark>
        </td>
        <td> and of the RXR mutants devoid of AF-1 and / or AF-2 supported a transient outgr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'> RXR-specific effects. It was found that expression of wild-type RXR and of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9DFBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RXR</mark>
        </td>
        <td> mutants devoid of AF-1 and / or AF-2 supported a transient outgrowth of erythro</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>marked contrast, expression of the dominant interfering deltaDNA-binding domain </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9DFBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RXR</mark>
        </td>
        <td>, containing a deletion of the entire DNA-binding domain, was incompatible with </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'> incompatible with erythroid cell growth in vitro, suggesting a pivotal role of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #E9DFBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">RXR</mark>
        </td>
        <td> for erythroid cell development. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T307'>Term ID: <a href='terminology.html#L307' target='_blank'>307</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>toxin ( SE ) induce a rapid, gradually accumulating, long-lasting tyrosine, and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEF9AD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">serine phosphorylation of Stat3</mark>
        </td>
        <td> ( but not Stat5 ) in allogen-specific human CD4+ T cell lines. In contrast, IL-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>CD4+ T cell lines. In contrast, IL-2 induces a rapid and transient tyrosine and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEF9AD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">serine phosphorylation of Stat3</mark>
        </td>
        <td>. Compared with IL-2, CD3 ligation induces a delayed Stat3 binding to oligonucle</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>ow that CD3 ligation by mAb and SE triggers a rapid, PP1-sensitive tyrosine and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEF9AD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">serine phosphorylation of Stat3</mark>
        </td>
        <td> in human CD4+ T cells. Moreover, we provide evidence that TCR / CD3 and IL-2 in</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T289'>Term ID: <a href='terminology.html#L289' target='_blank'>289</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>ytokine message induction in monocytic cells. A possible signaling role for the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADAB9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Syk tyrosine kinase</mark>
        </td>
        <td>. Activation of cytoplasmic tyrosine kinases is an important aspect of signal tr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>uent to cell adhesion include paxillin, pp125FAK, and the SH2 domain containing </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADAB9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tyrosine kinase Syk</mark>
        </td>
        <td>. In contrast, integrin ligation with antibodies induces tyrosine phosphorylatio</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>IL-1 beta message induction is unaffected. These observations indicate that the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ADAB9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Syk tyrosine kinase</mark>
        </td>
        <td> may be an important component of an integrin signaling pathway in monocytic cel</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T260'>Term ID: <a href='terminology.html#L260' target='_blank'>260</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D91321794' target='_blank'>91321794</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEBAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Inhibition of HIV-1 replication</mark>
        </td>
        <td> and NF-kappa B activity by cysteine and cysteine derivatives. HIV-1 proviral DN</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91321794' target='_blank'>91321794</a></td>
        <td style='text-align:right'> N-acetylcysteine ( NAC ) raise the intracellular glutathione ( GSH ) level and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEBAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">inhibit HIV-1 replication</mark>
        </td>
        <td> in persistently infected Molt-4 and U937 cells. However, inhibition of HIV-1 re</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91321794' target='_blank'>91321794</a></td>
        <td style='text-align:right'>ibit HIV-1 replication in persistently infected Molt-4 and U937 cells. However, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DAEBAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">inhibition of HIV-1 replication</mark>
        </td>
        <td> appears not to be directly correlated with GSH levels. Cysteine and NAC also in</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T238'>Term ID: <a href='terminology.html#L238' target='_blank'>238</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'> complex. While several lines of investigation have suggested that NF-kappa B / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CEEBDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Rel family members</mark>
        </td>
        <td> make up the CD28 response complex transcription factor, other work has not supp</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97376857' target='_blank'>97376857</a></td>
        <td style='text-align:right'>is specific for both the CD28RE and the adjacent AP-1 site. Of the NF-kappa B / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CEEBDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Rel family members</mark>
        </td>
        <td> tested, this CD28RE / AP-1-specific complex contains predominantly c-Rel, despi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>NF-kappa B / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CEEBDA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Rel family members</mark>
        </td>
        <td> regulating the ICAM-1 promoter in monocytic THP-1 cells. A kappa B-site was ide</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T235'>Term ID: <a href='terminology.html#L235' target='_blank'>235</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>eceded induction of the TF gene. In vitro binding studies demonstrated that the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FFAAEA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TF site</mark>
        </td>
        <td> bound translated c-Rel and p65 homodimers but not p50 / p65 heterodimers or p50</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>ut not p50 / p65 heterodimers or p50 homodimers. Base-pair substitutions in the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FFAAEA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TF site</mark>
        </td>
        <td> indicated that the presence of a cytosine at position 1 precluded binding of NF</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>tively bound to the TF kappa B-like site. Functional studies indicated that the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FFAAEA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">TF site</mark>
        </td>
        <td> conferred LPS inducibility on a heterologous promoter and was transactivated by</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T161'>Term ID: <a href='terminology.html#L161' target='_blank'>161</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>Regulation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CFEBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">granulocyte-macrophage colony</mark>
        </td>
        <td>-stimulating factor and E-selectin expression in endothelial cells by cyclospori</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>ressed the induction of NFAT in endothelial cells and inhibited the activity of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CFEBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">granulocyte-macrophage colony</mark>
        </td>
        <td>-stimulating factor ( GM-CSF ) gene regulatory elements that use NFAT by 60%. Cs</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CFEBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Granulocyte-macrophage colony</mark>
        </td>
        <td>-stimulating factor preferentially activates the 94-kD STAT5A and an 80-kD STAT5</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'>e 94-kD STAT5A and an 80-kD STAT5A isoform in human peripheral blood monocytes. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CFEBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Granulocyte-macrophage colony</mark>
        </td>
        <td>-stimulating factor ( GM-CSF ) induces immediate effects in monocytes by activat</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'> or transformed cells and the putative roles in functionality and cell biology. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CFEBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Granulocyte-macrophage colony</mark>
        </td>
        <td>-stimulating factor ( GM-CSF ) and interleukin ( IL ) -3 induced tyrosine phosph</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T156'>Term ID: <a href='terminology.html#L156' target='_blank'>156</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>ined. Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFCBCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">polymerase chain reaction</mark>
        </td>
        <td> amplification in monocytic U937 cells and in a chronically HIV infected U937 ce</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92134262' target='_blank'>92134262</a></td>
        <td style='text-align:right'>the CAGs. After the DNA fragment containing the CAG repeats is amplified by the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFCBCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">polymerase chain reaction</mark>
        </td>
        <td>, a primer extension is carried out; the extension of the end-labelled reverse p</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98090689' target='_blank'>98090689</a></td>
        <td style='text-align:right'>gulatory elements required for T-cell activation. We used reverse transcriptase-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFCBCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">polymerase chain reaction</mark>
        </td>
        <td> to examine both fetal and term neonatal cord bloods for mRNA expression of thre</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99155344' target='_blank'>99155344</a></td>
        <td style='text-align:right'>as been shown to correlate with X-inactivation. In this study, we have used the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFCBCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">polymerase chain reaction</mark>
        </td>
        <td> ( PCR ) with nested primers to analyze X-inactivation patterns of the HUMARA lo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99155344' target='_blank'>99155344</a></td>
        <td style='text-align:right'>ith X-inactivation. In this study, we have used the polymerase chain reaction ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFCBCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PCR</mark>
        </td>
        <td> ) with nested primers to analyze X-inactivation patterns of the HUMARA loci in </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99356019' target='_blank'>99356019</a></td>
        <td style='text-align:right'>r up to 90 min exposure time ELISA, EMSA ( electromobility shift assay ) and RT-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BFCBCA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PCR</mark>
        </td>
        <td> were used to measure protein tyrosine kinase activity, protein activity of NF-k</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T120'>Term ID: <a href='terminology.html#L120' target='_blank'>120</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99310627' target='_blank'>99310627</a></td>
        <td style='text-align:right'>GATA-1 and erythropoietin cooperate to promote </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9CFCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cell survival</mark>
        </td>
        <td> by regulating bcl-xL expression. The transcription factor GATA-1 is essential f</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99310627' target='_blank'>99310627</a></td>
        <td style='text-align:right'> bcl-2 and mcl-1. Consistent with a role for bcl-xL in mediating GATA-1-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9CFCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cell survival</mark>
        </td>
        <td>, in vitro-differentiated bcl-xL-/- embryonic stem cells fail to generate viable</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99310627' target='_blank'>99310627</a></td>
        <td style='text-align:right'>isruption. In addition, we show that erythropoietin, which is also required for </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9CFCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">erythroid cell survival</mark>
        </td>
        <td>, cooperates with GATA-1 to stimulate bcl-xL gene expression and to maintain ery</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T114'>Term ID: <a href='terminology.html#L114' target='_blank'>114</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'>nse to the different stimuli, whereas the levels of IL-2 produced by stimulated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CEEEFD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells from other elderly</mark>
        </td>
        <td> individuals were equivalent to those observed for stimulated T cells of young s</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'>c DNA mobility shift assays showed that decreased IL-2 production by stimulated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CEEEFD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells of elderly</mark>
        </td>
        <td> individuals was closely associated with impairments in the activation of both A</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'>s / c-Jun AP-1. The resting and stimulated levels of NF kappa B were reduced in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CEEEFD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">T cells from certain elderly</mark>
        </td>
        <td> individuals; however, alterations of NF kappa B did not correlate with changes </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T84'>Term ID: <a href='terminology.html#L84' target='_blank'>84</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'> B site appeared to bind RelA and c-Rel homodimers as well as heterodimers with </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAFBDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B1</mark>
        </td>
        <td>, but weakly NF-kappa B1 homodimers. In addition, both RelA and c-Rel, but not N</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'> RelA and c-Rel homodimers as well as heterodimers with NF-kappa B1, but weakly </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAFBDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B1</mark>
        </td>
        <td> homodimers. In addition, both RelA and c-Rel, but not NF-kappa B1, were shown t</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>1, but weakly NF-kappa B1 homodimers. In addition, both RelA and c-Rel, but not </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAFBDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B1</mark>
        </td>
        <td>, were shown to transactivate an ICAM-1 kappa B-reporter construct. In monocytic</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>phoretic mobility supershift assay, one of these complexes was shown to contain </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAFBDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B1</mark>
        </td>
        <td> and RelA, and to bind with higher affinity to the consensus kappa B site in the</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>icoid receptor was shown to repress activity of both the RelA homodimer and the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FAFBDE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-kappa B1</mark>
        </td>
        <td> / RelA heterodimer. We argue that in vivo RelA homodimers are likely to play a </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T41'>Term ID: <a href='terminology.html#L41' target='_blank'>41</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95166251' target='_blank'>95166251</a></td>
        <td style='text-align:right'>g PEBP2 alpha genes in T cells during thymic development. The PEBP2 alpha A and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DDEDFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PEBP2 alpha B</mark>
        </td>
        <td> genes encode the DNA-binding subunit of a murine transcription factor, PEBP2, w</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95166251' target='_blank'>95166251</a></td>
        <td style='text-align:right'>lated genes share the evolutionarily conserved region encoding the Runt domain. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DDEDFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PEBP2 alpha B</mark>
        </td>
        <td> is the murine counterpart of human AML1, which is located at the breakpoints of</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95166251' target='_blank'>95166251</a></td>
        <td style='text-align:right'>inent in the thymus. Furthermore, transcripts of PEBP2 alpha A and mouse AML1 / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DDEDFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PEBP2 alpha B</mark>
        </td>
        <td> were detected in T lymphocytes in the thymuses from day 16 embryos and newborns</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95166251' target='_blank'>95166251</a></td>
        <td style='text-align:right'>at PEBP2 is a T-cell-specific transcription factor. Transcripts of mouse AML1 / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DDEDFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PEBP2 alpha B</mark>
        </td>
        <td> were also detected in day 12 fetal hematopoietic liver and in the bone marrow c</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95166251' target='_blank'>95166251</a></td>
        <td style='text-align:right'>r and in the bone marrow cells of newborn mice. The implication of mouse AML1 / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DDEDFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PEBP2 alpha B</mark>
        </td>
        <td> expression in hematopoietic cells other than those of T-cell lineage is discuss</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T21'>Term ID: <a href='terminology.html#L21' target='_blank'>21</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96303658' target='_blank'>96303658</a></td>
        <td style='text-align:right'>cells with several chemoattractants at physiologically relevant concentrations. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACFEAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Activation of transcription factors</mark>
        </td>
        <td> through these receptors involves G-protein coupling and the activation of prote</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>stigated the effect of ER alpha ( referred to throughout as ER ) on DNA-binding </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACFEAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activities of transcription factors</mark>
        </td>
        <td> involved in regulating the expression of erythroid-specific genes, and, in part</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'>urally occurring sequence variation impacted transcription factor binding to an </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ACFEAD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activating transcription factor</mark>
        </td>
        <td> / cAMP response element binding ( ATF / CREB ) binding site ( located between t</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T13'>Term ID: <a href='terminology.html#L13' target='_blank'>13</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96388957' target='_blank'>96388957</a></td>
        <td style='text-align:right'>ntly this leukemia was further characterized by an exquisite sensitivity to all-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CC9B9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">trans retinoic acid</mark>
        </td>
        <td>'s differentiation effect and the production of a fusion gene altering the gene </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96388957' target='_blank'>96388957</a></td>
        <td style='text-align:right'>llows strict guidelines related both to the APL cell and the biodisposal of all-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CC9B9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">trans retinoic acid</mark>
        </td>
        <td>. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97028169' target='_blank'>97028169</a></td>
        <td style='text-align:right'>in FCS- clonogenic culture. On this basis, we have investigated the role of all-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CC9B9B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">trans retinoic acid</mark>
        </td>
        <td> ( ATRA ) and its isomer 9-cis RA in FL hematopoiesis. Both compounds modulate t</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T9'>Term ID: <a href='terminology.html#L9' target='_blank'>9</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99201482' target='_blank'>99201482</a></td>
        <td style='text-align:right'>ivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDEDA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">trifluoromethylbenzoic acid</mark>
        </td>
        <td>. The therapeutic potential of drugs that block the induction of cyclooxygenase-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99201482' target='_blank'>99201482</a></td>
        <td style='text-align:right'>been emphasized. When two 4-trifluoromethyl salicylate derivatives [2-acetoxy-4-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDEDA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">trifluoromethyl-benzoic acid</mark>
        </td>
        <td> ( triflusal ) and its deacetylated metabolite 2-hydroxy-4-trifluoromethylbenzoi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99201482' target='_blank'>99201482</a></td>
        <td style='text-align:right'>romethyl-benzoic acid ( triflusal ) and its deacetylated metabolite 2-hydroxy-4-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CDEDA9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">trifluoromethylbenzoic acid</mark>
        </td>
        <td> ( HTB ) ] were compared with aspirin and sodium salicylate as cyclooxygenase-2 </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T4'>Term ID: <a href='terminology.html#L4' target='_blank'>4</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95000924' target='_blank'>95000924</a></td>
        <td style='text-align:right'>NA-binding activity of NF-kappa B and AP-1 ( Fos / Jun ) complex in response to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EF9DBE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">phorbol myristate acetate</mark>
        </td>
        <td>, TNF-alpha, or immobilized antibodies to CD3 were monitored. These parameters w</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>ted NF-kappa B, and NFAT DNA-binding activity in T cells stimulated with either </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EF9DBE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">phorbol myristate acetate</mark>
        </td>
        <td> plus ionophore or antibodies against the CD3-T-cell receptor complex and simult</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>tional activity by GM-CSF. N-formyl-methionyl-leucyl-phenylalanine ( FMLP ) and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EF9DBE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">phorbol myristate acetate</mark>
        </td>
        <td> ( PMA ) induced tyrosine phosphorylation of 42- and 44-kDa proteins, which were</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T300'>Term ID: <a href='terminology.html#L300' target='_blank'>300</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99408303' target='_blank'>99408303</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99CCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Neutrophil maturation</mark>
        </td>
        <td> and the role of retinoic acid. Neutrophil maturation occurs in well defined mor</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99408303' target='_blank'>99408303</a></td>
        <td style='text-align:right'>Neutrophil maturation and the role of retinoic acid. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99CCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Neutrophil maturation</mark>
        </td>
        <td> occurs in well defined morphological stages that correlate with the acquisition</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99408303' target='_blank'>99408303</a></td>
        <td style='text-align:right'> neutrophil function. A variety of factors are known to play a role in terminal </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99CCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">neutrophil maturation</mark>
        </td>
        <td>, including the vitamin A derivative, retinoic acid. Retinoic acid can directly </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99408303' target='_blank'>99408303</a></td>
        <td style='text-align:right'>n turn, activate transcription of target genes. A role for retinoic acid during </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99CCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">neutrophil maturation</mark>
        </td>
        <td> has been suggested from a variety of sources. Here we present a review of the m</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99408303' target='_blank'>99408303</a></td>
        <td style='text-align:right'>n and the major evidence showing that normal retinoid signaling is required for </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99CCEC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">neutrophil maturation</mark>
        </td>
        <td>. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T290'>Term ID: <a href='terminology.html#L290' target='_blank'>290</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>Activation of a novel serine / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEEFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">threonine kinase</mark>
        </td>
        <td> that phosphorylates c-Fos upon stimulation of T and B lymphocytes via antigen a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>eus is mediated principally through the action of protein tyrosine and serine / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEEFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">threonine kinases</mark>
        </td>
        <td>. We have identified and characterized a novel serine / threonine kinase that ph</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>rine / threonine kinases. We have identified and characterized a novel serine / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEEFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">threonine kinase</mark>
        </td>
        <td> that phosphorylated the proto-oncogene product, c-Fos, and is termed Fos kinase</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>phorylation. Fos kinase was shown to be distinct from other identified serine / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CCEEFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">threonine kinases</mark>
        </td>
        <td>, including protein kinase A, protein kinase C, casein kinase II, MAP kinases, p</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T258'>Term ID: <a href='terminology.html#L258' target='_blank'>258</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>sue factor gene expression in monocytic cells is mediated by binding of c-Rel / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEEAFE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">p65 heterodimers</mark>
        </td>
        <td> to a kappa B-like site. Exposure of monocytic cells to bacterial lipopolysaccha</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>trated that the TF site bound translated c-Rel and p65 homodimers but not p50 / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEEAFE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">p65 heterodimers</mark>
        </td>
        <td> or p50 homodimers. Base-pair substitutions in the TF site indicated that the pr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>nd p65 and the absence of p50 in the TF complex and further showed that c-Rel / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEEAFE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">p65 heterodimers</mark>
        </td>
        <td> selectively bound to the TF kappa B-like site. Functional studies indicated tha</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'> c-Rel or p65. Taken together, our results demonstrated that binding of c-Rel / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AEEAFE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">p65 heterodimers</mark>
        </td>
        <td> to a novel kappa B-like site mediated LPS induction of TF gene expression in mo</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T245'>Term ID: <a href='terminology.html#L245' target='_blank'>245</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D97468093' target='_blank'>97468093</a></td>
        <td style='text-align:right'>on of the synthesis and of the hydrolytic activity of phospholipase C gamma 1 ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABDFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PLC gamma</mark>
        </td>
        <td> 1 ) in human T lymphocytes by IFN-beta. The increased level of PLC gamma 1 beco</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97468093' target='_blank'>97468093</a></td>
        <td style='text-align:right'>ma 1 ( PLC gamma 1 ) in human T lymphocytes by IFN-beta. The increased level of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABDFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PLC gamma</mark>
        </td>
        <td> 1 becomes evident after 90 min of IFN-beta treatment and is still detectable af</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97468093' target='_blank'>97468093</a></td>
        <td style='text-align:right'>er 90 min of IFN-beta treatment and is still detectable after 24 h. Neither the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABDFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PLC gamma</mark>
        </td>
        <td> 1 overexpression induced by IFN nor the increased hydrolytic activity of the en</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97468093' target='_blank'>97468093</a></td>
        <td style='text-align:right'>a can activate other transcription factor ( s ) distinct from ISGF3 to regulate </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DABDFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PLC gamma</mark>
        </td>
        <td> 1 expression. In addition, the ability of this enzyme to hydrolyse PIP2, also i</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T224'>Term ID: <a href='terminology.html#L224' target='_blank'>224</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>y virus infection. The effects of TNF-alpha on gene expression were examined by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9DCC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transient expression</mark>
        </td>
        <td> assays using reporter chloramphenicol acetyltransferase plasmids linked to regu</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92135145' target='_blank'>92135145</a></td>
        <td style='text-align:right'>ve inhibitor of NF-kappa B and discuss how these factors may be involved in the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9DCC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transient expression</mark>
        </td>
        <td> of IL-2 and IL-2 alpha genes during the immune response. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>ent ( HS-40 ) located 40 kb upstream of the zeta 2 globin gene. It was shown by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9DCC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transient expression</mark>
        </td>
        <td> assay that HS-40 behaved as an authentic enhancer for high-level zeta 2 globin </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>id cells. All sequence motifs within the functional core of HS-40, as mapped by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9DCC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transient expression</mark>
        </td>
        <td> analysis, appeared to bind a nuclear factor ( s ) in living K562 cells but not </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>gene expression is controlled, at least in part, by transcriptional activation. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9DCC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Transient expression</mark>
        </td>
        <td> of the luciferase reporter gene linked to serially deleted sequences of the 5'-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'>es ( with respect to the sequence of the LAI LTR ) within the 455-bp U3 region. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EA9DCC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Transient expression</mark>
        </td>
        <td> analyses in cells of neuroglial and lymphocytic origin demonstrated that some o</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T215'>Term ID: <a href='terminology.html#L215' target='_blank'>215</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>phoid cells, the inducibility of the different hybrid promoters by TNF-alpha or </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BDBDEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">phorbol ester</mark>
        </td>
        <td> varied in a cell type- and promoter context-specific manner; the levels of gene</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>ity. Although the intact beta interferon promoter was only weakly stimulated by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BDBDEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">phorbol ester</mark>
        </td>
        <td> or TNF-alpha, multimers of the PRDII NF-kappa B-binding domain were inducible b</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>synergized with signals delivered by T-cell antigen receptor engagement or by a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BDBDEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">phorbol ester</mark>
        </td>
        <td> to induce interleukin 2 production. Pervanadate activated NF-kappa B, as shown </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'>o IL-6 and anti-IgM in the human B cell lines AF10 and Ramos, respectively. The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BDBDEB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">phorbol ester</mark>
        </td>
        <td>, PMA, was also a potent inducer of Fos kinase activity in all of the above popu</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T202'>Term ID: <a href='terminology.html#L202' target='_blank'>202</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>) . Accordingly, electrophoretic mobility shift assays ( EMSAs ) indicated that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFCBBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">pyrrolidine DTC</mark>
        </td>
        <td> ( PDTC ) prevented NF-kappa B, and NFAT DNA-binding activity in T cells stimula</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>lectrophoretic mobility shift assays ( EMSAs ) indicated that pyrrolidine DTC ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFCBBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PDTC</mark>
        </td>
        <td> ) prevented NF-kappa B, and NFAT DNA-binding activity in T cells stimulated wit</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>receptor complex and simultaneously activated the binding of AP-1. Furthermore, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFCBBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PDTC</mark>
        </td>
        <td> differentially targeted both NFATp and NFATc family members, inhibiting the tra</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'> Strikingly, Western blotting and immunocytochemical experiments indicated that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFCBBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PDTC</mark>
        </td>
        <td> promoted a transient and rapid shuttling of NFATp and NFATc, leading to their a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>cleus of activated T cells. We propose that the activation of an NFAT kinase by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFCBBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">PDTC</mark>
        </td>
        <td> could be responsible for the rapid shuttling of the NFAT, therefore transiently</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T191'>Term ID: <a href='terminology.html#L191' target='_blank'>191</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D98038749' target='_blank'>98038749</a></td>
        <td style='text-align:right'>Regulation of Id3 cell cycle function by Cdk-2-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9BBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">dependent phosphorylation</mark>
        </td>
        <td>. The functions of basic helix-loop-helix ( bHLH ) transcription factors in acti</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98038749' target='_blank'>98038749</a></td>
        <td style='text-align:right'>gene regulatory ( E box ) sequences. Recently, cyclin E-Cdk2- and cyclin A-Cdk2-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9BBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">dependent phosphorylation</mark>
        </td>
        <td> of a single conserved serine residue ( Ser5 ) in Id2 has been shown to occur du</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98038749' target='_blank'>98038749</a></td>
        <td style='text-align:right'>lays an activity significantly greater than that of wild-type Id3 protein. Cdk2-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9BBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">dependent phosphorylation</mark>
        </td>
        <td> therefore provides a switch during late G1-to-S phase that both nullifies an ea</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>. In contrast to neutrophils, p38 was constitutively phosphorylated and agonist-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FA9BBB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">dependent phosphorylation</mark>
        </td>
        <td> and activation was not detected in human monocytes. Superoxide release stimulat</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T163'>Term ID: <a href='terminology.html#L163' target='_blank'>163</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>y 8 h and approximately 1000 VDR by 24 h. Radiolabeled VDR disappeared from the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9AABC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear compartment</mark>
        </td>
        <td> with a halflife of approximately 30 min if cells were cultured with identical c</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>where VDR halflife was approximately 30 min. No specific translocation into the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9AABC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear compartment</mark>
        </td>
        <td> was seen when isolated nuclei were incubated in [3H]calcitriol. Radiolabeled ho</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'> contrast to identical experiments with intact cells-did not disappear from the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9AABC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear compartment</mark>
        </td>
        <td> upon incubation of nuclei with identical concentrations of the unlabeled compou</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>extracts upon translocation of VDR might reflect interaction of both within the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9AABC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear compartment</mark>
        </td>
        <td>, thus initiating DNA-unwinding, a prerequisite of transcription initiation. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96074632' target='_blank'>96074632</a></td>
        <td style='text-align:right'>ffect of the hormone on the levels of p50 was demonstrable in the cytosolic and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C9AABC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear compartments</mark>
        </td>
        <td>; it required between 4 and 8 hr and was specific, as 25-hydroxyvitamin D3 and 2</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T137'>Term ID: <a href='terminology.html#L137' target='_blank'>137</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>-40 enhancer region in K562 cells, adult nucleated erythroblasts, and different </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99FFEE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nonerythroid cells</mark>
        </td>
        <td>. All sequence motifs within the functional core of HS-40, as mapped by transien</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>alysis, appeared to bind a nuclear factor ( s ) in living K562 cells but not in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99FFEE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nonerythroid cells</mark>
        </td>
        <td>. On the other hand, only one of the apparently nonfunctional sequence motifs wa</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99005376' target='_blank'>99005376</a></td>
        <td style='text-align:right'>ifferential regulation of coproporphyrinogen oxidase gene between erythroid and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99FFEE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nonerythroid cells</mark>
        </td>
        <td>. Coproporphyrinogen oxidase ( CPO ) catalyzes the sixth step of the heme biosyn</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99005376' target='_blank'>99005376</a></td>
        <td style='text-align:right'>ferential regulation of the promoter function of CPO gene between erythroid and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99FFEE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nonerythroid cells</mark>
        </td>
        <td>. Copyright 1998 by The American Society of Hematology </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T134'>Term ID: <a href='terminology.html#L134' target='_blank'>134</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D97263762' target='_blank'>97263762</a></td>
        <td style='text-align:right'>ke transcription factor in the activation of serum amyloid A gene in monocyte / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CDEFC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">macrophage cells</mark>
        </td>
        <td> by lipopolysaccharide. Serum amyloid A ( SAA ) has been linked to atheroscleros</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97263762' target='_blank'>97263762</a></td>
        <td style='text-align:right'> study, we investigated the induction mechanism of SAA gene in THP-1 monocyte / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CDEFC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">macrophage cells</mark>
        </td>
        <td> which play a critical role in the development of atherosclerotic fatty streak a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97263762' target='_blank'>97263762</a></td>
        <td style='text-align:right'>aque formation. We and others have shown that SAA gene is induced in monocyte / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CDEFC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">macrophage cells</mark>
        </td>
        <td> by lipopolysaccharide ( LPS ) . By promoter function analysis, we show that the</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97263762' target='_blank'>97263762</a></td>
        <td style='text-align:right'>. These results demonstrated that LPS-mediated SAA gene induction in monocyte / </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9CDEFC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">macrophage cells</mark>
        </td>
        <td> is primarily due to the induction of SAF activity. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T102'>Term ID: <a href='terminology.html#L102' target='_blank'>102</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D92134262' target='_blank'>92134262</a></td>
        <td style='text-align:right'>A novel primer extension method to detect the number of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EECEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CAG repeats</mark>
        </td>
        <td> in the androgen receptor gene in families with X-linked spinal and bulbar muscu</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92134262' target='_blank'>92134262</a></td>
        <td style='text-align:right'>otor neuron disease, was recently reported to be caused by amplification of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EECEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CAG repeats</mark>
        </td>
        <td> in the androgen receptor gene. We report here a simple and rapid strategy to de</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92134262' target='_blank'>92134262</a></td>
        <td style='text-align:right'>to detect the precise number of the CAGs. After the DNA fragment containing the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EECEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CAG repeats</mark>
        </td>
        <td> is amplified by the polymerase chain reaction, a primer extension is carried ou</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92134262' target='_blank'>92134262</a></td>
        <td style='text-align:right'>ied out; the extension of the end-labelled reverse primer adjacent to 3' end of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EECEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CAG repeats</mark>
        </td>
        <td> stops at the first T after CAG repeats with the incorporation of dideoxy ATP in</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92134262' target='_blank'>92134262</a></td>
        <td style='text-align:right'>led reverse primer adjacent to 3' end of CAG repeats stops at the first T after </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EECEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CAG repeats</mark>
        </td>
        <td> with the incorporation of dideoxy ATP in the reaction mixture. The resultant pr</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92134262' target='_blank'>92134262</a></td>
        <td style='text-align:right'>resis and autoradiography. This method could be quite useful to detect not only </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EECEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CAG repeats</mark>
        </td>
        <td> in SBMA but also other polymorphic dinucleotide and trinucleotide repeats. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T53'>Term ID: <a href='terminology.html#L53' target='_blank'>53</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>s in human monocytic cells and investigated the role of the signalsome proteins </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FBB9D; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IKK-alpha</mark>
        </td>
        <td>, IKK-beta, NF-kappa B-inducing kinase ( NIK ) , IKK-gamma ( NF-kappa B essentia</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>rapid but short-lived induction of IKK activity with a 3-fold greater effect on </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FBB9D; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IKK-alpha</mark>
        </td>
        <td> than on IKK-beta, peaking at 5 min. In contrast, LPS predominantly stimulated I</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>served at a later time point following LPS stimulation, which consisted of both </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FBB9D; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IKK-alpha</mark>
        </td>
        <td> and -beta activity. The endogenous levels of the signalsome components were una</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>e unaffected by stimulation. Furthermore, our studies showed association of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FBB9D; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IKK-alpha</mark>
        </td>
        <td> / beta heterodimer with NIK, Ikappa B-alpha and -epsilon in unstimulated cells.</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>Ikappa B-epsilon disappearance from and reassembly with the signalsome, whereas </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FBB9D; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IKK-alpha</mark>
        </td>
        <td>, IKK-beta, and NIK remained complex-associated. NIK cannot phosphorylate Ikappa</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'> stimulus-induced kappa B-dependent transcription more effectively than mutated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FBB9D; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IKK-alpha</mark>
        </td>
        <td> or -beta. Overexpression of IKK complex-associated protein inhibited stimulus-m</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T42'>Term ID: <a href='terminology.html#L42' target='_blank'>42</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>l repeat in T lymphocytes. CBF consists of two subunits, a DNA binding subunit, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEBEAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CBF alpha</mark>
        </td>
        <td>, and a second subunit, CBF beta, that stimulates the DNA binding activity of CB</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>ha, and a second subunit, CBF beta, that stimulates the DNA binding activity of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEBEAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CBF alpha</mark>
        </td>
        <td>. One of the genes that encodes a CBF alpha subunit is AML1, also called Cbf alp</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>imulates the DNA binding activity of CBF alpha. One of the genes that encodes a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEBEAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CBF alpha</mark>
        </td>
        <td> subunit is AML1, also called Cbf alpha 2. This locus is rearranged by chromosom</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>F alpha. One of the genes that encodes a CBF alpha subunit is AML1, also called </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEBEAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Cbf alpha</mark>
        </td>
        <td> 2. This locus is rearranged by chromosomal translocations in human myeloprolife</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>s in human myeloproliferative disorders and leukemias. An exogenously expressed </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEBEAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Cbf alpha</mark>
        </td>
        <td> 2-encoded subunit ( CBF alpha 2-451 ) stimulated transcription from the SL3 enh</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>disorders and leukemias. An exogenously expressed Cbf alpha 2-encoded subunit ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEBEAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CBF alpha</mark>
        </td>
        <td> 2-451 ) stimulated transcription from the SL3 enhancer in P19 and HeLa cells. A</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>r. The longest form, CBF beta-187, increased the transcriptional stimulation by </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEBEAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CBF alpha</mark>
        </td>
        <td> 2-451 twofold in HeLa cells, although it had no effect in P19 cells. Transcript</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>ct in P19 cells. Transcriptional activation by CBF beta required binding to the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEBEAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CBF alpha</mark>
        </td>
        <td> subunit, as a form of CBF beta that lacked binding ability, CBF beta-148, faile</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>transcription in T cells and leukemogenicity of SL3. However, no combination of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEBEAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">CBF alpha</mark>
        </td>
        <td> and CBF beta subunits that we tested was able to distinguish the 1-bp differenc</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T310'>Term ID: <a href='terminology.html#L310' target='_blank'>310</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96079922' target='_blank'>96079922</a></td>
        <td style='text-align:right'>ranscription ) pathway. We investigated the ability of PRL and IL-2 to activate </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BC99FD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Stat proteins</mark>
        </td>
        <td> in different T cell lines. The DNA binding specificities, the reactivities towa</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96079922' target='_blank'>96079922</a></td>
        <td style='text-align:right'> proteins in Nb2 and C196 T cell lines were investigated. A comparison with the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BC99FD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Stat proteins</mark>
        </td>
        <td> induced by interferon-gamma, PRL, and IL-6 in T47D mammary tumor cells was made</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96085174' target='_blank'>96085174</a></td>
        <td style='text-align:right'>oncomitantly, the tyrosine phosphorylation and DNA binding activity of multiple </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BC99FD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">STAT proteins</mark>
        </td>
        <td>. The STAT proteins utilized by IL-7 were identical to those induced by IL-2 and</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96085174' target='_blank'>96085174</a></td>
        <td style='text-align:right'>yrosine phosphorylation and DNA binding activity of multiple STAT proteins. The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BC99FD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">STAT proteins</mark>
        </td>
        <td> utilized by IL-7 were identical to those induced by IL-2 and could be identifie</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>Interferon-alpha activates multiple </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BC99FD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">STAT proteins</mark>
        </td>
        <td> and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99168986' target='_blank'>99168986</a></td>
        <td style='text-align:right'>nvolved in the regulation of T-cell mitogenesis. When we analyzed the nature of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BC99FD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">STAT proteins</mark>
        </td>
        <td> capable of binding to IL-2Ralpha, pim-1, and IRF-1 GAS elements after cytokine </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T309'>Term ID: <a href='terminology.html#L309' target='_blank'>309</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D93024468' target='_blank'>93024468</a></td>
        <td style='text-align:right'>ing specificity similar to that of NF-kappa B but is unrelated to this or other </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9DCCAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Rel proteins</mark>
        </td>
        <td> by functional and biochemical criteria. It can also be distinguished from other</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94254835' target='_blank'>94254835</a></td>
        <td style='text-align:right'>stead comigrated with c-Rel / p65 dimers. Antibodies against the NF-kappa B and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9DCCAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Rel proteins</mark>
        </td>
        <td> and UV cross-linking studies revealed the presence of c-Rel and p65 and the abs</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99146379' target='_blank'>99146379</a></td>
        <td style='text-align:right'>ed in T cells 3 days after activation, coincident with RANTES expression. While </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9DCCAA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Rel proteins</mark>
        </td>
        <td> play the dominant role in RANTES gene expression in fibroblasts, RFLAT-1 is a s</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T304'>Term ID: <a href='terminology.html#L304' target='_blank'>304</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>Kinetics of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9EEF9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear translocation</mark>
        </td>
        <td> and turnover of the vitamin D receptor in human HL60 leukemia cells and periphe</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>yelocytes, can be induced to monocytoid differentiation by calcitriol. Specific </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9EEF9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear translocation</mark>
        </td>
        <td> of [3H]calcitriol / VDR was examined after exposure of whole cells to 10 ( -9 )</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>00-fold excess of unlabeled ligand and subsequent isolation of nuclei. Specific </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9EEF9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear translocation</mark>
        </td>
        <td> of [3H]calcitriol / VDR was found to be time dependent reaching a maximum of ap</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>60. No effect was seen in ethanol treated controls. We conclude that a specific </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9EEF9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear translocation</mark>
        </td>
        <td> mechanism exists for calcitriol in both cell types examined, most likely due to</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95332324' target='_blank'>95332324</a></td>
        <td style='text-align:right'>roteins of about 65-75 and 120-125 kDa. In addition, integrin ligation leads to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9EEF9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear translocation</mark>
        </td>
        <td> of the p50 and p65 subunits of the NF-kappa B transcription factor, to activati</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T295'>Term ID: <a href='terminology.html#L295' target='_blank'>295</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>ncreased mRNA stability, the duration of mRNA accumulation was longer following </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AAFAAB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">LPS stimulation</mark>
        </td>
        <td> in primed monocytes, in addition to being of greater magnitude. Finally, primed</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96075792' target='_blank'>96075792</a></td>
        <td style='text-align:right'>accumulation in unprimed cells, but had no effect on primed monocytes following </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AAFAAB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">LPS stimulation</mark>
        </td>
        <td>. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>, peaking at 30 min. A second peak was observed at a later time point following </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #AAFAAB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">LPS stimulation</mark>
        </td>
        <td>, which consisted of both IKK-alpha and -beta activity. The endogenous levels of</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T286'>Term ID: <a href='terminology.html#L286' target='_blank'>286</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'>ranulocyte-macrophage colony-stimulating factor preferentially activates the 94-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F99BED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kD STAT5A</mark>
        </td>
        <td> and an 80-kD STAT5A isoform in human peripheral blood monocytes. Granulocyte-ma</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'>e colony-stimulating factor preferentially activates the 94-kD STAT5A and an 80-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F99BED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kD STAT5A</mark>
        </td>
        <td> isoform in human peripheral blood monocytes. Granulocyte-macrophage colony-stim</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'> lower molecular weight STAT5 isoforms. Freshly isolated monocytes expressed 94-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F99BED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kD STAT5A</mark>
        </td>
        <td>, 92-kD STAT5B, and an 80-kD STAT5A molecule. Whereas 94-kD STAT5A was clearly t</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'>rms. Freshly isolated monocytes expressed 94-kD STAT5A, 92-kD STAT5B, and an 80-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F99BED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kD STAT5A</mark>
        </td>
        <td> molecule. Whereas 94-kD STAT5A was clearly tyrosine phosphorylated and bound to</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'> expressed 94-kD STAT5A, 92-kD STAT5B, and an 80-kD STAT5A molecule. Whereas 94-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F99BED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kD STAT5A</mark>
        </td>
        <td> was clearly tyrosine phosphorylated and bound to the enhancer element, the gamm</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96329553' target='_blank'>96329553</a></td>
        <td style='text-align:right'>o the immobilized GRR element. Macrophages lost their ability to express the 80-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #F99BED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">kD STAT5A</mark>
        </td>
        <td> protein, but retained their ability to activate STAT5A. STAT5A-STAT5A homodimer</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T282'>Term ID: <a href='terminology.html#L282' target='_blank'>282</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D97211823' target='_blank'>97211823</a></td>
        <td style='text-align:right'>re thought to be critical for the transcription of genes involved in immune and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEFFFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">inflammatory responses</mark>
        </td>
        <td>. We have reported previously that a nuclear NF-kappa B activity was present in </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'>e role of this transcription factor in the regulation of gene expression in the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEFFFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">inflammatory response</mark>
        </td>
        <td>, NF-kappa B inhibitors have been suggested as potential therapeutic drugs for i</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99118181' target='_blank'>99118181</a></td>
        <td style='text-align:right'>g increasingly apparent that NF-kappa B plays a critical role in regulating the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEFFFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">inflammatory response</mark>
        </td>
        <td>. Data obtained from studies in our laboratories demonstrate that the proteasome</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99207658' target='_blank'>99207658</a></td>
        <td style='text-align:right'>osteroids are susceptible to modify functions of cells involved in the allergic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FEFFFB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">inflammatory response</mark>
        </td>
        <td>. They are in particular able to inhibit most of the pro-inflammatory functions </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T277'>Term ID: <a href='terminology.html#L277' target='_blank'>277</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95127261' target='_blank'>95127261</a></td>
        <td style='text-align:right'>Alternate </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AF9D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">immune system</mark>
        </td>
        <td> targets for TCDD: lymphocyte stem cells and extrathymic T-cell development. We </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'>LTR-directed gene expression in cells of the central nervous system ( CNS ) and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AF9D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">immune system</mark>
        </td>
        <td>, we amplified and cloned LTRs from proviral DNA in HIV-1-infected peripheral bl</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98230439' target='_blank'>98230439</a></td>
        <td style='text-align:right'>, which may, in turn, alter the course of viral replication in cells of CNS and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AF9D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">immune system</mark>
        </td>
        <td> origin. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99083144' target='_blank'>99083144</a></td>
        <td style='text-align:right'>es. Few, if any, studies have been made on the impact of these compounds on the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AF9D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">immune system</mark>
        </td>
        <td>. We sought to determine the activities of various environmental estrogens on th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99294118' target='_blank'>99294118</a></td>
        <td style='text-align:right'>l pathogenic mechanisms. Endogenous and therapeutic steroid hormones affect the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AF9D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">immune system</mark>
        </td>
        <td>, and inflammatory diseases are associated with activation of the hypothalamic-p</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99357866' target='_blank'>99357866</a></td>
        <td style='text-align:right'>nvolves the production of interleukin-12 ( IL-12 ) , a key signal of the innate </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9AF9D9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">immune system</mark>
        </td>
        <td>. Yet, for many pathogens, the molecules that induce IL-12 production by macroph</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T273'>Term ID: <a href='terminology.html#L273' target='_blank'>273</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'>Distinct DNase-I </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99FCB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">hypersensitive sites</mark>
        </td>
        <td> are associated with TAL-1 transcription in erythroid and T-cell lines. The tal-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'>ranscriptionally inactive alleles in established cell lines. Five major DNase-I </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99FCB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">hypersensitive sites</mark>
        </td>
        <td> ( HS ) were mapped in the tal-1 locus. HS I, IV, and V were exclusively observe</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'>ve alleles in established cell lines. Five major DNase-I hypersensitive sites ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99FCB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HS</mark>
        </td>
        <td> ) were mapped in the tal-1 locus. HS I, IV, and V were exclusively observed in </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'> Five major DNase-I hypersensitive sites ( HS ) were mapped in the tal-1 locus. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99FCB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HS</mark>
        </td>
        <td> I, IV, and V were exclusively observed in the erythroid / megakaryocytic cell l</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'>id / megakaryocytic cell lines that express tal-1 from the promoters 1a and 1b. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99FCB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HS</mark>
        </td>
        <td> II was weak in hematopoietic cell lines, absent in Hela, and greatly enhanced i</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'>ght be implicated in the cis-activation of tal-1 promoter 1b in this cell line. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99FCB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HS</mark>
        </td>
        <td> III was weak in HEL and Jurkat, and greatly enhanced in DU528, a T-cell line th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>ndothelial cells were also detected at the chromatin structure level, as DNasel </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #99FCB9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">hypersensitive sites</mark>
        </td>
        <td> within both the GM-CSF enhancer and the E-selectin promoter were suppressed by </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T250'>Term ID: <a href='terminology.html#L250' target='_blank'>250</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96239534' target='_blank'>96239534</a></td>
        <td style='text-align:right'>s type 1-infected human T lymphocytes support higher levels of 5S rRNA and tRNA </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9EAFCB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene transcription</mark>
        </td>
        <td> than chromatin or extracts from uninfected T lymphocytes. The viral protein Tax</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96239534' target='_blank'>96239534</a></td>
        <td style='text-align:right'> The viral protein Tax was likely responsible for this higher level of class II </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9EAFCB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene transcription</mark>
        </td>
        <td>, as purified Tax was found to stimulate both genes when added to the uninfected</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96239534' target='_blank'>96239534</a></td>
        <td style='text-align:right'>-component transcription assays and DNA binding assays identified the class III </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9EAFCB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene transcription</mark>
        </td>
        <td> factor TFIIIB as the principle target of Tax activity. Surprisingly, we find th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96303658' target='_blank'>96303658</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9EAFCB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Gene transcription</mark>
        </td>
        <td> through activation of G-protein-coupled chemoattractant receptors. Receptors fo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96303658' target='_blank'>96303658</a></td>
        <td style='text-align:right'>in-coupled serpentine receptors have been found to transduce signals leading to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9EAFCB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene transcription</mark>
        </td>
        <td> and translation in leukocytes. Transcription factors, such as NF kappa B and AP</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97211823' target='_blank'>97211823</a></td>
        <td style='text-align:right'>articularly abundant in lymphoid tissues and are thought to be critical for the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9EAFCB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">transcription of genes</mark>
        </td>
        <td> involved in immune and inflammatory responses. We have reported previously that</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97303223' target='_blank'>97303223</a></td>
        <td style='text-align:right'> the IL-4Ralpha chain may transduce intracellular signals that lead to Cepsilon </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9EAFCB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene transcription</mark>
        </td>
        <td> independently of its association with other chains. We show that ligand-induced</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97324097' target='_blank'>97324097</a></td>
        <td style='text-align:right'>e E74 site independent of mitogenic signaling. Thus, Elf-1 is able to stimulate </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9EAFCB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">gene transcription</mark>
        </td>
        <td> which may be required for the development and activity of lymphocytes. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T248'>Term ID: <a href='terminology.html#L248' target='_blank'>248</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'> alpha globin regulatory element ( HS-40 ) located 40 kb upstream of the zeta 2 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EF9C99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">globin gene</mark>
        </td>
        <td>. It was shown by transient expression assay that HS-40 behaved as an authentic </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'> or fetal origin. Although sequences located between -559 and -88 of the zeta 2 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EF9C99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">globin gene</mark>
        </td>
        <td> were dispensable for its expression on enhancerless plasmids, they were require</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>n. These data suggest that transcriptional activation of human embryonic zeta 2 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EF9C99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">globin gene</mark>
        </td>
        <td> and the fetal / adult alpha globin genes is mediated by erythroid cell-specific</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T226'>Term ID: <a href='terminology.html#L226' target='_blank'>226</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>pa B heterodimer was preferentially lost. Adding purified NF-kappa B protein to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFCE99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear extracts</mark>
        </td>
        <td> from cells with restricted expression overcomes this lack of binding. In additi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>cted expression overcomes this lack of binding. In addition, treatment of these </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFCE99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear extracts</mark>
        </td>
        <td> with sodium deoxycholate restored their ability to form the heterodimer, sugges</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'> the presence of an inhibitor of NF-kappa B activity. Furthermore, treatment of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFCE99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear extracts</mark>
        </td>
        <td> from these cells that had restricted expression with lipopolysaccharide increas</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>ls and peripheral blood lymphocytes-coincident rise of DNA-relaxing activity in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFCE99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear extracts</mark>
        </td>
        <td>. High affinity receptors ( VDR ) for 1,25-dihydroxycholecalciferol ( calcitriol</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>pound. The activity of DNA relaxing enzymes ( e.g. topoisomerases I and II ) in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFCE99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear extracts</mark>
        </td>
        <td> was measured using a PBR 322-relaxation-assay. Enhanced overall enzyme activity</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>using a PBR 322-relaxation-assay. Enhanced overall enzyme activity was found in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFCE99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear extracts</mark>
        </td>
        <td> by 1 h after incubation with calcitriol ( final ethanol concentration 0.0001% v</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>umber of specific nuclear binding sites. Enhanced activity of topoisomerases in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFCE99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear extracts</mark>
        </td>
        <td> upon translocation of VDR might reflect interaction of both within the nuclear </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96074632' target='_blank'>96074632</a></td>
        <td style='text-align:right'>eased the abundance of a specific DNA-protein complex formed upon incubation of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFCE99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear extracts</mark>
        </td>
        <td> from activated lymphocytes with a labeled NF-kappa B DNA binding motif. Further</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'>ivalent to those observed for stimulated T cells of young subjects. Analyses of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFCE99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear extracts</mark>
        </td>
        <td> by electrophoretic DNA mobility shift assays showed that decreased IL-2 product</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104462' target='_blank'>98104462</a></td>
        <td style='text-align:right'>at is upregulated in LPS toler ant human Mono Mac 6 cells. The same is true for </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #EFCE99; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">nuclear extracts</mark>
        </td>
        <td> taken from the murine P388D1 macrophage cell line when tested with the -516 mot</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T220'>Term ID: <a href='terminology.html#L220' target='_blank'>220</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>-1 beta, IL-6 and TNF alpha expression, both at the mRNA and protein level. The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C99BDD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">induced expression</mark>
        </td>
        <td> of IL-1 beta and TNF alpha mRNA in the monocytic THP-1 cell line increased as q</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>led several positive and negative regulatory elements involved in the basal and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C99BDD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">inducible expression</mark>
        </td>
        <td> of the IL-9 gene in C5MJ2 cells. An AP-1 site at -146 to -140 was shown to be i</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>on between -46 and -80 was identified as the minimum sequence for the basal and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #C99BDD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">inducible expression</mark>
        </td>
        <td> of the IL-9 gene in C5MJ2 cells. Within this region, an NF-kappa B site at -59 </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T212'>Term ID: <a href='terminology.html#L212' target='_blank'>212</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>ivation. Moreover, induction of tyrosine phosphorylation appears sufficient per </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CABEF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">se</mark>
        </td>
        <td> to initiate a complete activation programme. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99081619' target='_blank'>99081619</a></td>
        <td style='text-align:right'>nt CD4 ( + ) T cells into the cell cycle upon stimulation with the superantigen </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CABEF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">staphylococcal enterotoxin</mark>
        </td>
        <td> B ( SEB ) . IL-10 arrested cells at G0 / G1. IL-10 treatment prevented the down</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>tivation of Stat5 in murine T cells. Here, we show that CD3 ligation by mAb and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CABEF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Staphylococcal enterotoxin</mark>
        </td>
        <td> ( SE ) induce a rapid, gradually accumulating, long-lasting tyrosine, and serin</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'> cells. Here, we show that CD3 ligation by mAb and Staphylococcal enterotoxin ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CABEF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">SE</mark>
        </td>
        <td> ) induce a rapid, gradually accumulating, long-lasting tyrosine, and serine pho</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>3 activation is unaffected. In conclusion, we show that CD3 ligation by mAb and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CABEF9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">SE</mark>
        </td>
        <td> triggers a rapid, PP1-sensitive tyrosine and serine phosphorylation of Stat3 in</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T210'>Term ID: <a href='terminology.html#L210' target='_blank'>210</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>Cell-specific differences in activation of NF-kappa B </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9999B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">regulatory elements</mark>
        </td>
        <td> of human immunodeficiency virus and beta interferon promoters by tumor necrosis</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>sion assays using reporter chloramphenicol acetyltransferase plasmids linked to </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9999B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">regulatory elements</mark>
        </td>
        <td> from the HIV long terminal repeat ( LTR ) and the beta interferon promoter. In </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93183827' target='_blank'>93183827</a></td>
        <td style='text-align:right'>This observation directly demonstrates the existence of a Ca2+ signal-dependent </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9999B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">regulatory element</mark>
        </td>
        <td> obligatory for expression of some genes in T cells but not in fibroblasts. This</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>Transcriptional activation of human zeta 2 globin promoter by the alpha globin </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9999B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">regulatory element</mark>
        </td>
        <td> ( HS-40 ) : functional role of specific nuclear factor-DNA complexes. We studie</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93204975' target='_blank'>93204975</a></td>
        <td style='text-align:right'>interaction between human embryonic zeta 2 globin promoter and the alpha globin </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9999B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">regulatory element</mark>
        </td>
        <td> ( HS-40 ) located 40 kb upstream of the zeta 2 globin gene. It was shown by tra</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>pon treatment with MDHM. IL-1 beta and IL-6 genes contain AP-1 binding sites as </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9999B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">regulatory elements</mark>
        </td>
        <td>, the AP-1 protein being composed of c-jun and c-fos gene products. In THP-1 cel</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95036290' target='_blank'>95036290</a></td>
        <td style='text-align:right'>nitiates tal-1 transcription within exon 4. These results suggest that distinct </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9999B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">regulatory elements</mark>
        </td>
        <td> are associated with the use of the different tal-1 promoters. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95399771' target='_blank'>95399771</a></td>
        <td style='text-align:right'>he activity of granulocyte-macrophage colony-stimulating factor ( GM-CSF ) gene </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9999B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">regulatory elements</mark>
        </td>
        <td> that use NFAT by 60%. CsA similarly mediated a reduction of up to 65% in GM-CSF</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'> 5'-flanking region of the IL-9 gene has revealed several positive and negative </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9999B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">regulatory elements</mark>
        </td>
        <td> involved in the basal and inducible expression of the IL-9 gene in C5MJ2 cells.</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97456880' target='_blank'>97456880</a></td>
        <td style='text-align:right'>rotein-1 family proteins. We previously identified the P sequence as a critical </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9999B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">regulatory element</mark>
        </td>
        <td> of the human IL-4 promoter. In the mouse IL-4 promoter, there are five elements</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98090689' target='_blank'>98090689</a></td>
        <td style='text-align:right'>natal T-cell activation may be due to lack of expression of the transcriptional </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9999B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">regulatory elements</mark>
        </td>
        <td> required for T-cell activation. We used reverse transcriptase-polymerase chain </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99005376' target='_blank'>99005376</a></td>
        <td style='text-align:right'>c action between an SP-1-like element at -21/-12, asite at -59/-54, and a novel </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9999B; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">regulatory element</mark>
        </td>
        <td>, CPRE ( -- ) at -49/-41, is essential for the promoter activity in murine eryth</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T206'>Term ID: <a href='terminology.html#L206' target='_blank'>206</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99083144' target='_blank'>99083144</a></td>
        <td style='text-align:right'>in was a very low-potency agonist, having an EC50 of 1.5 microM. Similar to the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEBE9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">E2 response</mark>
        </td>
        <td>, the slope factors for alpha-zearalenol, zearalenone, and genistein were close </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99083144' target='_blank'>99083144</a></td>
        <td style='text-align:right'>enic activity, the industrial compound 4-octylphenol was able to antagonize the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEBE9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">response to E2</mark>
        </td>
        <td>; however, the response was three orders of magnitude less potent than H 1285. N</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99083144' target='_blank'>99083144</a></td>
        <td style='text-align:right'>5. Naringenin, a plant flavonoid, showed little or no ability to antagonize the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BEBE9C; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">response to E2</mark>
        </td>
        <td>. Overall, the results show that some environmental estrogens that display agoni</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T190'>Term ID: <a href='terminology.html#L190' target='_blank'>190</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D91190842' target='_blank'>91190842</a></td>
        <td style='text-align:right'>on factor that activates the T-cell receptor C alpha gene enhancer in a context-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE9FA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">dependent manner</mark>
        </td>
        <td>. The differentiation of T cells into functionally diverse subpopulations is con</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99083144' target='_blank'>99083144</a></td>
        <td style='text-align:right'>olysaccharide - ( LPS ) induced IL-1beta promoter-driven CAT activity in a dose-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE9FA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">dependent manner</mark>
        </td>
        <td>. The mycotoxins alpha-zearalenol and zearalenone both exhibited full agonist ac</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99083144' target='_blank'>99083144</a></td>
        <td style='text-align:right'>ns H1285 and ICI 182,780 effectively inhibited their agonist activity in a dose-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE9FA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">dependent manner</mark>
        </td>
        <td>. Representative environmental estrogenic compounds both from plant and industri</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99406845' target='_blank'>99406845</a></td>
        <td style='text-align:right'>t therapeutic concentrations resulted in monocyte apoptosis in a time- and dose-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CAE9FA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">dependent manner</mark>
        </td>
        <td>. Necrosis was excluded by propidium iodide staining. Proinflammatory cytokines </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T187'>Term ID: <a href='terminology.html#L187' target='_blank'>187</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96074632' target='_blank'>96074632</a></td>
        <td style='text-align:right'>-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9BCFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">dihydroxyvitamin D3</mark>
        </td>
        <td> [published erratum appears in Proc Natl Acad Sci U S A 1996 Jan 9;93 ( 1 ) :524</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96074632' target='_blank'>96074632</a></td>
        <td style='text-align:right'>ppears in Proc Natl Acad Sci U S A 1996 Jan 9;93 ( 1 ) :524] The effect of 1,25-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9BCFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">dihydroxyvitamin D3</mark>
        </td>
        <td> [1,25 ( OH ) 2 ) D3], a steroid hormone with immunomodulating properties, on nu</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96074632' target='_blank'>96074632</a></td>
        <td style='text-align:right'>required between 4 and 8 hr and was specific, as 25-hydroxyvitamin D3 and 24,25-</td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9BCFF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">dihydroxyvitamin D3</mark>
        </td>
        <td> were ineffective. Besides p50, 1,25 ( OH ) 2D3 decreased the levels of another </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T183'>Term ID: <a href='terminology.html#L183' target='_blank'>183</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96322726' target='_blank'>96322726</a></td>
        <td style='text-align:right'>er activation. Stimulation of the cAMP signal transduction pathway, which skews </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ECEAED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cytokine production</mark>
        </td>
        <td> toward a Th2 pattern, resulted in the preferential suppression of Stat1 activit</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98090689' target='_blank'>98090689</a></td>
        <td style='text-align:right'>tion. Fetal and neonatal lymphocytes are relatively resistant to activation and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ECEAED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cytokine production</mark>
        </td>
        <td> when stimulated either via their T-cell antigen receptors or lectins. The molec</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99172186' target='_blank'>99172186</a></td>
        <td style='text-align:right'>ranscription factor NF-kappa B. In parallel, NAC was shown to down-regulate the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #ECEAED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">production of cytokines</mark>
        </td>
        <td> by DC as well as their surface expression of HLA-DR, CD86 ( B7-2 ) , and CD40 m</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T164'>Term ID: <a href='terminology.html#L164' target='_blank'>164</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90140708' target='_blank'>90140708</a></td>
        <td style='text-align:right'>n a complex interplay of ubiquitous and developmentally regulated proteins. Two </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DDBDFE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">complementary DNAs</mark>
        </td>
        <td> were isolated that encode proteins, denoted ITF-1 and ITF-2, that are expressed</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90140708' target='_blank'>90140708</a></td>
        <td style='text-align:right'>icroE5 / kappa 2 motif found in both heavy and kappa light chain enhancers. The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DDBDFE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">complementary DNAs</mark>
        </td>
        <td> are the products of distinct genes, yet both ITF-1 and ITF-2 are structurally a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96185499' target='_blank'>96185499</a></td>
        <td style='text-align:right'>ylase activity. Both proteins were identified by peptide microsequencing, and a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DDBDFE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">complementary DNA</mark>
        </td>
        <td> encoding the histone deacetylase catalytic subunit ( HD1 ) was cloned from a hu</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T155'>Term ID: <a href='terminology.html#L155' target='_blank'>155</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D97303223' target='_blank'>97303223</a></td>
        <td style='text-align:right'> IL-4 receptor ( IL-4R ) in B cells is composed of two chains, the IL-4-binding </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BB9DCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IL-4Ralpha chain</mark>
        </td>
        <td>, which is shared with the IL-13R, and the IL-2Rgamma ( gammac ) chain, which is</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97303223' target='_blank'>97303223</a></td>
        <td style='text-align:right'> lack the gammac chain may involve signaling via the IL-13R. Alternatively, the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BB9DCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IL-4Ralpha chain</mark>
        </td>
        <td> may transduce intracellular signals that lead to Cepsilon gene transcription in</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97303223' target='_blank'>97303223</a></td>
        <td style='text-align:right'>psilon germline transcripts. These results suggest that homodimerization of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BB9DCE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IL-4Ralpha chain</mark>
        </td>
        <td> is sufficient to transduce Jak1-dependent intracellular signals that lead to Ig</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T150'>Term ID: <a href='terminology.html#L150' target='_blank'>150</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D94209654' target='_blank'>94209654</a></td>
        <td style='text-align:right'> signal transduction cascades which alter the expression of genes that regulate </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FCCAB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cellular proliferation</mark>
        </td>
        <td> and differentiation. The transmission of signals from the membrane to the nucle</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'>tyrosine kinase ( PTK ) -specific inhibitor herbimycin A dramatically decreased </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FCCAB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cellular proliferation</mark>
        </td>
        <td> without altering the activity of the human immunodeficiency virus-1 long termin</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97054651' target='_blank'>97054651</a></td>
        <td style='text-align:right'>ibited HIV-1 LTR activity at a concentration as low as 100 nM without affecting </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FCCAB; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">cellular proliferation</mark>
        </td>
        <td>. Electrophoretic mobility shift assay ( EMSA ) and supershift assay using an NF</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T147'>Term ID: <a href='terminology.html#L147' target='_blank'>147</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>production was analyzed by polymerase chain reaction amplification in monocytic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CE9CBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">U937 cells</mark>
        </td>
        <td> and in a chronically HIV infected U937 cell line ( U9-IIIB ) . TNF-alpha RNA wa</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>lly HIV infected U937 cell line ( U9-IIIB ) . TNF-alpha RNA was undetectable in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CE9CBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">U937 cells</mark>
        </td>
        <td>, whereas a low constitutive level was detected in U9-IIIB cells. Paramyxovirus </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'>rease in the steady-state level of TNF-alpha RNA in U9-IIIB cells compared with </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CE9CBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">U937 cells</mark>
        </td>
        <td>, suggesting that HIV-infected monocytic cells produced higher levels of TNF-alp</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D90376424' target='_blank'>90376424</a></td>
        <td style='text-align:right'> kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CE9CBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">U937 cells</mark>
        </td>
        <td>. However, in Jurkat cells, TNF-alpha dramatically enhanced the spread of HIV-1 </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91321794' target='_blank'>91321794</a></td>
        <td style='text-align:right'>( GSH ) level and inhibit HIV-1 replication in persistently infected Molt-4 and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CE9CBD; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">U937 cells</mark>
        </td>
        <td>. However, inhibition of HIV-1 replication appears not to be directly correlated</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T146'>Term ID: <a href='terminology.html#L146' target='_blank'>146</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D98104462' target='_blank'>98104462</a></td>
        <td style='text-align:right'>or necrosis factor ) gene is only very low, i.e. the cells are tolerant to LPS. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FD9DDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Tolerant cells</mark>
        </td>
        <td> still express the CD14 receptor and they can still be activated to mobilize NF-</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104462' target='_blank'>98104462</a></td>
        <td style='text-align:right'>proteins employing the -605 motif of the human TNF promoter () revealed that in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FD9DDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tolerant cells</mark>
        </td>
        <td> of the human monocytic cell line Mono Mac 6 there is a predominance of p50p50 o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104462' target='_blank'>98104462</a></td>
        <td style='text-align:right'> wild type motif gives efficient binding of p50p50 that again is upregulated in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FD9DDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tolerant cells</mark>
        </td>
        <td> whereas a mutant with a 3' G shows hardly any binding of p50p50. Conversely, th</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104462' target='_blank'>98104462</a></td>
        <td style='text-align:right'>by a C. These data show that the detection of upregulated p50 homodimers in LPS </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FD9DDF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">tolerant cells</mark>
        </td>
        <td> is dependent on subtle differences in the sequence of the DNA binding motif. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T145'>Term ID: <a href='terminology.html#L145' target='_blank'>145</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D92052106' target='_blank'>92052106</a></td>
        <td style='text-align:right'>ive. These differences in gene expression have not been molecularly defined. In </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CEFDD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">THP-1 cells</mark>
        </td>
        <td> with restricted HIV expression, there is an absence of DNA-protein binding comp</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'> elements, the AP-1 protein being composed of c-jun and c-fos gene products. In </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CEFDD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">THP-1 cells</mark>
        </td>
        <td> c-jun mRNA expression increased after incubation with MDHM while positive c-fos</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>jun expression was not modulated. c-myc mRNA expression, constitutively high in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CEFDD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">THP-1 cells</mark>
        </td>
        <td>, was induced in MDHM-stimulated PBMo. In conclusion, MDHM-stimulated induction </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94238882' target='_blank'>94238882</a></td>
        <td style='text-align:right'>NA expression was accompanied by different proto-oncogene responses in PBMo and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CEFDD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">THP-1 cells</mark>
        </td>
        <td>. These differences may represent different regulatory pathways of the two cell </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'>NF-kappa B / Rel family members regulating the ICAM-1 promoter in monocytic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CEFDD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">THP-1 cells</mark>
        </td>
        <td>. A kappa B-site was identified in the promoter of the intercellular adhesion mo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104459' target='_blank'>98104459</a></td>
        <td style='text-align:right'> were shown to transactivate an ICAM-1 kappa B-reporter construct. In monocytic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CEFDD9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">THP-1 cells</mark>
        </td>
        <td> TNF-alpha induced two nuclear complexes which in vitro bound to the ICAM-1 kapp</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T125'>Term ID: <a href='terminology.html#L125' target='_blank'>125</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>man leukemia cells and in low numbers in peripheral blood lymphocytes ( PBL ) . </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9DE9A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HL60 cells</mark>
        </td>
        <td>, expressing some characteristics of promyelocytes, can be induced to monocytoid</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D92215726' target='_blank'>92215726</a></td>
        <td style='text-align:right'>aximum of approximately 2100 binding sites / nucleus after 3 h of incubation in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9DE9A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HL60 cells</mark>
        </td>
        <td>, whereas a maximum of approximately 310 binding sites / nucleus was found after</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96437028' target='_blank'>96437028</a></td>
        <td style='text-align:right'>ls peaking after 60 minutes exposure to RA. E3 transcripts were RA-inducible in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #A9DE9A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">HL60 cells</mark>
        </td>
        <td>, but not in an RA-resistant subclone, HL60R, that harbors a mutated RAR alpha g</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T91'>Term ID: <a href='terminology.html#L91' target='_blank'>91</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D92135145' target='_blank'>92135145</a></td>
        <td style='text-align:right'> two nuclear proteins NF-kappa B ( consisting of subunits p50 an dp65 ) and the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> subunit of NF-kappa B ( p50 ) by itself, also called KBF1, are constitutively e</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93024468' target='_blank'>93024468</a></td>
        <td style='text-align:right'>and B lymphocytes but is not found in nonhematopoietic cells. This factor has a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> specificity similar to that of NF-kappa B but is unrelated to this or other Rel</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93024468' target='_blank'>93024468</a></td>
        <td style='text-align:right'>t can also be distinguished from other previously described lymphocyte-specific </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> proteins. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D93321228' target='_blank'>93321228</a></td>
        <td style='text-align:right'>rsistent expression of the c-fos protooncogene, associated to an increased AP-1 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> activity, whereas no variations of CREB or NF-kB were detected. Neither Bt2cAMP</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D94107268' target='_blank'>94107268</a></td>
        <td style='text-align:right'>ukin 2 production. Pervanadate activated NF-kappa B, as shown by an increase in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> activity of this transcription factor. We thus conclude that PTPases play a cru</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95000924' target='_blank'>95000924</a></td>
        <td style='text-align:right'>ssion vector. Secretion of IL-2 and TNF-alpha, surface expression of IL-2R, and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> activity of NF-kappa B and AP-1 ( Fos / Jun ) complex in response to phorbol my</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95166251' target='_blank'>95166251</a></td>
        <td style='text-align:right'>during thymic development. The PEBP2 alpha A and PEBP2 alpha B genes encode the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> subunit of a murine transcription factor, PEBP2, which is implicated as a T-cel</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>he viral long terminal repeat in T lymphocytes. CBF consists of two subunits, a </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA binding</mark>
        </td>
        <td> subunit, CBF alpha, and a second subunit, CBF beta, that stimulates the DNA bin</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95222739' target='_blank'>95222739</a></td>
        <td style='text-align:right'>binding subunit, CBF alpha, and a second subunit, CBF beta, that stimulates the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA binding</mark>
        </td>
        <td> activity of CBF alpha. One of the genes that encodes a CBF alpha subunit is AML</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95261059' target='_blank'>95261059</a></td>
        <td style='text-align:right'>closely related members of the ets transcription factor family, sharing similar </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA binding</mark>
        </td>
        <td> specificities mediated by similar DNA binding domains. PU.1 and Spi-B have been</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D95261059' target='_blank'>95261059</a></td>
        <td style='text-align:right'>on factor family, sharing similar DNA binding specificities mediated by similar </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA binding</mark>
        </td>
        <td> domains. PU.1 and Spi-B have been previously described as being predominantly e</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96079922' target='_blank'>96079922</a></td>
        <td style='text-align:right'>bility of PRL and IL-2 to activate Stat proteins in different T cell lines. The </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA binding</mark>
        </td>
        <td> specificities, the reactivities toward Stat-specific antisera, and the mol wt o</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96079922' target='_blank'>96079922</a></td>
        <td style='text-align:right'>tivities toward Stat-specific antisera, and the mol wt of IL-2 -and PRL-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> proteins in Nb2 and C196 T cell lines were investigated. A comparison with the </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96085174' target='_blank'>96085174</a></td>
        <td style='text-align:right'>rylation of Jak 1 and Jak 3 and concomitantly, the tyrosine phosphorylation and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA binding</mark>
        </td>
        <td> activity of multiple STAT proteins. The STAT proteins utilized by IL-7 were ide</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96239534' target='_blank'>96239534</a></td>
        <td style='text-align:right'>t or in reconstituted systems. Both limiting-component transcription assays and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA binding</mark>
        </td>
        <td> assays identified the class III gene transcription factor TFIIIB as the princip</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96279111' target='_blank'>96279111</a></td>
        <td style='text-align:right'>in this proximal promoter region abolished the promoter activity as well as the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA binding</mark>
        </td>
        <td>. Taken together, these results suggest that the cooperation of different transc</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96322726' target='_blank'>96322726</a></td>
        <td style='text-align:right'>nking cell surface CD3. Cell activation resulted in a delayed induction of STAT </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> activity, which was sustained for several days, was composed predominantly of S</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D96322726' target='_blank'>96322726</a></td>
        <td style='text-align:right'>signaling inhibited Stat1 at several different levels, including suppression of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA binding</mark>
        </td>
        <td> and down-regulation of Stat1 protein and mRNA levels. Our results demonstrate t</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97064186' target='_blank'>97064186</a></td>
        <td style='text-align:right'>ally involved in IL-12 signaling. Consequently, IL-12 also failed to induce the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> activity of STAT4-containing complexes in the nuclei of these Th2 clones. All T</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97162234' target='_blank'>97162234</a></td>
        <td style='text-align:right'>LPS ) . In this study we have investigated the effect of FCM on the LPS-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> activity of NF-kappa B, by means of electrophoretic shift assay ( EMSA ) . We p</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97207294' target='_blank'>97207294</a></td>
        <td style='text-align:right'>ducers and activators of transcription 6 ( STAT6 ) tyrosine phosphorylation and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA binding</mark>
        </td>
        <td> activity in X-SCID B cells with a wide range of gammac mutations. However, reco</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97207294' target='_blank'>97207294</a></td>
        <td style='text-align:right'>ith gammac enhanced IL-4-mediated responses including STAT6 phosphorylation and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA binding</mark>
        </td>
        <td> activity and resulted in increased CD23 expression. Thus, gammac is not necessa</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97263762' target='_blank'>97263762</a></td>
        <td style='text-align:right'>PS responsiveness. Gel electrophoretic mobility shift assay detected an induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> activity in these cells in response to LPS. Characterization of the DNA-binding</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97263762' target='_blank'>97263762</a></td>
        <td style='text-align:right'>DNA-binding activity in these cells in response to LPS. Characterization of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> protein by UV cross-linking, Southwestern blot, and antibody ablation / supersh</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97324097' target='_blank'>97324097</a></td>
        <td style='text-align:right'>id-specific transcription factor that belongs to the ETS protein family. It can </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">bind to DNA</mark>
        </td>
        <td> target sequences within a variety of cytokine genes. We demonstrate that Elf-1 </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98001571' target='_blank'>98001571</a></td>
        <td style='text-align:right'> EMSAs ) indicated that pyrrolidine DTC ( PDTC ) prevented NF-kappa B, and NFAT </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> activity in T cells stimulated with either phorbol myristate acetate plus ionop</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>Estrogen receptor diminishes </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> activities of chicken GATA-1 and-binding proteins. The estrogen receptor ( ER )</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>udy, we investigated the effect of ER alpha ( referred to throughout as ER ) on </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> activities of transcription factors involved in regulating the expression of er</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>bbit reticulocyte lysate. This lysate was also necessary for ER to diminish the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> activity of GATA-1. These results suggest that additional factor ( s ) are nece</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98089072' target='_blank'>98089072</a></td>
        <td style='text-align:right'>ted expression of erythroid-specific genes. We hypothesize that interference in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> activities of GATA-1 and-binding proteins is the mechanism by which the ER inhi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104462' target='_blank'>98104462</a></td>
        <td style='text-align:right'>LPS tolerance in monocytes / macrophages: three 3' cytosins are required in the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA binding</mark>
        </td>
        <td> motif for detection of upregulated NF-kappa B p50 homodimers. When monocytes ar</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98104462' target='_blank'>98104462</a></td>
        <td style='text-align:right'>in LPS tolerant cells is dependent on subtle differences in the sequence of the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA binding</mark>
        </td>
        <td> motif. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'> transcriptional activator functions AF-1 and AF-2, or AF-2 only, or the entire </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> domain, were introduced into erythroid progenitor cells via recombinant retrovi</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D98400423' target='_blank'>98400423</a></td>
        <td style='text-align:right'>nt interfering deltaDNA-binding domain RXR, containing a deletion of the entire </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> domain, was incompatible with erythroid cell growth in vitro, suggesting a pivo</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99007236' target='_blank'>99007236</a></td>
        <td style='text-align:right'>Inhibition of RNA polymerase II transcription in human cells by synthetic </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> ligands [see comments] Sequence-specific DNA-binding small molecules that can p</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99007236' target='_blank'>99007236</a></td>
        <td style='text-align:right'>n human cells by synthetic DNA-binding ligands [see comments] Sequence-specific </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> small molecules that can permeate human cells potentially could regulate transc</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99007236' target='_blank'>99007236</a></td>
        <td style='text-align:right'>s potentially could regulate transcription of specific genes. Multiple cellular </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> transcription factors are required by HIV type 1 for RNA synthesis. Two pyrrole</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99007236' target='_blank'>99007236</a></td>
        <td style='text-align:right'>r 1, and TATA-box binding protein. These synthetic ligands specifically inhibit </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA-binding</mark>
        </td>
        <td> of each transcription factor and HIV type 1 transcription in cell-free assays. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99207658' target='_blank'>99207658</a></td>
        <td style='text-align:right'>e cellular cytoplasm. When activated, glucocorticoid receptors form a dimer and </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">bind to DNA</mark>
        </td>
        <td> after migration into the nucleus. Interaction to DNA induces changes in the tra</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99305241' target='_blank'>99305241</a></td>
        <td style='text-align:right'>cts, and demonstrated its translocation to the nucleus, enhancement of specific </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FEEED; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">DNA binding</mark>
        </td>
        <td> capacity, and potentiation of trancriptional activity by GM-CSF. N-formyl-methi</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T89'>Term ID: <a href='terminology.html#L89' target='_blank'>89</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>monocytic cells and investigated the role of the signalsome proteins IKK-alpha, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FBDDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IKK-beta</mark>
        </td>
        <td>, NF-kappa B-inducing kinase ( NIK ) , IKK-gamma ( NF-kappa B essential modulato</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>ved induction of IKK activity with a 3-fold greater effect on IKK-alpha than on </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FBDDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IKK-beta</mark>
        </td>
        <td>, peaking at 5 min. In contrast, LPS predominantly stimulated IKK-beta activity,</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>a than on IKK-beta, peaking at 5 min. In contrast, LPS predominantly stimulated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FBDDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IKK-beta</mark>
        </td>
        <td> activity, which slowly increased, peaking at 30 min. A second peak was observed</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99386936' target='_blank'>99386936</a></td>
        <td style='text-align:right'>silon disappearance from and reassembly with the signalsome, whereas IKK-alpha, </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FBDDC; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">IKK-beta</mark>
        </td>
        <td>, and NIK remained complex-associated. NIK cannot phosphorylate Ikappa B-alpha d</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T86'>Term ID: <a href='terminology.html#L86' target='_blank'>86</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99310627' target='_blank'>99310627</a></td>
        <td style='text-align:right'>1 and erythropoietin cooperate to promote erythroid cell survival by regulating </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBB9B9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">bcl-xL</mark>
        </td>
        <td> expression. The transcription factor GATA-1 is essential for normal erythropoie</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99310627' target='_blank'>99310627</a></td>
        <td style='text-align:right'>oid cells, GATA-1 strongly induces the expression of the anti-apoptotic protein </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBB9B9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">bcl-xL</mark>
        </td>
        <td>, but not the related proteins bcl-2 and mcl-1. Consistent with a role for bcl-x</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99310627' target='_blank'>99310627</a></td>
        <td style='text-align:right'>cl-xL, but not the related proteins bcl-2 and mcl-1. Consistent with a role for </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBB9B9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">bcl-xL</mark>
        </td>
        <td> in mediating GATA-1-induced erythroid cell survival, in vitro-differentiated bc</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99310627' target='_blank'>99310627</a></td>
        <td style='text-align:right'> also required for erythroid cell survival, cooperates with GATA-1 to stimulate </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBB9B9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">bcl-xL</mark>
        </td>
        <td> gene expression and to maintain erythroid cell viability during terminal matura</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99310627' target='_blank'>99310627</a></td>
        <td style='text-align:right'>ythroid cell viability during terminal maturation. Together, our data show that </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBB9B9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">bcl-xL</mark>
        </td>
        <td> is essential for normal erythroid development and suggest a regulatory hierarch</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99310627' target='_blank'>99310627</a></td>
        <td style='text-align:right'>al for normal erythroid development and suggest a regulatory hierarchy in which </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BBB9B9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">bcl-xL</mark>
        </td>
        <td> is a critical downstream effector of GATA-1 and erythropoietin-mediated signals</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T64'>Term ID: <a href='terminology.html#L64' target='_blank'>64</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99406845' target='_blank'>99406845</a></td>
        <td style='text-align:right'>rifugation methods with a purity of >90% and were cultured in RPMI 1640 medium. </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FACEAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Monocyte apoptosis</mark>
        </td>
        <td> was determined by four independent methods, including annexin-V staining, TUNEL</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99406845' target='_blank'>99406845</a></td>
        <td style='text-align:right'>CHO ) . Stimulation with different GC at therapeutic concentrations resulted in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FACEAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">monocyte apoptosis</mark>
        </td>
        <td> in a time- and dose-dependent manner. Necrosis was excluded by propidium iodide</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99406845' target='_blank'>99406845</a></td>
        <td style='text-align:right'>tudy to demonstrate induction of apoptosis by GC in human monocytes. GC-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #FACEAF; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">monocyte apoptosis</mark>
        </td>
        <td> may be partially mediated through effects on IL-1beta production. It is conceiv</td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T63'>Term ID: <a href='terminology.html#L63' target='_blank'>63</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99406845' target='_blank'>99406845</a></td>
        <td style='text-align:right'>s anti-inflammatory capacity are still unknown. In our study, we determined the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FAEBA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">induction of apoptosis</mark>
        </td>
        <td> by GC in human monocytes. Peripheral blood monocytes were isolated by density c</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99406845' target='_blank'>99406845</a></td>
        <td style='text-align:right'>ll as GC-induced inhibition of IL-1beta. This is the first study to demonstrate </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FAEBA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">induction of apoptosis</mark>
        </td>
        <td> by GC in human monocytes. GC-induced monocyte apoptosis may be partially mediat</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99406845' target='_blank'>99406845</a></td>
        <td style='text-align:right'> their anti-inflammatory capacity in various diseases, at least in part, by the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #9FAEBA; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">induction of apoptosis</mark>
        </td>
        <td> in monocytes. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T58'>Term ID: <a href='terminology.html#L58' target='_blank'>58</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D91164434' target='_blank'>91164434</a></td>
        <td style='text-align:right'>Glucocorticoid receptors on mononuclear leukocytes in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFBCEE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Alzheimer's disease</mark>
        </td>
        <td>. Several lines of evidence suggest disturbances of the hypothalamic-pituitary-a</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91164434' target='_blank'>91164434</a></td>
        <td style='text-align:right'>ce suggest disturbances of the hypothalamic-pituitary-adrenal ( HPA ) system in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFBCEE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Alzheimer's disease</mark>
        </td>
        <td> ( AD ) . In an exploration of the potential role of the glucocorticoid receptor</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91164434' target='_blank'>91164434</a></td>
        <td style='text-align:right'>s of the hypothalamic-pituitary-adrenal ( HPA ) system in Alzheimer's disease ( </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFBCEE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AD</mark>
        </td>
        <td> ) . In an exploration of the potential role of the glucocorticoid receptor ( GR</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91164434' target='_blank'>91164434</a></td>
        <td style='text-align:right'>n an exploration of the potential role of the glucocorticoid receptor ( GR ) in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFBCEE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AD</mark>
        </td>
        <td>, GR density and affinity were assessed on mononuclear leukocytes of 12 AD patie</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91164434' target='_blank'>91164434</a></td>
        <td style='text-align:right'> ) in AD, GR density and affinity were assessed on mononuclear leukocytes of 12 </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFBCEE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AD</mark>
        </td>
        <td> patients and 12 healthy controls. GR binding characteristics did not differ bet</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D91164434' target='_blank'>91164434</a></td>
        <td style='text-align:right'>inical features. These data suggest that the abnormalities of the HPA system in </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #CFBCEE; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">AD</mark>
        </td>
        <td> are not related to a GR deficiency. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T31'>Term ID: <a href='terminology.html#L31' target='_blank'>31</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>Cutting edge: TCR stimulation by antibody and bacterial superantigen induces </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEFD9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Stat3 activation</mark>
        </td>
        <td> in human T cells. Recent data show that TCR / CD3 stimulation induces activatio</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>o oligonucleotide probes from the ICAM-1 and IL-2R alpha promoter. CD3-mediated </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEFD9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activation of Stat3</mark>
        </td>
        <td> is almost completely inhibited by a Src kinase inhibitor ( PP1 ) , whereas IL-2</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>t completely inhibited by a Src kinase inhibitor ( PP1 ) , whereas IL-2-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEFD9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Stat3 activation</mark>
        </td>
        <td> is unaffected. In conclusion, we show that CD3 ligation by mAb and SE triggers </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99369970' target='_blank'>99369970</a></td>
        <td style='text-align:right'>uman CD4+ T cells. Moreover, we provide evidence that TCR / CD3 and IL-2 induce </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #DEFD9E; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">Stat3 activation</mark>
        </td>
        <td> via distinct signaling pathways. </td>
    </tr>
</table>
<br/><br/>
<h2 style='margin:0' id='T28'>Term ID: <a href='terminology.html#L28' target='_blank'>28</a></h2><br/><table border='0'>
    <tr>
        <td><a href='corpus.html#D96211859' target='_blank'>96211859</a></td>
        <td style='text-align:right'>n of transcriptionally active c-Fos / c-Jun AP-1 may contribute to the impaired </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BADD9A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activation of NF</mark>
        </td>
        <td>-AT. </td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97458245' target='_blank'>97458245</a></td>
        <td style='text-align:right'></td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BADD9A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-AT activation</mark>
        </td>
        <td> induced by a CAML-interacting member of the tumor necrosis factor receptor supe</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97458245' target='_blank'>97458245</a></td>
        <td style='text-align:right'>The CAML ( calcium-modulator and cyclophilin ligand ) protein is a coinducer of </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BADD9A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">NF-AT activation</mark>
        </td>
        <td> when overexpressed in Jurkat T cells. A member of the tumor necrosis factor rec</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D97458245' target='_blank'>97458245</a></td>
        <td style='text-align:right'>ctivation of the transcription factors NF-AT, AP-1, and NFkappa B. TACI-induced </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BADD9A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activation of NF</mark>
        </td>
        <td>-AT was specifically blocked by a dominant-negative CAML mutant, thus implicatin</td>
    </tr>
    <tr>
        <td><a href='corpus.html#D99118181' target='_blank'>99118181</a></td>
        <td style='text-align:right'>roteasome plays an important role in the inflammatory cascade by regulating the </td>
        <td style='text-align:center;width:1px;white-space:nowrap;'>
        <mark class="entity" style="background: #BADD9A; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">activation of NF</mark>
        </td>
        <td>-kappa B. Indeed, the availability of selective and orally active proteasome inh</td>
    </tr>
</table>
</html>